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General introduction 
Introduction 
Each individual organism has to protect itself against a large variety of infectious microbial 
agents, such as bacteria, fungi and parasites to prevent pathological damage and death. In 
vertebrates, defense mechanisms against foreign substances, antigens, have evolved in the immune 
system, which has two functional divisions: the 'innate' immune system and the 'adaptive' immune 
system. 
The 'innate' immune system is aspecific and acts as a first line of defense, mediated by cells from 
thc myeloid lineage and soluble factors like complement and lysozyme. The main function of the 
'innate' immune system is to avoid entering of micro or gall isms into the body and to clear it of killed 
pathogens. In contrast to the 'adaptive' immune system, repeated infection does not improve the 
resistance of the 'innate' immune system. 
If the first line of defense is defeated, the second line of defense, the 'adaptive' immune system, 
which is very specific and can develop memory to earlier accounted pathogens, is activated. The 
specific immune response is mediated by lymphocytes belonging to the B andlor T lineages (B and 
T cells). Both Band T cells express receptor molecules on their cell membrane, which specifically 
can bind antigens. The T ceH receptor (TCR) can only bind antigens if these are processed into small 
peptides, and presented by major histocompatibility complex (MHC) class I molecules on the 
surface of host cells and MHC class II molecules on the surface of antigen presenting cells. 
Intracellular antigens are processed into small peptides and presented on the surface by the MHC 
class I complex. Recognition of the MHC-class I-peptide complex by the TCR of cytotoxic T cells 
results in killing of the presenting host cells. MHC class II molecules present processed peptides, 
which are derived from external clldocytosed antigens. Recognition of MHC class II-peptide 
complexes by the TCR ofT helper (T H) cells results in the production of cytokines and stimulation 
of cells of the immune system ('cellular' immune response). The B cell receptor (BCR) binds to 
unprocessed antigens. Stimulation of the BCR results in a 'humoral' immune response, i.e. the 
secretion of soluble immunoglobulins (Ig)J with the same binding specificity as the BCR to the 
triggering antigen. 
Ig molecules are composed of the unique combination of two identical heavy (H) and two 
identical light (L) chains. Both the Hand L chains have a constant amino acid sequence at their 
carboxyl teoninal region (C region), which mediates effector functions, such as membrane 
expression, complement binding and binding to other cells of the immune system. The amino 
tetminal end contains regions that vary in their amino acid sequence (V region). The amino acid 
variability of V regions is not distributed evenly throughout the length of these regions. In both H 
and L chain V regions three hypervariable regions, also referred to as complementary detennining 
regions (CDR), arc separated by intervening framework regions (FR). V region CDRs arc the 
antigen binding segments in the Ig. In Fig. I, a schematic representation of an Ig molecule is given. 
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ANTIGEN BINDING 
EFFECTOR FUNCTIONS 
Figure 1. Diagram of alZ Ig molecule. Two idelltical heavywc/zaill (H) and two idell!icallighl-chaill 
(L) polypeptides pair 10 form two idelllical antigen-binding sites, The VII. D. CR. V v JL ami CL 
domains are shown; the !tillge region is represellted by H, disulfide-bridges by -sSw. The 
approximate /ocaliol1s of the CDR alld FR relative to VH, D, Jy• VL alld JL are shown by different 
shadings 011 the left alld right respectively, of the molecule. 
B cell development in the mouse 
B cell development is a highly regulated process of ordered events. During this process, a podl of 
B celJs is generated, in which each B cell expresses one specific non-autoreactive Ig with a maxinlai 
affinity to a particular antigen. FurthemlOre, to protect the individual against a large variety of 
pathogens, the B cell repertoire has to be as diverse as possible. B cell development in mammals can 
be divided into two phases. The first, antigen-independent, phase is found in the fetal liver and bone 
marrow and involves differentiation of haematopoietic stem cells to B cells expressing a unique Ig 
on their membrane. After successful Ig assembly, B cells migrate out of the bone marrow into the 
peripheral lymphoid tissues. During the second, antigen·dependent, phase recognition of a specific 
foreign antigen may result in selective expansion and differentiation of the resting B cells into Ig-
secreting plasma ceHs or into memory B cells. 
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B cell development illlhe bone marrow 
B cell differentiation in the bone marrow was originally characterized by sequential V(D)J 
recombination of the Ig loci and expression of the Ig Hand L chains. In the mouse. B cell 
differentiation models have been developed using cell surface markers. such as CD45RfB220, 
CD43, HSA, BP-1, c-kit or interleukin-(lL)-2 receptor and cell size (Osmond, 1990, Hardy el al., 
1991, Melchers and Rolink, 1995). Despite much progress in elucidating the cellular stages ofB cell 
development, diverse phenotypic criteria and tenninologies are being used, which hanipers the 
comparison of experimental data, even when describing the same process. Here, we use the B cell 
differentiation model of Osmond et al. (1990) depicted in Fig. 2, whereas the corresponding B cell 
stages according to Hardy el al. (1991) and Melchers and Rolink (1995) are given in parentheses, 
respectively. B cell development in human shows remarkable parallels, as was recently reviewed by 
Ohio el al. (1998). 
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Figure 2. Lillear scheme of the B cell differentiatioll pathway, giving all oVel1'iew of the temporal 
e.\pressioll of the (pre-)BeR componellt molecules, sur/ace markers molecules and the 
rearrangement status of the 19H and L ehaill eompollellts. Differelltiation blocks result from 
(partial) deletion of murine genes elleoding esselltial/rauseriptioll factors (Pm'-5, Urballek et al., 
1994, NIIII el (1/" 1997), Ihe ),,5 gelle (Kitamllra el al., 1992), proleills alld DNA regiolls, lIecessa!)' 
Jar receplor gelle recombillatioll (RAG-I, Mombaerls el al., 1992, RAG-2, Shillkai el al., 1992, CE, 
HiramalslI el al., 1995, C, Chell el al., 1993, ZOIl el al., 1993, Jg Chell el al., 1993, Ehlich el al., 
1993), signalillg elemellts (Syk, 19a, Torres et al., 1996, Turner et al., 1995, /g, Gong alld 
Nussellzweig, /996) and membrane exon of the H chaill (tl1l~l Kitamura et al., J99 J). 
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The earliest cells which are committed to the B cell lineage are the early pro~B cells (fraction A, 
pro-B/pre-B-I), which constitute 1% to l.5% of the total BM B-cell population and have all 19 loci 
in genn~line configuration (~(L). However, not all cells within the early pro~B cell fraction are 
committed to the B cell lineage. About 20% to 40% of the cells in this fraction co~express in 
addition to the B cell markers B220 and CD43, also the NKl.l surface molecule, but lack VpreB, 
19-p and CD 19 expression (Rolink e/ al., 1996). These cells develop into natural killer (NK) cells. Li 
et 01. (1996) recently reported that cells with B lineage potential fonn a subpopulatioll within the 
early pro~B cell fraction, which is characterized by the expression ofthe surface marker AA4.l. 
Ig H chain V(D)J recombination is initiated at the B220+ CD43+ !l-C intennediate pro-B cell stage 
(fraction NB, pro-B/pre-B~I), characterized by the upregulation of HSA expression. In this stage 
15% of the cells are in S or G21M phases (Lin and Desiderio, 1995).lg H chain loci (Fig. 3) become 
accessible for recombination of a D (diversity) to a JUoining)H segment followed by the fusion of a 
V(variable)H gene segment to the pre-existing DJH segment at the late pro~B cell stage (fraction C, 
pro-B/pre-B-I). In this V(D)J recombination process anyone fonn of an array ofVH gene segments 
can be joined to one of many D and JH gene segments to generate CDR encoding antigen-binding 
domain of the Ig, which is then located close to the constant region encoding genes of the H chain 
(CH). Murine B cells lacking 19-13 expression are blocked at the intennediate pro-B cell stage, 
characterized by the presence of D to JH but absence of VH to DJn rearrangements (Gong and 
Nussenzweig, 1996). 
Productive 19 f-l rearrangement is monitored by the expression on the surface of a f.l·pseudo-L 
chain complex (pre-BCR)(Karasuyama el al., 1990) and coincides with the transition to a large 
rapidly cycliug pre-B cell stage (fraction C', large pre-B-II). This cell stage is characterized by 
downregulation of CD43 and recombination activating gene (RAG) expression and upregulation of 
HSA expression. The pseudo L chain consists ofA5 and Vpre-B gene encoded proteins, homologous 
to J).-C). and V). respectively (Kudo e/ al., 1987, Bauer e/ al., 1988, Sakaguchi ef al., 1986, Piliai ef 
al., 1987, Hollis e/ al., 1989) and is thought to have a chaperone function in expressing the 19 fl 
chain on the cell membrane. 
Expression of the pre-BCR plays a critical role in the transition from the pro-B to the large pre-B 
cell stage. Dismption of RAG-I or RAG-2 expression (Mombaerts e/ al., 1992, Shinkai e/ al., 1992) 
prevents the fonnation and expression of a pre-BCR and results in an arrest at the transition from 
pro-B to pre-B cells. A developmental blockade was observed at the same stage in mice with a 
mutation in the membrane exon ofthe Jl chain gene (Kitamura ct aI., 1991), or a disruption of the 19 
JII gene segments (Chen e/ al., 1993, Ehlich e/ al., 1993) or A5 gene (Kitamura ef al., 1992), 
preventing membrane deposition of the pre-BCR. However in the latter case, the block appeared to 
be leaky, leading to the development of a small number of functional B cells. Signaling through the 
pre-BCR results in a feedback inhibition ofH chain V(D)J recombination to ensure the expression of 
the functionally rearranged 19 H chain locus, whereas the other allele, often still in D-Ju or gemlIine 
configuration (Alt et al., 1984) is not expressed, a phenomenon called 'allelic exclusion' (Storb et 
aI., 1994). 
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After an interleukin (IL)~7 dependent proliferative expansion, in which 70% of the cells are in S 
and G2IM phase (Karasuyama e/ al., 1994, Rolink e/ al., 1994), the Il+L-CD43"·large pre-B cells 
leave the cell cycle to become J.1 +LTD43- resting small pre-B cells (fraction D and small pre-B-II). 
Within this population less than 5% of the cells are in Sand G2/M phases. At this stage RAG 
expression is upregulated (Grawunder et al., 1995), followed by the initiation of Ig L chain 
rearrangements. In mammals, only two isotypes of L chain are produced, IgK and IgA. In mice the 
IgK locus consists of several hundred V K gene segments, five JK gene segments and one CK gene 
segment. In the IgA system there are four C/.. genes, each with its own lA, gene and two VA genes 
(Fig. 3). Ig L chain gene assembly at the K locus nonnally precedes rearrangements of the A locus 
(Hieter e/ al., 1981, Zeu e/ al., 1993). In the majority of B cells and B cell lines K loei are 
rearranged, while the A loci are still in their geml-line configuration leading to a 20-fold 
overrepresentation of K+ B cells in mice (McIntrie et al., 1970, Zou et al., 1993). However, IgA 
rearrangement does not require rearrangement of the IgK locus. A small fraction of progenitor B 
cells rearrange IgA.- before IgK (Zou et aL, 1993) and in mutant mice, unable to rearrange their IgK 
locus, the Ig/.. locus is rearranged with an increased efficiency (Takeda et al., 1993). Downstream of 
CK there is a K-deleting element (Kde) known to be involved in deleting the K genes in those B cells 
which rearranged their Ig/..locus (Siminovitch et al., 1985). 
Expression of a complete Ig, rearranged Hand L chain at the IgM+ immature B cell stage 
(fraction E) is accompanied by a decrease in the expression ofVpre-B, A5, RAG-l and RAG-2 (Li et 
al., 1993) and ensures allelic exclusion, which, in the case of IgK and IgA chains, is called isotype 
exclusion (Rajewsky, 1996). With the acquisition of antigen specificity, maturing B cells pass 
through a tolerance-susceptible stage (Goodnow et al., 1995) in which IgM1oWIgD- cells undergo 
nested L chain rearrangements (receptor editing) and the more developed IgMhighIgD- cells acquire 
sensitivity to apoptosis upon auto-antigen binding (Tiegs e/ al., 1993, Melamed e/ al., 1988). B cells 
that do not bind auto-antigen acquire differentiation markers on their cell surface, such as IgD, 
CD2l and CD23, and migrate out of the bone marrow to colonize peripheral lymphoid organs 
(fraction F). 
A crucial aspect of V(D)J recombination regulation is its target specificity. H chain 
rearrangements precede L chain rearrangements and both occur only in B lymphocytes. It is now 
thought that enhancers have a clear function in positioning DNA binding proteins (Serwe and 
Sablitzky, 1993, Takeda e/ al., 1993, Xu e/ al., 1996) and in DNA methylation, thereby affecting 
DNA accessibility (Lichtenstein et al., 1994). Immediately upstream of each gennline VH and VL 
segment, a transcriptional promoter is located. High~level expression from the promoters of 
rearranged VB and VK genes depends on the activity of the intronic IgH enhancer (E~l) and the IgK 
intronic enhancer (EK) elements, respectively. These enhancers are located within the J-C intron 
regions (Blackwell et al., 1989). Powerful enhancers have also been identified downstream of the 
Ca, CK and C)' genes: the EH3' (Pettersson e/ al., 1990), the IgK3' (Meyer and Neuberger, 1989) 
end the A enhancer (Blomberg et al., 1991) respectively. Hiramatsu and co-workers (1995) showed, 
using transgenic substrates, that the IgK3' enhancer contained a suppressive element that controls 
stage and celt type specific IgK gene rearrangements. Possibly, these enhancer elements are able to 
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locally open the chromatin structure giving access to the recombination machinery (Stanhope-Baker 
e/ al., 1996), It has been reported that low level transcription of unrearranged Ig gene segments 
(gennline transcription) usually precedes V(D)J recombination (AU et at., 1987, Yancopoulos et al., 
1986, Schlissel and Baltimore, 1989). Whether this is a consequence of the open chromatin struchlre 
or whether it may also enhance DNA accessibility is not clear yet. In comparison, gcnnIil1c 
transcription plays an important role in targeting the IgH class switch recombination. Class 
switching is directed to distinct classes by cytokines, which induce transcription of the targeted 
DNA sequences. These transcripts are processed, resulting in spliced 'switch' transcripts. Switch 
recombination can be directed to IgGl by the heterologolls human metallothionein IIA promoter in 
mutant mice. Induction of the stmcturally conserved. spliced switch transcripts is sufficient to target 
switch recombination to IgGl, wheras transcription alone is not (Jung et al., 1993). 
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Figure 3. Schematic diagram of murine IgH and IgL gelles. Recombil1ase-recoglli!ioll sites are 
depicted by triangles, class switch sequences are represellted as hate/led circles. 
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Enzymes involved in regufation of V(D)J recombination 
V(D)J recombination is a process in which both Band T cells make double strand breaks in their 
somatic DNA. The generation of double strand breaks has to be a tightly regulated process and many 
enzymes are involved. The cis acting elements in the recombination process are the recombination 
signal sequences (RSS), which consist of a heptamer and a nonamer separated by a spacer of either 
12 base pairs (on the 3' end) or 23 base pair (on the 5' end). These RSS fonn hairpin stmctures, in 
which a RSS with a 12 base pair spacer can anneal to a complementary RSS with a 23 base pair 
spacer, looping out the intervening sequences. Van Gent el af. (1995) were the first to show in a cellM 
free system, that lymphoid specific proteins, encoded by the RAGM 1 and -2 genes, were sufficient to 
catalyze DNA cleavage at RSS in a two step mechanism. In the hairpin structure the 3'OH end, 
generated by the nicking of DNA at the heptamer sequence of the RSS, attacks the phosphodiester 
bond of the antiparaUel strand, thereby releasing the hairpin signal ends from the hairpin coding 
ends (Van Gent e/ al., 1996). Others (Hoim e/ (II., 1997, Grawunder e/ al., 1997a), have shown that 
nicking and double strand cleavage at RSS occurs in a stable complex of DNA with the RAG 
proteins, which disassembles after completion of the reaction. Although RAGM 1 and M2 by 
themselves are able to achieve the DNA cleavage, the efficiency of the reaction is enhanced by other 
nuclear components, like DNA bending high mobility group proteins (HMG)M 1 and 2 (Sawchuk el 
al., 1997, Van Gent e/ al., 1997). 
After the cleavage step, the hairpilll1ed coding end must he opened to aHow further processing 
and DNA double strand break repair. Enzymes known to be involved in hairpin opening and 
modification are DNAMdependent protein kinase (DNA-PK), a heterodimeric complex of Ku70 and 
Ku86, and possibly the RAGMI and M2 proteins themselves. DNAMPK is probably involved in 
phosphorylating endonucleases, which might be the RAG proteins, to activate them to open the 
hairpin. In the natural occurring mutant mouse strain with severe combined immunodeficiency 
(SCID) (for review see Bosma and Carroll, 1991), due to a defect in the gene coding for DNA-PK, it 
was demonstrated that coding end structures could not be opened (Roth et af., 1992). The generation 
of Ku70M and Ku86Mdeficient mice demonstrated that the heterodimeric complex of Ku70 and Ku86 
is involved in the fomlation of coding and signal joints (Zhu et af., 1996, Nussenzweig et af., 1996). 
It has been proposed by Gottlieb e/ af. (1993) that the Ku70/86 complex served as a binding site for 
DNA-PK. However, in Ku70·deficient mice, low levels of nomlal codingMjoint formation occurs, in 
contrast to mice with defects in DNA-PK, which makes this model less attractive. In addition to the 
DNA-PK stimulating role (Gottlieb et af., 1993). an additional role for the Ku 70/86 complex in 
replacing the RAG proteins from the signal ends and thereby allowing their ligation was proposed 
(Zhu e/ al., 1996). 
After the hairpins are opened, the four DNA ends are modified by other enzymes. To increase the 
genetic variability of the Ig, tenninal deoxy transferase (TdT), which is lymphoid specific, can add 
nucleotides to coding and signal ends independent of the template. The coding ends, but not the 
signal ends, could also be subject to nucleotide loss due to the action of yet unidentified llucleases. 
Most likely, the signal ends are protected from nuclease but not TdT activities (Agrawal et al., 1997) 
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in a complex where all four ends are close to each other. This would also explain the occurrence of 
the so-called hybrid joints, in which a signal end is coupled to a coding end (Lewis et aI., 1988). The 
coding ends are then subject to alignment over a very short region of homology. A possible role for 
the flap endonuclease (FEN)-l, which removes 5' excess DNA, and polymerase 13, which fills in 
DNA gaps, have been proposed in this reaction (Grawunder et al., 1997b), although this is as yet not 
clear. The blunt signal and the aligned coding ends are then ligated together by a complex fonned by 
XRCC4 and DNA ligase IV (Grawunder e/ al., I 997b), although others believe it is DNA ligase I, 
which fonns a complex with ERCC4, is responsible for the ligation (Ramsden, et aI., 1997). 
B cell dijferellliatioll ill the periphery 
Most newly produced IgM+IgD- B cells from the bone marrOW migrate via the blood stream into the 
B cell areas of the spleen and lymph nodes. The spleen is an important lymphoid organ, involved in 
immune responses against all types of antigen that appear in the circulation. Its complex anatomical 
organization, with distinct compartments containing specialized cell types, provides a micro-
enviromllent which allows different cell-celt interactions and detennilles the direction of developing 
immune responses (Van den Eertwegh et al., 1992). Many of tile new B cell emigrants fail to receive 
a positive selection signal in the spleen and die within a few days (Allman et al., 1993). The small 
subset of B cells that is positively selected, enters the primary B cell follicles and become 
recirculating B cells, characterized by the upregulation of the anti~apoptotic protein bcl-2 levels and 
membrane IgD expression and downregulation of heat stable antigen (liSA) expression (Allman et 
al., 1993, Hardy e/ al., 1995, Best e/ al., 1995). In addition to B cells, the B cell follicles contain a 
variety of stromal celis, like follicular dendritic cells (FDC), which may produce factors needed for 
the chemoattraction (Foster el al., 1996) of B cells into the follicle and for upregulating proteins 
such as bcl-2. As these survival factors are limited, migration into these follicles of newly produced 
B cells is inhibited by the presence of follicular B cells. Recirculating B cells migrate between the 
follicles of secondary lymphoid organs and have an average life-span of 6 weeks (Fulcher and 
Basten, 1997) 
B cell activation of all types of antigen, i.e. T cell independent (TI) type I and II and T cell 
dependent (TD), leads to accumulation ofB cells in the outer T cell zone (Van den Eertwegh et al., 
1992, Claassen e/ al., 1986, Liu e/ al., 1988, 1991, Jacob e/ al., 1991). In response to TI-I 
(lipopolysaccharide) and TI-II antigens, proliferating B cells undergo plasma cell differentiation 
within the outer T cell zone or red pulp, but follicular B cell proliferation is moderate. In the primary 
response to a TD antigen, B cells take up, process and present antigen to T H cells in the outer T cell 
zone. Co-stimulation of T Hand B cells is mediated by CD40-CD40L and CD86-CD28 interactions 
(Faehetti e/ al., 1995, Van Essen et al., 1995, Grewal e/ al. 1995, Ferguson e/ al., 1996). Cognate 
interaction with antigen specific T H cells results in either the formation of foci of antibody-
producing plasma cells in the outer T cell zone or the migration to a network of FDC in B cell 
follicles where they fomt genninai centers (GC). Failure of T wB cell interaction leads to B cell 
apoptosis within a few days (Cyster e/ al., 1995). In the dark zone of the GC, the .ctivated B cell 
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immigrants differentiate into centroblasts, characterized by high proliferation rates. During this 
proliferation phase, affinity maturation of the Ig occurs due to random somatic mutations in the Ig H 
and L chain V regions (Jacob et al., 1991). Centroblasts then migrate into the GC light zone and 
differentiate into centrocytes. In the GC light zone FDC have sequestered antigens in the fonn of 
immune complexes via their complement receptors. Only those centrocytes with a BCR that has a 
higher affinity than the original antibody can bind to the antigen bound by the FOC. The mechanism 
of rescuing the B cell by the FDC is not clear yet, but probably involves interaction though adhesion 
molecules (Lindhout el al., 1993). Competition for antigen and subsequent rescue from apoptosis 
provides a mechanism for selection ofB cells with high affinity BCR, whereas B cells bearing lower 
affinity BCR due to the somatic mutations are deprived from FDC mediated rescue and go into 
apoptosis. Rescued B cells retrieve antigen from FOC and present them on the MHC class II 
molecules to antigen-specific OC T cells. Recent experiments have shown that the syk tyrosine 
kinase, an effector of the BCR signal transduction pathway, is also involved in the presentation of 
peptide-MHC-II complexes. (Lankar el al., 1998). If the T cell recognizes the processed antigen-
MHC-II complex it will express CD40L and cytokines, including IL-4 and IL-IO (Butch ef al., 1993, 
Ledennan et al., 1992, Casamayor-Palleja el al., 1995) which initiate Ig isotype switching (Malisan 
ef al., 1993). In mice the CH locus contains CI.t, C6, Cy3, Cy1, Cy2b, Cy2a, Co, and Ca genes which 
detemline the Ig isotype class; IgM, IgD, IgG3, IgGl, IgG2b, IgG2a, IgE and IgA respectively. An 
activated B cell can join the V(D)J-rearranged region of the H chain to different constant region 
genes, allowing the generation of different effector functions. In addition CD40L binds to CD40, 
expressed on the B cell surface and mediates downregulation on the Fas/CD95 apoptosis pathway 
(Rathmell et al., 1996). The positively selected centrocytes then differentiate into plasma cells or 
into memory cells, which wiIljoin the recirculating lymphocyte pool (Lilt et al., 1991) 
B cell populatiolls 
Based on the cell surface phenotype, anatomical localization and developmental characteristics, 
murine B cells can be divided into three subpopulations: B-la, B-lb and B-2 (conventional) B cells. 
B-1 cells are derived -from progenitor cells in the omentum and fetal liver, and are characterized 
by a self-renewal mechanism from mature B-1 cells, whereas de 110)'0 generation is temlinated in 
post natal life (Lalor et al., 1989). The B-1 subpopulation can be subdivided into B-1a and B-lb 
populations based on two key differences. Firstly, in contrast to B-Ib, B~la cells express the 
glycoprotein COS on their cell surface. Secondly, upon bone marrow transplantation from adult 
mice to irradiated recipients, B·lb cell levels are reconstituted to half the nonnal size, whereas B-la 
cells remain absent (Kantor el al., 1992). B-J cells are predominantly found in the adult peritoneal 
and pleural cavities (Hayakawa el al., 1985, Kroese et al., 1992) and generate a large percentage of 
the IgA-producing plasma cells in the gut (Kroese et al., 1989). A detailed description of the origin 
ofmmine B-1 cell lineages is given in Herzenberg and Kantor (1993). 
B-2, or conventional B cells derive from the fetal liver and bone marrow in adult life and are 
characterized by a constant de novo synthesis from progenitor cells in the bone marrow during post 
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natal life. Conventional mature B cells are predominantly located in the secondary lymphoid organs, 
like spleen, lymph node and Peyers patches. 
X-linked agammag1ob!JJiucmiil 
Studies on natural occurring inununodefi.ciency diseases have given us mor~ insight into 
lymphocyte development. Most of the 50 gen.etic immunodeficiencies recognized safar, show an 
autosomal recessive mode of inheritance (Rosen et al., 1997, Stielml., 1993), affecting only one 
generation within a pedigree. In about 70-80% of the cases, patients are males (Conley et al., 1994). 
reflecting the fhct that a sQbstantial fraction of the best characterized immunodeficiencies are 
inherited on the X chromosome. Due to the X-linked mode of inheritance, affected males are not 
confined to one generation within a pedigree. making the X-linked immunodeficiency diseases to 
the most prevalent ones. Immunodeficiency diseases which have been mapped to the X-chromosome 
are: X-linked severe combined inununodeficiency (XSCID), X-linked hyper-IgM syndrome, 
Wiskott-Aldrich Syndrome (WAS), X-linked lymphoproliferative syndrome (XLP), Properdin 
deficiency (PD), X-linked chronic granulomatous disease (X-CGD) and X-linked 
agalllmagiobulinemia (XLA). The genes responsible for these X-linked immun04eficiency diseases 
have been identified using various appro~ches, including positional cloning (Table 1). 
Table 1. X-linked immunodeficiencies 
Disorder Locus Cells affected Gene designation References 
X-CGD Xp21 Gr(\nulo~ytesJ Monocytes Gp91-pho~ /-3 
PD Xpll Macrophages/Complement Properdin 4,5 
WAS Xpll Platelets, TIB lymphocytes WASP 6,7 
Gran~tlocytes, Monocytes 
XLA Xq22 B lymphocytes Btk 8,9 
X-linked Xq26 T -B lymphocyte interaction CD40 ligand 10-14 
hyperlgM 
XLP Xp25 TIB lymphocytes SAP/SH2DIA 15 -17 
XSCID Xq13 TIB lymphocytes IL-yc receptor 18,19 
References: 1: Dinauer et al., 1987,2: Smith et al., 1991,3: Teahan et al., 1987,4: Groundis el al., 
1988, 5: Nolan el ai., 1991,6: Deny el ai., 1994,7: Nonoyama and Ochs, 1998,8: Tsukada el ai., 
1993,9: Vetrie el ai., 1993, 10: Allen el ai., 1993, 11: Korthauer el ai., 1993, 12: DiSanto el ai., 
1993, 13: Amffo et ai., 1993, 14: Ramesh el ai., 1993, 15: Skare el ai., 1987, 16: Sayos el al., 1998, 
17: Coffey el ai., 1998, 18: Noguchi el al., 1993, 19: Sugamura el al., 1996. 
Three out of 5 X-linked immunodeficiency genes that are involved in specific immunity, encode 
intracellular signaling molecules (XLA, XLP and WAS). 
Clil/;cal aspects of XLA 
XLA has an incidence of _5/106 (Sideras et al., 1995) and was the first humoral immunity 
disorder to be described. Bmton (1952) reported an 8-year-old boy, who had suffered from recurrent 
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bacterial infections since the age of 41/ 2 years and lacked detectable levels of senUll 
inununoglobulil1s due to a general inability to synthesize these antibodies. He further noted that the 
condition of the patient improved dramatically upon administration of gammaglobulins, showing a 
relationship between control of infection and gammaglobulins. 
Matemal antibodies levels, obtained by transplacental passage are protecting the patient against 
infections during the first months of life, but in the majority the onset of symptoms is within the 
first year of life (reviewed in Sideras e/ al., 1995). Patients suffer from serious recurrent pyogenic 
infections, in most cases confined 10 upper and lower ainvays, but meningitis, osteomyelitis, arhtritis 
and gastrovintestinal manifestations have also been reported (Ochs e/ al., 1980). \Vithoul treatment, 
patients die from these infections between 2 months and 5 years of age (reviewed in Sideras and 
Smith, 1995, Rosen et al., 1997, TiImners e/ al., 1991). Due to the therapy with antibiotics and 
gammaglobulins, the frequency of bacterial infection decreases, but there is only a weak 
prophylactic elTect (Mease el al., 1981, McKilmey el al., 1987, Hennaszewski el al., 1993). With the 
current treatment, patients can reach adulthood. However, substituted immunoglobulins do not reach 
the mucous membranes and most patients still suffer from chronic infectious diseases, leading in 
many patients to pulmonary failure in their third decade. 
Cellular aspecls oj XLA 
XLA is generally regarded as a block in B cell development at the level of the pre-B cell. Senllll 
Ig levels of all classes are vcry low or absent in XLA patients due to the lack of plasma cells in the 
secondary lymphoid organs. B cells are present in the periphery, although their numbers are severely 
rcduced and they exhibit an immature IgMhigh phenotype (Conley et al., 1985). In the bone marrow, 
pre-B cells expressing cytoplasmic Cj..l hut no surface Ig are present at Honnal or slightly decreased 
numbers (Pearl et al., 1978). Since hardly any surface Ig-positive B cells can be detected in XLA, 
the transition from the prcvB cell stage to later stages in B cell development is affected. However the 
developmental blockade at the prevB cell stage is not absolute and there is phenotypic heterogeneity 
among patients (Wedgwood e/ al., 1980, Krantman et at.) 1981, Landreth et al., 1985, Leikley et al., 
1986, Campana et al., 1990). To characterize the heterogeneity among patients and the relation to 
XLA severity, further analyses on BM samples of a larger group of patients with currently available 
tools for genetic analysis and recently found B celt markers is needed (Conley and Cooper, 1998). 
The XLA defect is intrinsic to B cells as was demonstrated by the unilateral X chromosome 
inactivation in XLA affected B cells of carrier females (Conley e/ al., 1986, 1988, Fearon e/ al., 
1987). In females, one of the two X chromosomes of somatic cells is randomly inactivated during 
early embryogenesis. The inactive state of the X chromosome is maintained in all progeny cells, 
leading to thc inactivation of one X chromosome in one half of the cells while the other X 
chromosome is active in the other half of the cells. In female XLA carriers, the precursor B cells 
having the defective XLA gene on their active X chromosome, will be arrested in differentiation, as 
is found in XLA affected males. No developmental arrest occurs in those B cells, that have the intact 
gene on the active Xvchrolllosome. As a result, XLA carriers manifest a B cell population with an 
13 
Chapter 1 
unilateral X chromosome inactivation pattem. Unilateral X chromosome inactivation was only 
demonstrated in the B cell population and not in other haematopoietic lineages such as T cells, 
monocytes and granulocytes. These findings showed that the XLA defect is intrinsic to and specific 
for the B cell lineage (Conley et al., 1986, Fearon et al., 1987). The X·chromosome inactivation 
pattems were used for genetic counseling to analyze XLA carrier status in females at risk (Fearon et 
al., 1987, Conley e/ al., 1988, Hendriks and Schuunnan, 1991). 
Genetics of XLA 
The gene affected in XLA patients was suggested to be localized on the X chromosome by the 
predominant occurrence of the disease in males (Janeway et al., 1953) and this narrowed the search 
for the gene to one chromosome. Using a series of DNA probes recognizing restriction fragment 
length polymorphisms (RFLPs) close genetic linkage was shown between the XLA gene and the X 
chromosome markers DXS 17 (S21) and DXS3 (p 119-2) at Xq22 (Kwan e/ al., 1986, Mensink e/ al., 
1986, Malcolm e/ al., 1987). The availability of flanking RFLP markers provided reliable methods 
for prenatal diagnosis and carrier detection in XLA pedigrees. No recombination of the XLA gene 
could be detected in over 100 meioses with DXSI78 (p212) in the Xq21.3-Xq22 region, setting the 
order of loci in this region: ccntromer-DXS3-(XLA, DXSI78)-DXS94-DXSI7-telomer (Guioli e/ 
al., 1989, Kwan el al., 1990). The 7cM ("'7Mb) of DNA, encompassing the region in which the 
XLA gene was located, was further narrowed by linkage analysis with two other polymorphic 
markers, DXS442 and DXSIOI (Lovering e/ al., 1993, Parolini e/ al., 1993, de Weers e/ al., 1992), 
reducing the XLA candidate region to 2 Mb of DNA. 
Isolation of the gene affected ill XLA 
The gene defective in XLA was isolated independently by two groups, using different approaches 
(Vetrie e/ al., 1993b, Tsukada e/ al., 1993). 
Vetrie and co~workers (1993b) used positional cloning to identify the gene. From a 5.2 Mb Yeast 
Artificial Chromosome (YAC) contig, a clone positive for DXS178 was chosen and used to enrich 
region~specific cDNA clones from libraries constmcted from B cell lines. In parallel, cosmid clones 
that hybridized to the Y AC were also isolated and used to construct a physical map ofthe Y AC. One 
of the isolated cDNA clones detected DNA point mutations in two unrelated XLA patients, 
indicating that the gene from which they were derived was the gene affected in XLA (Vetrie et al., 
1993b). The cDNA clone was sequenced and was found to encode a cytoplasmic tyrosine kinase. 
The same gene was isolated by Tsukada and co·workers (1993), who were primarily interested in 
isolating novel tyrosine kinases involved in B cell differentiation. Using the kinase domain of a 
previously isolated tyrosine kinase, Ltk, as a probe for a mouse B cell progcnitor cDNA library, they 
isolated a gene of which the corresponding human cDNA mapped to the Xq22 region, by fluorescent 
in situ hybridization (FISH). These findings, combined with expression studies in cell lines derived 
from patients, suggested that this gene was very likely to be the XLA gene. 
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The X-linked immunodeficiency phenotype is caused by a mutation ill the Btk gelle 
The CBNN mouse strain, carrying an X-linked immunodeficiency (xid), is characterized by a 
wide array of immune defects (reviewed in Scher et al., 1982). These mice have low levels of semm 
IgM and IgG3, whereas the levels of other isotype classes are Bonnal (perlmutter et al., 1979, Slack 
et al., 1980). Peripheral B cell numbers are moderately reduced and carry an immature phenotype 
(IgMhigh/lgDloW, Hardy et al., 1983), whereas the B-1 (CD5+) B cells are absent. Xid mice do not 
respond ill vivo to T cell independent class II (TI-II) antigens, typified by haptenated-Ficoll and 
other polysaccharide antigens, whereas T cell dependent (TD) responses are nonnal. Moreover, xid 
B lymphocytes responses to ill vitro stimuli, such as Ig receptor crosslinking, IL-5, lL-lO, CD38 and 
LPS are absent or impaired (Mond et al., 1983, Go et al., 1990, Hitoshi et al., 1993, Santos-
Argumcdo et al., 1995, Koike et al., 1995). Like XLA, also xid results from an intrinsic B cell defect 
as was demonstrated by X-inactivation studies in female mice heterozygous for the xiff mutation 
(Nahm et al., 1983, Forrester et al., 1987). The gene defective in xld was mapped to the mouse X 
chromosome, between the loci for phosphoglycerate kinase (Pgk-l) and the murine GLA gene (Ags) 
(Brown et al., 1993). Comparative mapping studies of the mouse and human X chromosome have 
shown that the mouse X chromosome containing the xid locus is highly conserved and shares 
homology to the human Xq21.3-Xq22 region, containing the XLA locus. The finding that xid and 
XLA map to the same conserved region of the mouse and human X chromosome, respectively, and 
the fact that both disorders are only affecting B cells, suggested that also xld phenotype could be 
caused by a mutation in the Blk gene. First, it was demonstrated that the Btk gene mapped to the xid 
locus (Thomas et al., 1993, Hendriks et al., 1994) and direct sequencing analysis demonstrated that 
the Btk gene in xid mice calTied a mutation converting the arginine residue at position 28 into a 
cysteine (R28C) (Thomas et at., 1993, Rawlings et at., 1993). Initially, the mild phenotype of the xid 
mice, compared to the human XLA phenotype, was explained by the fact that the R28C mutation 
was located in a non-catalytic domain of Btk that mediates protein-protein interaction and therefore 
had only moderate effects on Btk function. Predictions were made that the same mutations in the 
human Btk gene would also result in a mild phenotype (Vorechovsky et al., 1993). However, the 
identification of a mutation in the human Btk, converting Arg28 to a histidine and thereby affecting 
the same codon as is altered in xid did not result in a mild phenotype of the patients in one XLA 
pedigree (De \Veers et al., 1994a). This finding suggested that mice do not develop a phenotype as 
severe as the human XLA, and this was confinned by gene targeting experiments, resulting in a 
dismpted Btk kinase domain (Kahn et al., 1995, Chapter 2). In table 2 the features of XLA and xid 
are compared. 
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Table 2. Comparison of the phenotypes of human XLA and murinexid 
Studied phenotype XLA xid 
Early pre-B cells in bone marrow Nonnal Nonnal 
Peripheral B lymphocytes 
Rearrangement ofIg genes 
Inununoglobulin levels 
Phenotype of heterozygous 
female carriers 
X-inactivation pattern in 
female carriers 
Other haematopoietic 
lineages 
Absent or low 
(residual cells have 
IgM"'" phenotype) 
Nomlal 
All isotypes absent 
or low 
Nornlal 
Reduced and show 'immature' 
IgMhigh phenotype 
CD5 positive subset absent 
Nomlal 
IgM and IgG3 levels reduced 
No TI-II response 
Nonnal 
Non-random inactivation Non-random inactivation 
in B cells in B cells 
Unaffected, random 
X-inactivation pattern 
Unaffected, random 
X-inactivation pattem 
Genomic organization aud e.\pression of mouse and human Btk geJ/e 
The genomic organization of both Illurine and human Btk were detennined using mouse 129SV 
genomic lambda, PI phage clones and genomic cosmid clones (Sideras et al., 1994, HagmaIlll et al., 
1993, Ohta ef al., 1994, Rawlings ef al., 1993). In addition, 93 kb of the human region and 89 kb of 
the murine region, containing Btk and adjacent genes coding for several other proteins, such as u-
galactosidase (GLA), the ribosomal protein L44L, the RNA-binding protein FTP-3 and the 
deafiless/dystonia peptide (DDP) have been completely seqnenced (Oelijen ef al. 1997, GenBank 
accession no. U78027 and U58105, respectively). A physical map of the murine Btk loci is depicted 
in Fig. 4. The coding regions were divided into 19 exons, spanning approximately 43.5 kb in the 
mouse and 37.5 kb in humans. Whereas the 5'-UTR is encoded by the first exon and part of the 
second exon, exon 19 encodes 23 carboxyl temlinal amino acids as well as the 3'-untranslated 
region (3'-UTR). Immediately upstream of the non-coding exon I, multiple putative transcription 
start sites have been mapped. Sequencing of the human and murine Btk promoter region 5' of ex on I 
revealed that there were no obvious TATA or CAAT like motifs present, consistent with the 
presence of multiple transcription start sites, which is seen more often in TATA-Icss promoters 
(Geng et al., 1993, Travis el al., 1991, Matsuzawa et al., 1991). 
Btk expression was investigated in human, using culhlred cell lines, leukemias and peripheral 
blood samples (de Weers et al., 1993, Genevier et al., 1994, Smith e( al., 1994a, Futatanani et al., 
1998). In the mouse, Blk expression was analyzed in cultured cell lines, as well as ill vi\'O, by flow 
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eytometric analysis of LaeZ activity in a mouse with a targeted, in frame, insertion of a LacZ 
cassette in the Btk gene (Chapter 2) and intracellular flow cytometry (Chapter 4). Btk is expressed 
throughout B cell development, from the earliest pro-B celt stage up to mature B cells, except in 
plasma cells and not in T cells. Btk is also expressed in cells of the myeloid lineage, but is not 
required for myeloid differentiation, since cells from the myeloid lineage are not affected in XLA 
nor inxid (Sideras and Smith, 1995). 
Not much is known about the DNA elements that regulate the Btk expression. The tissue-specific 
and differentiation stage-specific expressiol1may, at least in part, be accomplished by -450bp of the 
Btk promoter region, which contains several binding sites for the transcription factors Sp I, Sp3 and 
PU.l (Himmelman et al., 1996, Mtiller et al., 1996). Although transient transfection experiments 
implicate PU.l as a major regulator, Btk expression is not abolished in fetal liver of PU.l-deficient 
mice ( ~1tiller el al., 1996). This implies that other elements may also be required in the absence of 
PU.l. Such clements, needed for appropriate Btk expression might be located further upstream or 
downstream of the promoter region. To date, the reported transfeetion studies have only focused on 
the -400 bp promoter region and do not address the question of the importance of the ill vivo 
chromatin structure for Blk gene expression. Recent large-scale sequencing studies which compared 
93 kb of the human sequence around Etk to 89 kb of the murine sequence in the same region 
(Oeltjen et al., 1997) revealed highly conserved intronic regions. The importance of the conserved 
regions was highlighted by an XLA patient with a mutation in a conserved region in intron one, 
containing an Spl binding site (Rohrer and Conley, 1998). 
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Figure 4. Scheme of the gellomic organization of the murine Blk gene. ExollS are represented by 
filled boxes alld numbered J to 19, EcoRi restriction sites are indicated as E. 
Blk protein 
Both murine and human Btk consist of 659 amino acid, showing 99.3% homology, and have a 
molecular weight of 77 kDa. Btk is a cytoplasmic Src-Iike protein tyrosine kinase (PIK) belonging 
to the Tee family of related tyrosine kinases, which is characterized by the absence of a N-tenninal 
myristylation site and a C-tenninal negative regulatory tyrosine residue and the presence of 
pleckstrin homology (PH), Tee homology (TH), src-homology (SH)3, SH2 and SH 1 domains 
(Rawlings e/ al., 1994, Smith e/ at., 1994b). In addition to Btk and Tee (Mano e/ at., 1990, 1993) 
other members of the Tec family are the T cell homologue Itk (Siliciano et al., 1992) and Bmx 
17 
Chanter 1 
(Tamagnone et al., 1994). The linear structure ofBtk is depicted in Fig. 5 and shows the different 
domains. 
The kinase domain (SH1), located at the C tenninal region, consists of about 250 amino acids and 
shares homology to the Src family of protein kinases. The SIfI region contains 9 invariant and 15 
highly conserved residues, involved in ATP binding and catalysis (Hanks et al., 1988, Vihinen et al., 
1994). To date, the only substrate associated with Blk ill vil'o, is the DNA~binding protein BAP-135 
or TFU-I (Yang ef al., 1997, Roy ef al., 1997, Gmeneberg ef al., 1997). PLC-y is likely to be another 
substrate ofBtk. BCR-induced tyrosine phosphorylation ofPLC-y is compromised in Btk~deficient 
DT40 cells (Takata et al., 1996), and in xid mice, the generation of inositol 1,4,5-triphosphate by 
PLC-y is decreased upon BCR crosslinking (Rigley el al., 1989), indicating a role for Btk in the 
pathway emanating from the BCR and proceeding downstream through PLC-y. Furthennore, ill vitro 
overexpression experiments show that participation in PLC-y activation is a general property of Tee 
kinases (Fluckinger ef al., 1998, Scharenberg ef al., 1998). 
Another region that shares homology to the Sre-family is the SH2 domain, located at the N-
tenllinus of the SHI domain. In Btk the SH2 domain includes about 100 amino acids. This domain 
is found in a large number of signaling molecules and is involved in the specific interaction with 
phosphorylated tyrosine residues of other signaling molecules (Songyang et af., 1993). SH2 domains 
have been shown to playa role in modulating enzymatic activity and in the recmitment by tyrosine 
phosphorylated signaling molecules (Cantley ef al., 1991, Walksman ef al., 1992). 
Next to the SH2 domain, the SH3 domain is located. It consists of about 60 amino acids. SH3 
domains were shown to bind to proline and hydrophobic stretclws in other proteins (Ren et af., 1993, 
Pleiman et aI., 1994a) and is like SH2 domains involved in locating signaling molecules to certain 
areas in the cell. Association of the Btk-SH3 domain with signaling molecules, such as the Src-like 
kinase Lyn (Cheng ef aI., 1994), the proto-oncogene p120,b1 (Cory ef al., 1995) and WASP (Yang ef 
01., 1995), the protein defective in the \Viskot-Aldrich syndrome and involved in cytoskeietal 
organization, have been demonstrated ill vitro, although the physiological significance of these 
interactions in unknown. 
The N-temlinal region contains a 100 amino acid long PH domain. Originally, the motif was 
identified in the protein kinase C substrate Pleckstrin. PH domains recmit signaling molecules to the 
cell surface through specific interactions with phospholipids and proteins important for the 
activation of these signaling molecules (reviewed in Lemmon e/ al., 1996). Direct interactions 
between the PH domain ofBtk and the py subunits ofG proteins and the «-subunit of the Gq class of 
G proteins have been demonstrated (Touhara e/ af., 1994, Tsukada et af., 1994, Bence et al., 1997), 
but the functional relevance in the Btk signaling pathway still has to be proven. Physical association 
of the PH domain of Btk with the calcium dependent protein kinase C (PKC) isofoTIus: a, PI and 
PH, as well as with the calcium independent isofofllls E and ~, have also been shown ill'vitro, 
whereas PKC-PI showed also in vivo association with Btk (Yao el af., 1994). Recently, membrane 
association of Blk by binding of the PH domain to inositol phosphates was shown (Salim et af., 
1996, Rameh et al., 1997). Moreover, Blk membrane association depends directly 011 PI(3,4,5)PJ 
levels (Bolland el af., 1998, Scharenberg e/ 01., 1998, see below). The R28C mutation in xid mice 
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was the first genetic evidence for the functional importance of this domain (Thomas et al., 1993, 
Rawlings e/ al., 1993). The importance of the PH domain was also demonstrated by the E41 K Btk 
gain-of-function mutant, isolated in a random mutagenesis scheme (Li et al., 1995), which showed 
an increased membrane localization and tyrosine phosphorylation when transfectcd into 3T3 
fibroblasts. The E41K Btk mutant induced growth of 3T3 fibroblast in soft agar cultures and 
relieved the IL-5 dependence ofpre-B cell line Y16. 
Between the PH domain and the SIB domain a stretch of about 70 amino acids is present and is 
called the TH domain as the domain was first identified in the Tee protein (Smith el al., 1994b). So-
far, this TH motif has only been identified in proteins belonging to the Tee t:1I11ily. The TH domain 
is divided into two subdomains, the Btk motif and a proline stretch. The Btk motif consist of a 
stretch of 27 conserved amino acids of which 7 are invariant. The function of tIils region is not yet 
clear. Next to the Btk motif a prolin stretch is present, which may serve as a binding site for SH3 
containing tyrosine kinases, like Fyn, Lyn and Hck (Cheng et al., 1994, Yang et aI., 1995). 
Interestingly, the SH3 domain ofBtk itself may bind to this prolin-rich region and in this way have a 
regulatory function (Smith et al., 1994b). 
Finally, adjacent to the PH domain the presence ofa Zn~finger motif has been detected (Hyvonen 
e( al., 1997). The function of this motifin Btk is unknown. However, its importance for Btk fUllction 
was demonstrated by a mutation in this motif resulting in XLA. 
The putative binding proteins to the individual Btk domains are summarized in Table 3. 
Table 3. putative binding partners for Btk and its domains 
Btk domain Binding proteins References 
PH PKC-a,pI,pII,s,t; isofonns Yao el al., 1994 
SH1 
SH2 
SH3 
TH 
G protein ~y-subunits Touhara et al., 1994, Tsukada e( al., 1994 
Gq protein a-subunit Bence et al., 1997 
nositol phosphates Salim et al., 1996, Rameh et al., 1997 
BAP-135ITFII-I Yang el al., 1997, Roy el al., 1997, 
pTyr proteins 
Lyn 
p 120,bI 
WASP 
Fyn, Lyn, Hck 
Grueneberg el al., 1997 
Cantley el al., 1991, Wa1ksman el al., 1992 
Cheng el al., 1994 
Cory el al., 1995 
Yang et al., 1995 
Cheng el al., 1994, Yang el al., 1995 
To date over four hundred mutations, including deletions, insertions, missense and nOll-sense, 
have been characterized in XLA patients distributed throughout the Blk coding region (Vihinen et 
al., 1998, http://w\Vw.helsinki.fIlscience/signallbtkbase.html). These studies showed that 
approximately one tlilrd of the human Blk mutations cause single amino-acid substihltiolls (Vihinen 
et al., 1997, 1998, Saha e( ai" 1997, Vorechovski el al., 1997, Haire et al., 1997, Brooijmans et al., 
1997, de \Veers el al., 1997, Gaspar et al., 1998, Futatani et al., 1998, Holinski-Feder et al., 1998). 
The amino-acid substitutions tend to cluster in the kinase domain, although they have been seen in 
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all other domains, except the SH3 domain. Remarkably, amino-acid substitutions often lead to the 
absence ofBtk (Futatani et al., 1998, Gaspar et al., 1998). There is no clear cOlTelation between Btk 
genotype and the severity ofthe phenotype ofXLA patients. 
PH 
138 
auto® 
Y223 
215 280 
Kinase 
377 
Lyn® 
Y551 
Figure 5. Linear strlicture of the Btk protein. Shown are the differellt domaills. The positi01ls of the 
E41K lIlutatioll alld the R28C xid 11If1tatioll are indicated. Numbers represellt the amino acid 
positiolls. The positions of tyrosine residues Y223 alld Y551, il1l'ob'ed ill Elk activation are shown. 
Regulatioll of Blk activatioll 
Btk activation is associated with an increased tyrosine phosphorylation and an increase in 
catalytic activity. Stimulation of the BCR induces tyrosine phosphorylation of Btk ill vivo, both in 
human B cell lines and tonsilar lymphocytes (De Weers et al., 1994b, Hinsheiwood et al., 1995) as 
well as in murine B cell lines (Saouf et al., 1994, Aoki et al., 1994) and is accompanied by an 
increase in its kinase activity ill vitro. Btk has also been shown to be phosphorylated and activated 
upon stimulation ofreceptors for IL-5 (Sato et al., 1994), IL-6 (Matsuda et al., 1995) in B cells and 
FcsRI in mast cells (Kawakami et al., 1994). Kinetic analyses of protein kinase activation in a 
murine cell line revealed that Src-like tyrosine kil1ases were activated immediately after BCR 
engagement, followed by the activation of Btk within minutes (Saouaf el al., 1994). Two tyrosine 
residues are important for activation of Btk. One tyrosine residue is located at amino acid position 
551 (Y551) in the catalytic domain and the second one, an autophosphorylation site, in the SH3 
domain at amino acid position 223 (Y223) (Fig. 5.). The role of the two tyrosine residues in Btk 
phosphorylation following stimulation of BeR, IL-5-receptor and FCER! were investigated using 
antibodies, specific for phosphorylated Y551 and Y223 (Wahl e/ al., 1997). Following receptor 
stimulation, Y551 was rapidly phosphorylated, accompanied by autophosphorylation of Y223 and a 
subsequent dephosphorylation ofY551 followed by dephosphorylation of Y223. Phosphorylation of 
the Btk SIB domain may playa role in the negative regulation ofBtk activation, as was indicated by 
the finding that additional Y223 to phelylalanine mutation or deletion of the SH3 domain further 
activated the transfonning activity of the E41K Btk mutant (Park et al., 1996). Src-like tyrosine 
kinases play important roles in phosphorylating Y551 of Btk as was shown in Btk-Lyn/Fyn co-
transfection experiments (Rawlings et al., 1996, Afar et al., 1996, \Vahl et al., 1997). Btk 
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phosphorylation was augmented by increased dosage of Lyn or Fyn, whereas co*expression of Btk 
with a kinase*inactive Lyn (K275G) did not result in an increase in Btk tyrosine phophorylation, 
placing Btk downstream ofLyn and Fyn activation. In contrast, co*expression ofBtk with Syk failed 
to increase Btk phosphorylation and activation (Scharenberg et al., 1995). 
Co*expression of Btk and PI3*K, which generates the membrane binding site PI(3,4,5)IP), 
also result in enhanced Btk phosphorylation (Li et al., 1997), suggesting that membrane targeting of 
Btk mediated by the PH domain, places Btk in proximity to Lyn, which like other Src-family 
members can bind via their SH3 domain to the Btk proline stretch (Cheng et al., 1994, Yang et al., 
1995), and thereby promoting Lyn*depelldent phosphorylation. The impOliance of this interaction 
was demonstrated by the impainnent of tyrosine phosphorylation of a kinase-inactive Btk with a 
point mutation in the TH domain that abolished binding of SH3 containing proteins (Yang et al., 
1995). Recmitment to the membrane seems to be important for Btk activation as is demonstrated by 
R28C (xid) and E41 K alterations of the PH domain leading to loss of function and activation of Btk, 
respectively (Salim et al., 1996, Ferguson et al., 1995). As the Btk PH domain can also bind inositol 
phosphates, py subunits of G proteins and PKC isofOlIDs, these interactions and those directed by 
other Btk domains may allow Btk to integrate membrane-targeting signals with those generatcd by 
Src-kinases-linked receptor activation. Membrane association and phophorylation of Y551 by Lyll 
appears to activate Btk by unblocking its catalytic site. Autophosphorylation of Y223 in the SH3 
domain may be an early target of the catalytic domain and may lead via further confonl1ational 
changes of Btk to the creation of binding sites for other signaling proteins known to interact with 
Blk. Similarly. phosphatases and phosphokinases, influencing Btk phosphorylation and activation 
may regulate interactions of Btk with other proteins. The phosphatase SHIP has been shown to 
reduce the levels of P(3,4,5)IP) and thereby decrease the membrane association of Btk (Bolland et 
al., 1998, Scharenberg et al., 1998), which is therefore the first pathway identified that, together 
with PI-3K, can specifically regulate Btk activity (Fig. 6). 
Signaling 
The B cell receptor complex (BeR) 
The BCR belongs to a class of receptors which includes the TCR as well as receptors for the Fc 
regions. Characteristic for thcse receptors is that they are multi component and that ligand binding 
and signal transduction are compartmentalized into distinct receptor units (Kurosaki et al., 1997). In 
the BCR, the ligand binding unit is the mcmbrane Ig. All Ig classes can be expressed on the 
membrane or be secreted, depending on differential mRNA splicing (\Vall et al., 1981). Membrane 
19 has only a short cytoplasmic part, and upon 19 crosslinking, intracellular signals are transduced by 
nOI1*covalently associated, disulfide liked hetcrodimers Ig~a and Ig-p (CD79o: and CD79P 
respectively, Rombach e/ a/., 1988). Ig-u (34 kDa) is encoded by the mb-J gene and Ig-p (38 kDa) 
by the B29 gene (Rombach e/ a/., 1990, Campbell e/ a/., 1991). The B29 gene is expressed 
throughout the B cell development whereas the mb-l gene expression is tumed off in plasma cells 
21 
Chapter 1 
(Fig. 3, Sakaguchi ef al., 1988, Hennanson ef al., 1988). Both Ig-a and Ig-p have one Ig-like 
extracellular domain, a 22 amino acid transmembrane part and a cytoplasmic domain of 
respectively 61 and 48 amino acids. The cytoplasmic domain contains a sequence motif of 
approximately 26 amino acids, which is named immnnoreceptor tyrosine based activation motif 
(IT AM) is characterized by six conserved amino acids in the sequence DlEx7DfExxYxxLIIx7 YxxLII 
(in single-letter amino acid code, where x represents any amino acid, Reth, 1989, Cambier, 1995). 
When a p mutant, unable to associate with Ig-a and Ig-Jl was introduced into RAG.J· mice, failures 
in signaling for allelic exclusion and a developmental blockade at the transition from pro- to pre-B 
cells was observed. The phenotype could be rescued by introducing chimeric molecules, consisting a 
fusion of the mutant p to the cytoplasmic domain of Ig-Jl and Ig-a (Papavasiliou et al., 1995a, 
1995b). However, in mice deficient for Ig-Jl, while still expressing Ig-a, a complete impainnent in B 
cell development was observed before the VII to DJH occurred (Fig. 3, Gong and Nussenzweig 
1996). In Ig-a tnmcated mice, lacking the ITAM, pre-B cells were present, but diminished by a 
factor of2 to 4, whereas the number of peripheral B cells was decreased to-fold (Fig. 3, Torres e/ 
al., 1996). These data suggest that, at least parts of, both Ig-a and Ig-p are required for the fonnation 
of an Ig-alIg-Jl heterodimeric complex, needed for signaling and/or membrane expression of the 
(pre-) BCR. It would therefore be interesting to see, at which stage B cell development is blocked in 
mice that completely lack Ig-a. 
The pre-BCR and BCR have critical roles in B cell development. Expression of a pre-BCR in 
early B cells are needed for maturational progression as has been demonstrated in mice models 
unable to express a pre-BCR (see Fig. 3) As this progress is thought to occur in the absence of 
foreign antigen, it is still not clear whether it is an (endogenous) ligand or expression of the pre-BCR 
by itself that stimulates progression to the more mature phases ofB cell development. Like pre-BCR 
expression is needed for early B ceU development, Lam and co-workers (1997) have demonstrated 
that expression ofa BCR is critical for later stages ofB cell development. Using Cre-LoxP mediated 
interferon inducible V H gene dismptioll, they created a mouse model in which the effect of the BCR 
could be investigated without disturbing pre-BCR mediated B cell development. Loss of the VH 
gene leads to a decrease ofBCR expression and apoptotic death. This presumably means that the B 
ceU must somehow continuously receive signals through the BCR in order to stay alive. Since not all 
living B cells are activated, the BCR must generate multiple signals or vary its signal strength in 
order to make a distinction between B cell maintenance and activation. 
BCR fl';ggered s;gnal transducUoll pathways 
Signals from the (pre-)BCR and co-receptors such as CDI9, CD22, CD45 and FcyIlB (see below) 
are integrated inside the cell allowing the B cell to react appropriately to a variety of stimuli. The 
biochemical events triggered by BCR and co-receptor engagement include the recmitment and 
phosphorylation of proteins and the subsequent activation of downstream signaling cascades. The 
most rapid event upon BCR crosslinking is the increased tyrosine phosphorylation and activation of 
8rc-family tyrosine kinases (Src-PTKs), including Lyn, Blk, Fyn, Lck and Fgr (Burkhardt et al., 
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1991, Yamanashi el al., 1992, \Vcchsler et al., 1995). IlIl'itro binding studies have shown that Lyn 
and Fyn are already associated with the amino~temlinal residues of the Ig~a chain from the non~ 
stimulated BCR (Pleiman et al., 1994). The activity ofLyn is regulated by the tyrosine kinase Csk 
and thc transmembranc phosphatase CD45, which can phosphorylate and dephosphoryJate the 
carboxyl~tenninal tyrosine residue ofLyn, respectively (Yanagi et al., 1996, Rata et al., 1994). The 
Sl-I2 domain of Lyn is thought to bind to its own phosphorylated tyrosine, Y527, leading to 
repression ofkillase activity (Cooper et al., 1993). The mechanism for initial Src~PTK activation is 
still not clear, but it is very likely that intennolecular phosphorylation of the autophosphorylatioll 
site in the catalytic domain is involved. Src~PTKs members are able to phosphorylate the two 
tyrosine residues in the IT AM domains ofIg~a and Ig~p. The phosphOlylated ITAMs provide a SH2 
binding site for Syk, but also for the Src-PTKs themselves. After binding the activity of Syk is 
greatly enhanced by phosphorylation. In addition Btk is phosphorylated by Lyn (Rawlings et al., 
1996). Src-PTKs, Syk and Btk are likely to contribute to the activation a variety of downstream 
signaling pathways. 
The three most studied pathways stimulated by PTK activation in BCR signaling are the 
phospho-inositidc hydrolysis, the Ras and the PI3~K pathway (Fig. 6). 
The phospho-inositide hydrolysis pathway (Fig. 6: A) was the first signaling cascade shown to be 
activated after BCR cross-linking. Syk, and probably Etk, are required for the activation 
phopholipase (PL)-C-y (Takata e/ at., 1994, 1996), which is involved the hydrolyses of membrane 
phosphatidylinositoi 4,5~biphosphate (PI4,5P2) to fOfIlI the second messengers diacylglycerol 
(DAG) and inositol 1,4,5-triphosphate (IP,) (Bijsterbosch e/ at., 1985). DAG is known to activate 
most of the protein kinase C (PKC) family. Substrates for PKC are the cA1vlP response element 
binding protein (CREB) transcription factor (Xie e/ al., 1995, 1996) and the G protein Ras, thereby 
activating the mitogen activated protein (MAP) kinase pathway (Gold el al., 1992). An isofonn of 
PKC, PKC~t. is shown to be able to phosphorylate Syk ill vitro and thereby decreasing its activation, 
suggesting a negative feedback system (Siderenko et al., 1996). IP) plays a role in the release of 
calcium from intracellular stores, which on its tum lead to the activation of enzymes such as 
calcium-dependent protein kinase II and calcineurin, a protein serine/threonine phosphatase. 
A second intracellular signaling pathway activated upon BCR ligation involves Ras (Fig 6: B, 
Lazams e( al. 1993, Harwood et al., 1993), which can also be activated in the absence of PKC 
activation (Richards et al., 1996). It is currently thought that stimulation of the BCR leads to Syk 
mediated phosphorylation of Shc (Nagai e{ al., 1995) and assembly at the membrane of a complex 
containing one She, two Grb2 and one mSOS molecule (Ravichadrall el al., 1995, Hanner et al., 
1997). The recmitmellt of the nucleotide exchange factor mSOS to the membrane is sufficient to 
activate Ras as was shown in experiments using an membrane localized mSOS (Holsinger et al., 
1995). The activated fonn of the G-protein Ras, Ras-GTP, on its tum can activate the classical MAP 
kinase pathway. The pathway appears to be important for activating transcription via enhancer 
senUll response elements (SRE) (McMahon et al., 1995) found tn the genes c-fos and egr-l, both 
coding for transcription factors. 
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BCR stimulation induces a third signaling pathway, the recmitment and activation of 
phosphatidylinositol 3 kinase (PI3-K, Fig 6: C),). \Vith a proline-rich region PI3-K can bind to the 
SH3 domains ofLyn and Fyn. (Pleiman et al., 1994a). Little is known about the function ofPI3-K. 
One of the products, PI3,4,5P), generated by the phosphorylation of PI4,5P2, is a membrane binding 
site for Btk (Salim ef al., 1996, Bolland ef al., 1998) and downstream targets for PI3-K products 
may be Ser/Thr kinases, such as Akt and PKC-S (Franke ef al., 1995). 
Recent experiments in the chicken DT40 lymphoma cell line showed that Btk transduces signals 
in the pathways leading to activation ofERK and JNKl, but not in the pathway leading to p38 MAP 
kinase activation (Fig. 6, Jiang et al., 1998). 
BeR 
/./ TY 
G,b2lSoS j 
~Ras 
(8) 
Targets 
FcYRIl 
ICRAC 
~ [ca2+J! 
~\ 
DAG IP3 ~ j [ca2+J! ER 
PKG 
I 
Targets 
calcJaUrin 
CaM kinases j 
Targets Targets 
(c·fos, erg-1) (Akt, PKG",) (JNK, ERK, CREB) (JNK) 
Figure 6. S;gllalillg pathways activated by the BCR. Boxes indicate the major signaling components 
that become tyroshte phosphOlylated upon BCR engagement. Arrows represent either the 
phosphOlylation of the s;gnalillg components by BCR-activated killases (Src-like PTKs, Syk 01' Btk) 
01' tlte COllllect;OJl behveell these signaling components and downstream signalillg events by protein-
protein interactions, phosphOl)'latioll or the action of second messengers. 
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Co-receptors illl'ohwi ill BCR signaling 
The activation of downstream signaling pathways depends on the co-crosslinking of the BCR 
with other transmembrane proteins. The BCR response may be enhanced or inhibited through the 
recmitment of SH2-colltaining signaling proteins by co-receptors, such as CD 19, CD22 and FcyIIB, 
upon activation by a variety of ligands. 
CD 19 is a B cell specific 95 kDa glycoprotein with two extracellular Ig-like domains, a 
transmembrane segment and a large cytoplasmic tail, containing nine consen'ed tyrosine residues 
(Zhou ef al. 1991, Tedder ef (II., 1989, 1997). Expression of CDI9 is regulated by the pax-5 gene 
encoded B-cell-specific transcription factor (BSAP, Kozmik el al., 1992) and is found from early 
pre-B cells until plasma cell differentiation (Zhou e/ al. 1991, Tedder ef (II., 1989). CDI9 fonns a 
complex together with CD21 (receptor for complement factors iC3b, C3d,g and C3d) and other 
membrane proteins as CDSI and Leu-13. Signaling through the CD19 complex reduces the BCR 
signaling threshold as was demonstrated in CDl9-deficient and CD 19-overexpressing mice (Zhou el 
al., 1994, Engel el al., 1995, Sato et al., 1997). CD19-deficient mice show an unperturbed 
conventional B cell development, but lack GC fomlation causing impaired antibody responses, in 
particularly to T cell dependent antigens (Engel et al., 1995, Rickert et al., 1995). In contrast, 
numbers of the self-renewing CD5+ BMI B cells in the peritoneum are severely decreased, suggesting 
that CD 19 plays an important role in signaling needed for the optimal proliferation and maintenance 
of this population of B cells. Overexpressing of CD 19 in transgenic mice lead to a dose dependent 
blockade at the immature B cell stage in the bone marrow. BCR stimulation results in tyrosine 
phosphorylation of a small number ofBCRMassociated CD 19 molecules leading to the recmitment of 
PIM3K by its SH2 domain, and subsequent activation. PI3-K activity is also stimulated by the 
binding via its SH3 domain to the BCR associated Src-PTKs (Pleiman el al., 1 994a). When 
complement factor C3d, a ligand for CD22, is bound to the BCR antigen and thereby stimulating 
the co-ligation of the BCR with the CD19 complex, CDl9 phosphorylation is enhanced, leading to 
elevated recmitment and activation of PI-3K (Fearon el al., 1995). So, probably, BCR-CDI9 co* 
ligation results in enhanced rccmitment ofPI3-K by CD19 and the simultaneously binding of PI3-K 
to Src-PTK and CD19 will greatly increase its activity. 
FcyIIB receptor stimulation is involved in inhibiting BCR signaling. In the cytoplasmic tail ofthe 
FcyIffi receptor a 13 amino acid tyrosine phosphorylated tyrosine immunoreceptor tyrosine 
inhibitory motif (ITIM) is present, which is probably involved in binding the SH2 domain of the 
phosphotyrosine phosphatase SHP-I and subsequent activation. Co-crosslinking of the FcyIIB 
receptor to the BCR does not have any affect on the overall profile and time course of tyrosine 
phosphorylation induced by BCR stimulation, except the phosphorylation PLC-y2, which appears to 
be only transient upon BCR-FcyIffi co·ligation (Sarkar et al., 1996). The significance of tile FcyIffi 
stimulated inhibitory pathway was demonstrated in moth-eaten mice, which due to a defective SHP-
1 (D'Ambrosio el al., 1995), showed an impaired B cell proliferation inhibition. FcyIIB-deficient 
mice (Takai et al., 1996). displayed a slightly elevated Ig response to both thymus-dependent (TD) 
and thymus-indcpendent (TI) antigens. In addition, Bolland and co-workers (1998). showed the 
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inhibitory effect of another SH2 containing inositol polyphosphate phosphatase, named SHIP, that is 
recruited and activated upon FCyIIB-BCR co-ligation (Fig. 6.). SHIP is able to dephosphorylate the 
membrane phospholipid PI(3,4,5)P" creating PI(3,4)P, and the solnble I(l,3,4,5)P, to 1(1,3,4)P, 
(Damen et al., 1996, Lioubin et al., 1996). In their experiments, using wildtype chicken DT40 celis, 
they showed that reducing PI(3,4,5)P) levels by SHIP resulted in a decrease of extracellular calcium 
influx. In SHIP-deficient cells, however, a hyperresponsiveness to BCR stimulation was observed 
due to increased levels of PI(3,4,5)P, suggesting an (indirect) role of PI(3,4,5)P, or associated 
proteins in opening the calcium channels in the membrane. 
A negative role in BCR signaling has been reported for CD22 upon co-cross-linking (O'keefe et 
al., 1996, Sato el al., 1996, Otipody el al., 1996). CD22 belongs to the Ig superfamily and 
expression in the mouse is found on all subsets ofmahlre B cells (Erickson et al., 1996). Murine 
CD22 recognizes a2,6-sialylated carbohydrate chains, which is highly expressed on cells in 
secondary lymphoid organs (Van der Merwe et al., 1996). CD22 associates with the BCR and 
tyrosine residues in its cytoplasmic domain are rapidly phosphorylated upon BCR or CD22 cross-
linking (Schulte et al., 1992, Peaker et al., 1993, Leprince et al., 1993). Phosphorylation of tyrosine 
residues in three ITIM motifs are involved in recmiting and activating SHPI (Doody et al., 1995, 
Campbell et al., 1995).The cytoplasmic domain also contains two ITAM motifs, by which it can 
recmit the signaling protein Lyn, Syk, PI3-K and PLC-yl (Tuscano et al., 1996a, 1996b, Law et al., 
1996), which suggest also a positive role for CD22 in BCR signaling" It has been shown that 
ligation ofCD22 alone can induce B cell proliferation (Tuscano et al., 1996a). Whether CD22 is a 
positive or negative regulator might be determined by its association with the BCR. In non-
lymphoid microenvironment the level of o:2,6-sialylated carbohydrate is low, favoring CD22-BCR 
association through o:2,6-sialylated sugars expressed on IgM and thereby inhibiting BCR signaling. 
In secondary lymphoid tissues however, high levels of o:2,6-sialylated sugars are expressed, leading 
to dissociation of the BCR associated CD22 and pennitting enhanced signaling. 
Dowllstream targets for Btk 
BCR engagement leads to the activation of Src-like protein kinases and the subsequent 
phosphorylation ofSyk and Btk followed by the activation ofRas- and PLC-dependent phospholipid 
hydrolysis signaling pathways. In Btk deficient chicken DT40 cells, following BCR engagement, 
PLC-y2 phosphorylation was reduced, accompanied by a decrease in I(3,4,5)P) generation and 
subsequent Ca2+ release (Takata et al., 1996). In contrast, the Ras pathway, which can be activated 
by DAG, a product ofPLC-y activation, was unpehlrbed in Btk deficient DT40 cells (Takata et al., 
1996). Syk is also essential for the PLC and Ras activated signaling pathways (Nagai et al., 1995, 
Takata et al., 1994). However, Syk activation was not impaired in Btk deficient DT40 cells, but 
disruption of Syk expression also lead to loss of calcium signaling (Takata et al., 1994), suggesting 
that Syk and Btk have distinct non-redundant functions in Ca2+ signaling. Moreover, overexpression 
of wildtype or E41K mutated Blk in Ramos B cells lead to an enhanced sustained extracellular 
calcium influx, whereas it had only a limited effect on the initial calcium release. In contrast, 
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overexpression of wild type Syk had no effect on the sllstained calcium influx, while overexpression 
of dominant-negative Syk, dramatically inhibited the initiation of calcium signaling (Fluckinger el 
al., 1998). As Btk activation is preceded by Syk activation upon BCR engagement, the increase in 
I(3,4,5)P) levels by Btk above those generated by Syk, may lead to sustained increases in [Ca2+] 
through the opening of biochemically differently operating calcium channels in the cell membrane 
and the inhibition of calcium fe-uptake by the intracellular stores (Fluckinger et 01., 1998). This is 
consistent with the finding that opening of calcium release-activated calcium (CRAC) ehaIUlCl 
occurs only upon generation of high levels ofI(3,4,5)P, (Parekh el (1/., 1997). 
Another downstream target for Btk is transcription factor BAP-l35/TFII-I, which has recently 
been found to associate ill vivo with Btk and is transiently phosphorylated in response to BCR 
crosslinking (Yang and Desiderio, 1997). However, the localization ill the cell of these interactions 
remain unclear, since there are no studies yet, reporting a nuclear localization for Btk, although the 
presence ofa nuclear localization signal in Btk has been reported (Vetrie et al., 1993b). 
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Aim of the thesis 
X-linked agammaglobulinemia (XLA) is one of the most frequent inherited immunodeficiency 
diseases in man and characterized by an almost complete arrest of B cell differentiation at the pre-B 
cell stage. The gene defective in XLA has been identified to code for a cytoplasmic protein tyrosine 
kinase, Bmton's tyrosine kinase (Btk). The natural occurring R28C mutation in the Blk gene of 
CBAIN mice results in a relative mild B cell disorder. The Blk gene is expressed throughout B cell 
differentiation, from the earliest stage identified, the pro-B cells up to mature B cells, except in 
plasma cells. To date, numerous interactions of the individual domains of Btk with various protein 
or lipid molecules have been reported. To study the impact of these interactions on B cell 
differentiation in vivo, we have developed mouse models, in which wild-type or mutated Blk can be 
appropriately expressed as transgenes. For these studies we used transgene constmcts containing the 
MHC-JI Locus control region or the CD19 promoter, which were shown to provide position 
independent, copy number-dependent expression and could therefore be used to target genes to B 
lineage cells. To be able to answer the central question why B cell development is arrested in XLA 
patients, the aim of this thesis is to investigate the role of Btk at the individual steps of B celJ 
development. In addition, we wanted to study the regulatory elements that are responsible for Btk 
gene expression, to be able to manipulate Blk expression ill W·VO. 
In chapter 2, the generation of a Btk-deficient mOllse, by an in-frame insertion of a LaeZ gene is 
described. Using the IaeZ activity, Blk expression could be studied ill vivo. The phenomenon of X-
chromosome inactivation in Blk +/- heterozygous female mice enabled us to evaluate the ill vivo 
competition between B cell progenitors expressing wild type Blk and those expressing the Blk -lLacZ 
allele in each successive step of development. This model enabled the detection of subtle defects of 
Btk-deficient cells, characterized by only minor selective disadvantages, which were not recognized 
in the phenotype of affected male. In addition, this model has been used for back-crosses with other 
transgenie Blk mouse models. 
In chapters 3 and 4 the generation of two yeast artificial chromosome (Y AC)-transgenic mouse 
strains is described, in which high-level expression of human Blk is provided by endogenous 
regulatory cis-acting elements. These mouse models were generated to address the question, whether 
human Btk can compensate the absence of Btk in the mouse. \Ve could also investigate whether 
regulatory sequences are conserved between humans and mice. These experiments arc the first step 
to analyze the regulation of the Blk gene expression ill vivo (and to subsequently manipulate Blk ill 
vivo). We choose to start with transgenic expression of a 340 kb YAC clone, as essential regulatory 
elements may be located far upstream or downstream of the Blk gene itself. 
In chapter 3 we describe the generation of Y AC transgenic mouse strains, using a 340-kb 
transgene, Y c340-hBlk, which contained the Blk gene and 100 kb of 5' flanking DNA and 200 kb 3' 
flanking DNA. The expression pattem of the transgenic human Elk was found to parallel that of the 
endogenous murine gene. Furthennore, transgenic human Elk expression on a murine Btk-deficient 
background fully corrected the xid phenotype. 
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In chapter 4 the exprcssion pattcm of Btk is studied in various haematopoietic lineages, using 
intracellular flow cytometry. The expression pattem of murine Blk was compared to the expression 
pattem of the human Blk from a Yc240~hBtk transgene, which in addition to the entire Blk gene, 
contained 5 kb Y flanking DNA and 200 kb 3' flanking DNA. As was for Y c340~hBtk transgene, Btk 
expression from the Y c240-hBtk transgene on a Btk-deficient background fully corrected the xid 
phenotype. In parallel, (putative) regulatory elements within the Btk gene itself were characterized. 
The role of SpIt3 and PU.l, binding to the Btk promoter was studied, using ill vitro transfection 
assays as well as targeted disruption of the genes coding for Sp I and Sp3 ill vi\'O. Finally, possible 
regulatory sequences within the human Btk gene were identified using DNAseI I~ypersensitivity site 
mapping. 
To identifY signaling pathways that are activated by Btk late in B cell development ill vivo 
(chapter 5), we generated :MHC-II-hBlk transgenic mice, which either overexpress wild-type hBtk. 
or various levels of the E41K gain-of-function Blk mutant, which represent a constitutive activated 
fonn of Btk. Whereas wildtype Blk overexpression had no adverse effects on B cell function, and 
essentially corrected the xid phenotype, E41K-rnutant Blk expression resulted in a block in the 
development of follicular recirculating B cells. 
\Ve also wanted to analyze the functions ofBtk activity early in B cell differentiation in the bone 
marrow. In chapter 6, the ill vivo effect of the E4l K-Blk was investigated using the early active, B 
cell specific CD19 promoter. \Vhile wildtype CD 1 9-driven Blk expression resulted in the correction 
of the xid phenotype, E41K-Blk expression, driven by the CD19 promoter lead to a developmental 
block at the transition ofIgM!OW to IgMhigh immature B cells in the bone marrow. Furthennore a role 
for Btk in the regulation ofIg L chain assembly was obscrved. 
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Druton's tyrosine kinase (lltk) is a cytoplasmic protein 
kinase Ihat is defeclh'c in X-linked agammuglobulin-
aemia in Illan and in X-linked immunodeficiency ill 
the monse, There is contronrs), regarding the slages 
of n cell dcnlopment that arc dependenl on Btk 
fUlIction, Todetermine the point in B cell differentiation 
at which defeels in Btk become apparent, we generated 
a mouse model by inactivating the Blk gene through 
an in-frame insertion of a lacZ reporter by homologous 
recombination in embryonic slem cells, The phenom-
enon of X-chromosome inactivation In Blk+l- helero-
ZygOlis female mice enabled us to e\'aluate Ihe com-
petition between B cell progenilors expressing nild-
type Blk and those expressing the BllrllacZ allele in 
each snccesslye step of development, Allhough Blk was 
already expressed in pro-B cells, the first selecth'c 
disad\'antage only became apparent at the transition 
from small pre-D cells to Immature n cells in the bone 
marrow, A second differentiation arrest was fOllnd 
during the maturation from IgDtO"IgMhlgr. 10 
IgDMghIgMtow stages in the periphery, Our results 
show that Blk expression is essential at two distinct 
differentiation steps, bolh past the prc-B cell stage. 
Ke)11'ords: B cell development/Btkiimmunodeficieneyl 
XLNxid 
Introduction 
D lymphocyte differentiation proceeds through successive 
steps involving two distinct phases (Figure 0. TIle first 
antigen-independent phase occurs in the bone marrow and 
includes the ordered rearrangement of immunoglobulin 
(lg) heavy and light chain variable region genes, leading 
to the generation of surface IgM-bearing B cells (Alt 
e/ ai" 1987; Rolink and Melchers, 1991). In the mouse, 
the Ig~.'(~ precursor B cells can be divided into four groups 
based on their differential expression of the cell surface 
markers CD43, heat stable antigen (lISA) and BP-I (Hardy 
e/ af., 1991). In the second phase, the immature IgM+ B 
cells leave the bone marrow and undergo antigen-driven 
proliferation and selection in secondary lymphoid tissues, 
where they gain an IgDhighIgMlow surface phenotype and 
differentiate into either plasma cells or memory B cells 
(Hardy elaf., 1983; Nossal, 1993). 
Bruton's tyrosine kinase (Btk) is a cytoplasmic protein 
tyrosine kinase that is essential for B cell differentiation; 
mutations in the B/k gene lead to X-linked agumma-
globulinaemia (XLA) in man and to X-linked immuno-
deficiency (.lid) in the mouse (reviewed in Conley et al .• 
1994; Rawlings and Witte, 1994; Sideras and Smith, 
1995), Blk encodes a 659 amino acid protein that, like the 
sre family of tyrosine kinases, contains an SH2 and an 
SH3 domain and a single catalytic domain (Tsukada 
et af" 1993; Vetrie el al., 1993). Btk, together with the 
homologous Tee, Ilk, Bmx and Txk genes, comprise a 
subfamily with a unique N-temlinal region that contains 
a pieekstrin homology (PH) domain (Musacchio ef af., 
1993) and a proline-rich Tee homology domain (Vihinen 
et al., 1994) but lacks a myristylation site for membrane 
anchoring, 
XLA patients display a large variety of genomic 
mutations, including deletions. insertions and point 
mutations in all domains, but missense mutations were 
found to be confined to the PH, SH2 and kinase domains 
(Vihinen e/ af., 1996), XLA patients suffer from protracted 
and recurrenl bacterial infections caused by \'ery low 
serum concentrations of all Ig classes (Bruton, 1952). In 
the peripheral blood, surface Ig+ B cell numbers are 
scverely reduced, and in lymphoid tissues, plasma cells 
are virtually lacking; the small numbers of B cells that 
remain have an aberrant Igl"ilhigh surface phenotype 
(Conley, 1985). In the bone marrow, the number of pre-
B cells is either nomlai or decreased, and those pre-B 
cells present have a decreased proliferative activity (Pearl 
e/ al., 1978; Campana et af., 1990). Therefore, XLA 
reflects an almost complete failure of B cell precursors to 
differentiate into mature B cells. This defect is intrinsic 
to the D cell, because female XLA carriers manifest a 
unilateral X·chromosome inacti\'ation in the peripheral 
blood B lymphocyte population (Conley ef af., 1986; 
Fearon et af" 1987) becausc of a selective disadvantage 
of cells that ha\'e the defective Blk gene on the active X 
chromosome. 
A less severe B cell deficiency has been observed in 
the CBAIN mouse strain carrying the xiti mutation, which 
alters a highly conserved arginine (Arg28) in the PH 
domain into cysteine (Rawlings e/ al., 1993; 1110ma., 
e/ af., 1993). xid mice have -50% fewer B cells in the 
spleen than normal, and the residual cells manifest an 
IgMhighlgD10II' profile and cannot make antibodies to type-
2 thymus-independent antigens (reviewed in Scher, 1982). 
In the serum of these mice, IgM and IgG3 concentrations 
are low, but other Ig classes arc normal. 
The milder phenotype of murine xill compared with 
human XLA cannot be explained by the nalure of the 
mutations involved. Mutation of the same Arg28 amino 
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rcciKulaling (ells tbt ha\-e he.!n ,de.:led in the periphery. 
acid into histidine ha<; been observed in patients with 
classic severe XLA phenotypes (de Weers el af., 1994a; 
Ohta er af .• 1994). Furthermore, the extensive phenotypic 
analysis of mice deficient for Blk in their germline (lJlk-
kiu-), which were generated recently by gene targeting, 
showed that the general absence ofBtk protein also results 
in a xid phenotype (Kahn el a/., 1995). 
Btk is expressed throughout B cell differentiation, except 
in plasma cells (de Weers el al., 1993; Smith et af., 
1994). and is implicated in several receptor-coupled signal 
transduction pathways, such as interleukin (IL)-SR, JL· 
6R. IL-IOR, CD38 and CD--tO (Go el af., 1990; Hasbold 
and Klaus, 1994; Sato el al., 199-'; Matsuda et al .• 1995; 
Santos-Argumedo el lIf., 1995). Stimulation of the BCR 
induced tyrosine phosphorylation of Btk ill \,1"1'0 and its 
kinase acti"ity illl';lro (Aoki et af., 1994; de Weers el (II .. 
1994b; Saouaf £'f af., 1994). 
At present it is not known which of the signalling 
functions of Btk are responsible for the immunodeficient 
phenotypes of XLA and xid. l\·loreover, the exact slage in 
B cell differentiation at which defects in Btk become 
apparent is also unclear. III the XLA patients analysed, 
the numbers of pre-B cells in the bone marrow varied: 
they were either not detectable or present in reduced or 
nomlai numbers (Pearl el al .• 1978; Campana elllf., 1990). 
Incidentally, pre-B cells exhibited a rare TdT+ phenotype. 
In the mouse, the .rid or Blk-kin- mutations do not appear 
to affect pre-a cell numbers or proliferative capacities 
(Reid and Osmond, 1985; Kahn et af., 1995). The only 
obvious eftcct of the absence of Etk on the bone marrow 
B lineage fractions was a deficiency of recirculating 
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mature IgM+lgD+ B cells (Figure I, fraction F). which 
would imply that B cell differentiation up to the immature 
IgM+lgO- B cell is normal (Kahn el af., 1995). However, 
the analyses of X-chromosome inactivation patterns in 
bone llIarrow from mice heterozygous for the xid mutation 
(Forrester et al .• 1987) produced evidence for a slightly 
earlier arrest indifferenliation: from the pre-B cell (fraction 
0) 10 the immature B cell (fraction E). In contrast with 
these findings, in \,1"1'0 competition experiments of nonnal 
C57BU6- and Blk- ES-derived B cell precursors indicated 
a deficit in the ability to expand between the pro-Bllarge 
pre-B (fractions A-C) and the pre-B cell (fraction D) 
(Kemer et af., 1995). Thus, the differentiation stage of B 
cell precursors in which [11k expression appears to be 
critical in mice and humans remains puzzling. 
To gain further insight into the role of Blk in the 
expansion and differentiation of 8 cen precursors. we 
have also generated a mouse model in which the Btk gene 
is inactivated but have labelled the cells at the same time 
by inserting a l(/cZ reporter by homologou~ recombination 
in ES cells. Because of the proces~ of random X-chromo-
some inactivation in Btk+{- heterozygous female mice. 
each X chromosome is active in about half of the cells 
within the bone marrow and the peripheral compartment. 
This phenomenon enabled us to evaluate the competition 
between cells expressing wild-type nlk and those 
expressing the Blk-/lacZ allele in each successive step of 
B cell development. This approach allows the novel 
detection of subtle defects that only lead to minor selective 
disadvantages, which may not be recognized in the pheno-
type of affected males. 
Results 
Generation of Btk-/lacZ-expressing mice 
To inactivate the Blk gene, we constructed a vector that 
contained an in-frame fusion of 1.5 kb 5' gcnomic 
sequences of Blk (at the Mwd site in exon 8) to the 
nuclear localization signal (nls) of the SV40 large T 
antigen and the Escherichia cali lacZ gene (Figure 2A). 
The targeting vector included the herpes simplex virus 
(HSV) thymidine kinase gene for negative selection, the 
neomycin resistance gene for positive selection and 8 kb 
of 3' Blk homology. 
The linearized plasmid was transfected into EI4 ES 
cells and, after double selection, surviving clones were 
screened by Southern blotting of HcaRI digests (Figure 
2B). Four homologous recombination e\'ents were obtained 
out of 356 clones. These were karyotyped and subjected 
to further analysis to ensure that they carried intact Blk 
exons 1-7 and only a single laeZ copy (data not shown). 
Two of the Blk- clones with a 70--90% nomlal karyotype 
were injected into mouse blastocysts to generate chimeric 
mice that transmitted the Blk- allele through the germline. 
Male chimeras were bred to FVB or C57BU6 mice to 
obtain heterozygous (Ble'-) females or hemizygous (Blk-I 
Y) males (Figure 2B). 
Western blotting experiments were perfomled on cell 
Iysates from 5 week-old mice, using a polyclonal rabbit 
antiserum specific for Btk amino acids 163-218 to show 
the absence of Btk protein. The nomlal Blk gene encodes 
a 77 kDa protein thilt was detected in the spleen of Ble 
male and Blk+!- female mice, but not in the spleen of 
Blk- mules nor in any thymus samples (Figure 2C). 
Transcription of the targeted allele would result in a 
hybrid mRNA, containing Blk sequences fused to nls/acZi 
poly(A). By utilizing the regular first ATO in the Blk gene 
inexon 2, Btk (amino acids 1-234}-nlslacZfusion proteins 
of 140--150 kDa would be generated in splenic B cells of 
Blk- male mice. No such proteins could be detected in 
Western blotting anillyses using the available Btk-specific 
antiserum (Figure 2C). However, evidence for transcrip-
tional and translational activity of the targeted locus was 
provided by the detection of J!-galactosidase activity in 
Blk- male and Ble'- female mice (see below). 
The Btk-IY mice manifest an xid-like 
immunological phenotype 
The effect of the IJtk-lIacZ mutation on B cell maturation 
was jnvestigated by flow cytometric analyses of cell 
samples from the spleen, mesenteric lymph node (MLN), 
thymus and peritoneal cavity (Table I). No significant 
differences could be detected between nomlal male or 
female mice and the Blk+l - females. The phenotype of the 
Bfk-fY mice wa.~ characterized by decreased numbers of 
B220+ B cells in the periphery and a severe deficiency 
of CD5+ B cells jn the peritoneum. Thymocyte and T cell 
numbers were not affected. In the myeloid compartment, 
no differences between the Btk-fY and their nOmlu\ 
littermates were observed (dillil not shown). 
In 5 week-old Blk-fY mice the serum concentrations of 
IgM and Jg03 were reduced significantly (50 and 20% of 
normal, respectively). The ill vitro antibody responses to 
lipopolysaccharide of spleen cells demonstrated a severe 
deficiency in the production of Ig03 (0.11 ::I:: 0.04 ~Iglml 
Inactivation of Blk by insertion of LacZ 
in Blk-fY mice ilnd 6.5 :': 1.2 J1g1ml in nomlallittemlates). 
wherea~ the production of Ig"'f, IgOI and IgG2u was 
equivalent in the two groups. Together with the 
IgMhi:;.hJgDk .... surface profile of peripheral B cells (see 
below), these findings indicate that the immunological 
defects of the Blk-fY mice are similar to those observed 
in xid or Blk-kin- mice (Kilhn t'l al., 1995). 
Expression of the Btk-/lacZ allele in the 
haematopoietic compartment 
TIle introduction of the lueZ gene allowed us (i) to 
determine the Bfk expression piltlem in the affected male 
mice and (ii) to evaluate the competition between cells 
expressing Wild-type Blk and those expressing the Blk-I 
laeZ allele in heterozygous females by using fluorescein-
di-J!-D-galactopyranoside (FDG) as a fluorogenic substrate 
in conjunction with flow cytometry. 
A majority of the B220+ B cell precursors in the bone 
marrow of Blk- males, and virtuillly all mature B cells in 
the periphery, e.'l:pressed laeZ (Figure 3A). Because of the 
process of random X-chromosome inactivation. -40--50% 
of the B220+ bone marrow cells were !tICZt- in Blk+ l-
heterozygous female mice, with fluorescence intensities 
comparable with those in males. In contmst, only a snlilll 
fraction of peripheral B cells in these mice expressed lacZ 
(Figure 3A). These findings illustrated a profound selection 
against those B cells thilt lack Btk, which has also been 
observed inxid (Nahm ef al., 1983; Forrester el al., 1987) 
and XLA (Conley el al., 1986; Pearon el al., 1987). 
No laeZ activity was detected in the peripheral CD4+ 
or CD8+ T cell popUlations. In the thymus of Blk- males, 
lacZ expression was restricted to a small fraction (8.3 ::I:: 
0.3%) of the CD4-CD8- cells. These cells, which conld 
not be detected in Btk+l - females, were found to be surface 
JgM+ and B220+, and most probably represent B cells 
present at \'cry low numbers in the thymus (Myama-Jnaba 
ef al., 1988). The Blk-ty mice manifested laeZ activity in 
nearly all the ER_MP2()high cells (de Bmijn ef al., 1994) 
of the monocyte lineage in the bone marrow and the 
~lae-l+ peritoneal macrophages (Figure 3B). TIle ER-
~'IP20""'<.lium fraction of gmnulocyte precursors in the 
bone marrow manifested heterogeneous levels of laeZ 
expression. The mature granulocyte population in the 
spleen (Mac-l +/Gr-l +) contained 52 :': 6% of cells with 
a significant lueZ activity. There was no evidence for a 
critical function of Blk in the expansion or proliferation 
of cells inlhe myeloid lineage: in the heterozygous females 
the numbers of laeZ+ myeloid cells were approximately 
half those found in the BI1:- males. The variation in the 
fractions of laeZ+ cells between different female mice 
(e.g. 28--63% in peritoneal macrophages) most probably 
reflected individual differences in the X-chromosome 
inactivation ratios of the haemiltopoietic compartment. 
Btk- B cells show a defect in the maturation to 
IgM10WIgOhlgh stages in the periphery 
Cell samples from spleen, MLN, peripheral blood and 
peritoneal cavity of 5 week-old mice were evaluated for 
laeZ activity in conjunction with their surface expression 
of IgM and IgD (Figure 4 and Table II). The Blk-fY mice 
exhibited a selective deficiency of the mature 
IgMlu·~lgDlligh. population in the peripheral compartment, 
as found previously for the xid or Blk-kill- mice (Hardy 
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Fig. 2, inser1ion of a {aeZ reporter to disrupt the murine Btk gene. (A) A partial genomic map of the wild'l)pe (lop) and the targeted (bottom) 
Illurine Blk gene (Sideras el af., 199..\), encompassing exons 5-19, which arc highlighted as clo,ed boxes, In between the gene·targeting (omtru,t is 
sho\\n, containing BS, the h~rp<'s simplex TK gene, the nuclear localization signal (nls) of simian lirus large T fused to £.en/l IneZ and the 
neomydn resistance gene (neo). The expected EeaRI fragments and their sizes before and after homologous r<'Combination are indica1ed. B, ifamlll: 
E, teaR!. (8) Southern blot analysis of DNA from a targeted (Blk-fY) and the I\ild,type EI4 ES cell clone, and of DNA from mouse tails, 
demonstrating germline transrrussion of the mutation. DNA samples were digested with £CaRl and probed with a human B/k cDNA fr"gment 
encompassing exol1s 2-11 (de Weers", 01., 1993), .",hich shows an unaltered 8.1 kb band corresponding to nons 2 and 3. The 14 kb fr"gment i<; 
from the \Iild·type allele and the 10.3 kb fragment is from the targ~ted allele. The weak -13 kb frolgment (in the two Blk-fY lanes) probably 
represents incomplete digestion of the EeoRI site in the nls because the fragment also hybridizes to a laeZ probe. The genotypes are indicated atlhe 
top {wild.type m:!le (Blk+fY) or female (8Ik+I+), mutated male (Blk-IY) and heterolygous female (Blk+l-)1. (C) Western biOI analysis of Blk protein 
expression in total ~dJ Iysates from spleen ceHs or thymoqtes. Blk was detected by a pol)'donal rabbit antiserum raised against a fmion protein of 
glutathione S·transferase and amino acids 163-218 of the human Btk gene. The gen«ypcs are given at the top: the position of the wild·typc 77 kDa 
BIk band is indicated. 
et aI., 1982. 1983; Kahn el af .• 1995). Because a small 
fraction of peripheral B cells in Blel- heterozygous 
females express /acZ. it was possible to specifically 
analyse the surface phenotype of those cells that have the 
Blk-lfacZ allele on the active X chromosome. The gated 
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lacZ- mature B cells exhibited an IgMlIgD surface profile 
similar 10 that of B cells in nonnal mice, whereas 
the gated lacZ-expressing cells manifested an Igr..lh;P. 
phenotype reminiscent of Ihe B cell population found in 
Blk-fY mice (Figure 4). This phenomenon, which was 
Table I. Flow C)1ometrk anal);;!s of the p.;ripherJllymphoc}te 
compartment 
Spleen 
Total nucleJled cells (XltJi) 
B120+ cells (~:() 
91 ± 2\ 
28 ±!O 
12 ± I 
6.3 ± 0.2 
178 ± 58 
59 ± 5.3 
8.6:!: 1..1 
5.9 ± 1.1 
CD-t+ cd!s {'kl 
CDS+ cells ('k) 
MLN 
B220+ cells (%) 
CD-t+ ceUs ('X) 
CDS+ cells ('X) 
Pcritoneum 
24 ± 8.8 
47 ± 6.6 
26 ± 0.9 
42 ± 2.5 
36 ± 0.9 
19 ± 1..1 
CD5+lgM+ B cells ('Xl 
CD5-lg~l+ B cells (%) 
CD5+lgM- T ,ells (%) 
0.3 ± 0.1 
2,7 ± 0.7 
2.2 ± 1.0 
8.5 ± 4.2 
6..1 ± 1.8 
2.3 ± 0.6 
'Mice wen: 6-8 wcd:s old. Numb?rs of mke analy~eJ are (\\0 l<1 four 
for spleen and MLN and four to eight for p.;ntoneJl celis, 
Blk-N Blk +/-
A I I 
~ :~ ......... ~ :~'j .".' 
';" '''¥. . •... 
.. ~~;: . ' ,. , . 
'.. .' .. oi" .. ~ oi" ."'. .. .. 
-----lacZ ----. 
B 
-----lacZ-----+ 
FIg. J. Sele.:tion against Blk-lIacZ+ cclls in the B lincage but not in 
tiJ<, myeloid lineJge. 1\m·colour flo\\' cytometric analysis of lacZ 
expre,sion using FOG in 5 week·old Blk-I'I' males and heterozygous 
BlkH- females. (A) The B cell compartment was analysed by stain.ing 
wilh anti·B22O-APC fM bone mmow and anti·B22O-PE for MLN 
cells, (0) 1\\0 dbtinct bone marrow myeloid populations are reveJled 
by staining with ER·~IP20: monoc)te,; are ER·:\1P2cf'fh antI 
granuloqtcs are ER·MP20~· .. "L"'~. The peri(one.l.( m~crorhage 
population was g.lted by forv .. aro and side scatter, and rewJled by 
staining \\ilb anti-~lac~l-PE. Data are 5hown as dot plot<; 
r~presentative of the mice examined. Th<l p.<'rcentages of /<uZ+ ccJls 
within the indkated gate;; are sbo\\n. 
Inactivation of Btk by insertion of LacZ 
Table n. E'1re",j(ln llf /ac"7. in !h" peripberJ( B cell comrJrtmenl in 
female Blk' mice 
Ase P':r>:enl1ge of lud:L all, 
\\\eek:s) 
Spleen (n = )) 35.7 Z. 55 17.J z.5J 1.8 :.'.: 1.0 
Spken (n " .t) 20 21.6 :!: 6.9 7J ::!:: 1.8 U::!::O..t 
~ILN (n " 2) 5 31.1 :!: 6.9 S.6 ::!:: 2.0 1.6::!:: [1.1 
Bh-..J(n" .t) 5 )0.0 :.'.: 7.0 [6.1:.'.: 6.5 1.7 ::!:: 15 
Pelill,;':uru (~ .. 3) 5 I.S:!: 1.1' J.5 ::!:: 3.! 1.7 :!: U.6 
The p<"rcentage, (meJn ± standard deviations) of lacZ+ cells are 
gil'en \\itbin the gated population. The,e \Jlue> are corrected for 
indi\'idual X...:hromosome inacti\Jtion ratios using the l<lcZ e'pr<,~sl\'fl 
\'Jlues from both pentoneJI mJcrophages ~nd ER·:\{P2ij~:'~ mC'noc)us 
in the bone marrow. In the BI/..-I'I' mice, {acZ activity WJS detected in 
9O-95'X of eelh: the vJckground value, in \, ild.t}p<' m~!e or femnle 
mie" were l-.t'l for peritoneJ! reU, and <2~~ for Ihe,0ther lymphoid 
ti,wes. 
"The IgMt-'fhlgOh • B ,ell frJetion in the p.;ritoneum conshb mainly 
of CD5 + cells. 
found in the spIcen, MLN and peripheral blood, also 
implied that the fraction of lacZ~expre.ssing cells in the 
heterozygous females decreased during maturation, from 
..... 30% in Ig~l~jghrgo\'''A' to almost undetectable levels in 
IgM!(\\\IgOhigh mature B celis (Table II). The finding that 
lacZ expression in the IgMhi.,hlgO!O\\ fraction in Blk+!-
females was less than half that in males implied a selectiye 
disadvantage of Blk-lIllcZ-expressing cells at the stage in 
which the B cells from the bone marrow emerge into the 
periphery, 
To invcstigate whether selection against Btk-deficient 
cells becomes more pronounced with increasing age, we 
analysed spleens from mice that were aged >4 months. 
The fraction of lacZ-expressing cells was found to be 
reduced when compared with 5 week-old mice, but never-
theless >20% of cells within the Ig~lhighlgD\(\'" population 
still expressed the mutated allele. 
In the peritoneum of Blk+l- female mice, the de\'elop· 
ment of both the conventional and the CDS+ B cells that 
express laeZ appeared to be compromised. TIle fraction 
of lacZ+ cells within the CD5+ (2.5 ± 0.8%, 1/ = 5) or 
in the conventional B cell popUlation (4.2 ± 1.5%, 1/ = 
5) did not exceed background values. Similar results were 
obtained when peritoneal B cells were classified on the 
basis of the Ig expression pattem (Table II). 
Btk- B cell progenitors show impaired 
differentiation from ti,e pre·B cell stage onwards 
A flow cytoUletric analysis of bone marrow cell suspen· 
sions of 5 \\'eek~old IJ!k-ty mice and nomlal Iillemlates 
revealed no significant alterations in the fractions of (he 
myeloid or lymphoid/erythroid lineages or in the total size 
of the B220+ B cell precursor compartment {Table IIJ}. 
Blk-ty mice had fewer IgM+IgO- immature B cells 
(fraction E; ~ 70% of nOOllal) and showed a significant 
decrease in the IgMlo\\JgOhigh mature B celis (fraction F,; 
~IO% of nomlal; Table III), Similar to the observations 
made on per>~eral B lymphocytes. the numbers of 
IgMlv"IgDhigh . I "me B cells (fraction F1) were reduced 
severely in both the affected males and the laeZ+ popula-
tion in heterozygous femalcs (Figure 5A), The analyses 
of gated lacZ- and lacZ+ population'> of B220+ bone 
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f.'ig. 4. The df,:.:t of the BII;- mutation on the ~urface IgMlIgD prollle of peripher.ll B cells. Tri--colour flow C)toructric analp!~ of spleen. MLN and 
p"ripher.d blood from 5 week-old HIJ:+ N normal male>, BIJ:-/Y affe':led males and gated farL and /acZ+ cells from BIJ:tI- heterozygous female,_ 
The diHribulion of cells owr the three compJltments (T. IgMkl"'gO"'fh; II, IgMhJ$hlgD~jP.; III, IgMr.;~hlgD'';''\; Hardy e/ til., 1981) in per.:entages is 
indicated. Cells were loaded \Iith FDG and stained with anti-IgD.PE, biotinylated anti-igM and strept[l\,idin-TriColol. Data are sholl'n as 5% (or 
10% for the gated f{lf;Z+ cell. from Blk+!- femal~s) probability contour plots. ~ad cells were gated out, tmed on forward and side scatter 
characteristics. 
Table III. Aow c}\ometric analysis of bone marrow edt populations 
Cell fraction Surface mJlkers Btk-N \\~Id·type 
(n = 4) (n '" 8) 
MonoC)tes ER-MP1o"·ip. 10 ± 2.7 10 ± 0.4' 
Granulocytes ER-MP10"'.<oj 40 ± 3,0 32 ± 1.5 
Lymphoidlel)'throid ER-MP1o- 48 ± 8.8 55 ± 10 
Total B lineage 8210+ 23 ± 12 24 ± 7 
Pro·8 (A, B and C) 8210+CD·O+ 5.3 ± 2.7 4,6 ± 1.6 
Pre-8 (0) B210+CD..J3-lgM- 11 ± 4 12 ± 5 
Immature B (E) BnO+lgMtlgD- 4.1 ± 0.7 6.1 ± J.7h 
Mature B (F) 
Fm IgM~i&J1lg0kr,o. 0.62 :!:: 0.08 0.66 ± 0.16 
F" IgMhrt<~lgD"'P. 0040 ± 0.12 0.63 ± 0.37 
P, IgMlvAlgD~:F> 0.08 ± 0.02 0.8-\ ± 0.62' 
Total (ell numbers (one femur and one tibia) were 53.0X liP ± 
7.lxHI' (or the BIJ:-ty mice and 46.0XHf ± 6.6Xlcf> for wild·type 
mice. 
The per.:entages (mean ± standard de\'iation) from total nucleated 
cells ",ith the indicated phenotype are given. 
'For non·parametric consideration of the hypothesiS that the Blk-N 
mice manifested signiticant differences in cell numbers compared with 
wild.tn,.;: liUermates, the Mann-Whitney U-te,t was applied. Except 
for B lineage populations E and Ft. the values were nOl significantly 
different. 
bnte denease in BIJ:-ty mice was just significant, with a one·tailed P 
\'alue of 0.036. 
'The decrease in Blk-N mice ",as significant, with a one-tailed P 
\"alue of 0.001. 
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marrow cells from Btk+l- female mice further revealed 
abundant lacZ expression in IgM-IgD- cells (fractions A-
D) and IgM+lgD- cells (fraction E). 
To identify the precise stage at which B-cell differenti-
ation is impaired in the Bt~ precursors, we performed 
four-colour flow cytometry using markers specific for lhe 
successive stages of B cell development. In the earliest 
stage (B220+C043+HSA~, fraction A), ~59% of cells in 
Blk~fY males were found to express lacZ (Figure 5B and 
C), In a1l foII~wing diffe~e~tialion stages, lacZ activitl 
was detccted III the maJonty of cells. In the Ble-
heterozygous female mice, ~30% of fraction A cells were 
lacZ+, Le. about half the number found in the Btk- males. 
Therefore, the expression of Blk did not appear to be 
essential for the survival of B cell progenitors at this very 
early stage. Selection against the Btk'i!acZ+ cells was also 
not observed in the pro-B cells of fraction B or ill the 
pre-B ceIls (fractions C and D) (Figure 5C). These results 
indicate that development up to the large pre-B cell 
(fraction D) is not affected by the Btk mutation. The 
first selective disadvantage of Btk-deficient cells became 
apparent at the transition from pre-B cells to immature B 
cells (fraction E). The percentages of lacZ-expressing cells 
in heterozygous females decreased from 43% in fraclion 
D 10 29% in fraction E (Figure 5C), When the immature 
B cells develop into the IgMh;ghlgOlow B cells of fraction 
F, the percentage of lacZ-expressing cells remains at 
~30%, a value which was also found for the IgMhighIgD!\m 
Inactivation of Btk by insertion of LacZ 
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fig. 5. The BII..- mutation affc(ls the development of B eel! precuJ>oJ> from the small pre-B to the mature B cell stage. (A) Bone marrow eel! 
susperuions from 5 week·old Blk+/Y normal males, Blk-{Y affe.:ted males ano.! BlkH- heterozygous females were stained with FOO for /acZ, anti· 
B22O-APC. anti·IgD·PE and anti·!g.\1 (biotin)·la!ed)f~trertaviO'!in-Red 613. Gated 8220+ (male samples), B210+/lacZ' and B210+//tlcZ+ cells (from 
a heterozygous femak) are disph)·eJ. Data are ShOllTI as 5'J probability contour plots. The gale, (or ffaoions A-D and E and the indil'idUJI F 
f[;1(\ion<; are ShOIH!. Dead cells were gated out, vaseJ on fO['llard and side scatter characteliltks. (8) Bone marrow cell suspelllions from 5 w~k-()ld 
mice were loaded Ilith FDG and mined with anti·B22O-APC. anli·CD·D·PE and ami·HSA (biminylated)lstreptavidin-Red 613. Fraction A WJ.<; 
identified hy Jnalysing the lUll" side scauer and the HSA- fwoion (gate in kft contour plot) for the e~rression uf CD-13 and B220 (right contour 
plot). shO\\n fur a BI/;-{Y mouse. Fraction A (B220+Co..t)+HSA-) was analysed for /acZ expression, and the fe,;ult i, dilplayed01\ a hil\ogrJm. The 
percentage of lacZ· cells ~\'ithin fmcllon ,\ is indicated for an affe.::ted nute and a heterozn;ous female mou,e. (e) QuaotitJtion nf the percentJge nf 
lacZ+ cdls in the individual B lineage fmoioM in the oone marrow of Blk-)Y male and Blel- female mice. Bone marrow cell w<pen<ion< were 
analys~d for /<1cZ "pressjon using I'DG and stained with ami·822O-APC. The B220+ frJction5 Ilere c1a,,~ified nn the basi, ~)f the C·\Pfc,,[on of tll"n 
additional markers labelled II ith PE (anti·lgD. anti·CD-13 or anti·IISA) or ~trepl;l.\"idin-Red 613 tbiotinylaud anti·lgM or anti·BP·1) as fo.llo\\"s: 
HSKCD-t3+ (fractinn A).HSAd;I1 BP.I- (fraction B), Br-I.+CD~J+ (frJction C). CD.B+lg~l- (frJction OJ, IgM+lgD- (ffanion E), igM">"lgDh.< 
(fraction I'm), IgMr"f~lgD':fh (fraction Fn) and !gM~"'lgD";$h (fraclion Ft). Data shnlln are the mean values::':: standard deviations nblaincd fwm the 
anal)ses in fuur Bt/;- male mice and five (fractions A-D) or ~e\"en (fra{lion, E and F/ hetewzygous fcm:lle mice. The \":lIues for the femJk mice Jre 
corrected for indh'idual X-chromt';t'me inactivation rJtio> (see legend to TaMe Ii). The numbcrs aoo\"e Ihe bars represent the mean \'alue of the rJtio 
b.;tw~n lacZ+ cell percenMge, in heterl.lJ:ygou, females and in Ille BI1..-{y males for each B lineage cdl fraction. U,ing the non-par'lmelric tl\(l-
tailed Wilcoxon ~igned-rJnk test, the,e value, were ~ignilk.llltly different from 0.50 for fm,lions E, Fill, I'll and FJ (I' = 0.016 in all four fr~C!!('n'). 
B cells in the peripheral lymphoid compartment (Table 
II). During further maturation within the F fraction, 
selection against Blk-deficient cells was more profound. 
Finally, in the IgM10\'lgOhigh fraclion, lacZ expression was 
virtually absent. 
Discussion 
To determine the stage in B cell development at which 
defects in Btk become apparent, we generated a mouse 
model in which the [Uk gene is inactivated through an in-
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frame insertion of a laeZ reporter. The Btk-fY mice had 
moderately reduced B cell numbers in the periphery, a 
specific deficiency of IgM10\' IgOhiSh mature B cells, an 
absence of peritoneal C05+ B cells, reduced IgM and 
IgG3 serum concentrations and their splenic B cells 
exhibited defecth'e IgG3 production upon lipopoly-
saccharide stimulation ill vitro. TIlese findings confirm 
those of Kahn et al. (1995). that mice deficient for Blk in 
their gennline exhibit an xid phenotype and that the 
elimination of lJlk function docs not lead to an almost 
complete block in B cell development, which is typical 
for XLA in man. 
The presence of the laeZ reporter enabled us to deter-
mine the Btk expression profile ill l'ivo. Moreover, because 
of the competition between cells expressing wild-type Blk 
and those expressing the Brk-llaeZ allele in heterozygous 
females. our strategy allowed the detection of the prolifer-
ative disabilities of Blk-deficient cells in each successive 
step of B cell development. The results clearly show that 
defects in Btk do not generally affect proliferation or 
survival throughout B cell differentiation, as has been 
proposed (Coniey. 1985), but rather that Etk is essential 
at two distinct steps, i.e. at the transition from small pre-
B cells to immature B cells in the bone marrow, and 
during the antigen-driven matumtion of selected B cells 
in the periphery. 
The expression pattern of Btk 
The Blk-llaeZ mutation was designed to visualize the Btk-
deficient cells in affected males and heterozygous females 
on the basis of /aeZ activity using FOG as a substrate and 
resulting in fluorescence values that were ~20-30 times 
background levels. The absence of any detectable Btl:-
laeZ fusion proteins of the expected size in Western 
blotting probably indicates that our an!i·Btk antiserum 
does nol recognize such fusion proteins. The alternative 
explanation, of a translation start further downstream, is 
not vcry likcly because only the 77 kDa protein starting 
at the first ATG is nonnally present ill I'im (Tsukada 
et al., 1993) and the ATG at the introduced lacZ cassette 
does not fulfil the sequence context criteria for an initiation 
codon (Kozak, 1987). 
The Btk expression profile was detennined using the 
laeZ gene activity under the control of the endogenous 
Btk promotcr and regulatory elements. Consistent with 
previous findings in cell lines (de Weers el al., 1993; 
Tsukada et al .• 1993: Genevier et al., 1994: Smith et al., 
1994), we found expression orthe Blk gene to be restricted 
to the myeloid and B cell compartments. Within the 
monocyte-macrophage lineage, lJtk expression appeared 
to be abundant in all cells. In the granulocyte population 
in bone marrow and spleen. Btk was expressed in a major 
fraction of the cells but at variable levels. Peripheral T 
cells did not contain detectable amounts of Btl: and, 
moreover, we did not find any evidence for Blk expression 
in the earlier stages of T cell development in the thymus. 
The analyses of B220+ cells in the bone marrow and 
the peripheral compartment showed that the Blk gene is 
expressed in the vast majority of cells throughout B cell 
differentiation. TIle finding of Elk-expressing cells in the 
very early fraction of HSA- pro-B cells in the bone 
marrow, fraction A, implies that Blk expression precedes 
the exprcssion of mallY other genes associated with early 
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B cell development, such as TdT, ~"b-1. V p«.n. ).5. RAG-
I and RAG-2 (Li {'t al., 1993). The fact that not all 
cells in fraction A uniformly express Btk may partly be 
explained by its heterogeneous nature because it appears 
that not all the cells are completely committed to the B 
lineage (Hardy {'t al., 1991: Rolink el al., 1996). 
Btk is not required for the generation of mature 
myeloid cells 
Blk was found to be expressed in the bone Illarrow 
myeloid cells, in splenic granulocytes and in peritoneal 
macrophages. The absence of any selective disadvant-
age of Blk-deficient cells in heterozygous females demon-
strates that Blk expression as such is not required for the 
expansion or differentiation of the various mature myeloid 
cell populations. TIlis conclusion is further supported by 
the apparently 1I0ffim! macrophage fllllction observed in 
xid mice (Scher, 1982) and the random X-chromosome 
inactivation patterns found in peripheral blood granulo~ 
cytes of XLA carriers (Conley et 0/., 1986; Fearon el al .• 
1987). The neutropenia that is frcquently observed in 
XLA patients has been assumcd to be secondary to 
ongoing infection because it resolves after Ig substitution 
therapy (Kozlowski and Evans, 1991). The absence of 
any detectable effects of Blk deficiency on myeloid cells 
may by explained by redundancies within tyrosine kinase 
pathways or may indicate that Btk is involved in a 
signalling pathway that is not essential for myeloid cell 
survival. 
Btk Is critical only past the pre·B cell stage 
The analyses of IneZ expression in the bone marrow of 
Blk+l - heterozygous female mice showed that Blk-deficient 
B cell progenitors develop to the small pre-B cell stage 
at normal frequencies. FurthemlOre, because 1I0ne of the 
pro-B or pre-B fractions contained >50% !m,zt cells, 
there was also no accumulation of B cell precursors that 
are blocked in differentiation. TIle earlie~t detectable 
seiecth'e disadvantage of Elk-deficient cells wa~ recog-
nized at the transition from small prc-B to immature B 
cells. In the heterozygous females only 29% (reduced 
from 50%) of the immature B cells expressed lacZ, which 
is in good agreement with the reduction in size of this 
population in affected males (70% of !lonnal). These 
findings agree with previous findings that .lid pro-B or 
pre-B cells are unaffccted by this mutation. whether in a 
hemizygous male (Reid and Osmond, 1985) or in competi-
tion with !lomlill cells in a heterozygous female (Forrester 
el al., 1987). In contrast, Kahn et al. (1995) noticed an 
increase in the pro-B cell population in both CBAJN xid 
and Btk-kill- mice, indicating some role for Blk in the 
transition from pro-B to pre-I:: cells. However, the signi-
ficance of this finding is unclear becallse xid mice with a 
C57BU6 background manifested a slightly reduced pro-B 
cell fraction size. Our results are in apparent connict with 
those obtained by Kerner et al. (1995). who ob~er\'ed a 
severe failure of Btk- cells to expand to the smali pre-B 
cell stage in ill l'il"O competition assays, in which Hlk" ES 
cells were injected into wild-type blastocysts. We cannot 
formally exclude the possibility thut there are functional 
differences in the respective mutations, but both targeted 
disruptions almost certainly represent true null alleles. 
Alternatively. it is conceivable that the selection ugaimt 
Blk- pre~B cells may result frolll genetic background 
differences between 129 ES cell-dcrived H-2t>:fLy9.1+ 
cells and C57BlJ6 blastocyst-derived H-2b/Ly9.2+ cells. 
In this context, the same Blk- ES cells only partially 
rescued peripheral B cell numbers in RAG-2-defident 
hosts (I-15t;'c, of nomlal). whereas blastocyst comple-
mentation by Blk-kill- ES cells (Kahn et 01 .• 1995) resulted 
in chimeras with B cell numbcrs comparable with those 
in :dd mice (60-70% of normal). Because in heterozygous 
mice Blk-expressing and Btk-deficient cells arise through 
the process of X-chromosome inactivation, there are no 
additionlll genetic differences between the two cell types 
in our Btk-{facZ mouse model. 
A dramatic selection against Btk- cells only occurs late 
in B cell differentiation, during antigen-driven proliferation 
and maturation of the B cells. In the heterozygous females, 
the more immature IgMhighIgD1\".,· cell population still 
contains a substantial pro~rtion of Btk-deficient cells, 
whereas in the Ig~'11o"lgD igh mature D cell population 
these cells are virtually absen!. With increasing age, 
selection against the Btk-deficient B cells becomes more 
pronounced. In this respect, there are no diffcrences 
between our Btk-deficient mice and the .lid mice (Forrcster 
et al., 1987). The major diftcrentialion arrest in the 
periphery is consistent with a crucial function of Btk in B 
cell receptor signalling. This hypothesis is also supported 
by the observed lowcr responses of .tid B cells to anti-Ig 
antibodies (Rigley et 01., 1989), and is substantiated further 
by the findings of tyrosine phosphoT)'lation of Btk ill \'il'O 
accompanied by an increa.~e in its kinase activity ill \'ilro 
after B cell receptor stimulation (Aoki et ai" 1994; de 
Weers et 01., 1994b; Saouaf et al., 1994). 
Because affected males lack CD5+ B cells in the 
peritoneum, it was not surprising to see that Btk-deficient 
CD5+ B cells were also absent in heterozygous females. 
However, the finding that laeZ-expressing cells were also 
not detected within the conventional B cell popUlation in 
the peritoneum would argue for a more critical role for 
Btk in the development of conventional B cells in the 
peritoneum compared with other peripheral lymphoid 
compartments. 
Functional roles of Btk in early 8 cell development 
Our findings imply that in the mouse Btk is not involved 
in signalling pathways essential for the proliferation of 
pro-B and early prc-B cells, which is stroma cell-dependent 
and driven by ILs such as IL-4, JL-5 and in particular 
IL-7 (Rolink and l\felchers, 1991). Tn addition, the fraction 
of lacZ+ cells in Bte'- female mice rcmains the same 
(-30'70) between the immature B cells in the bone marrow 
(fraction E) and the IgMhighlgD(~'" B cells in the periphery 
(Figure 5C and Table II). Together with earlier findings, 
that the homing properties and recirculating abilities of 
.tid B lymphocytes are nomlal (Sprent ('I 01., 1985), our 
results indicate that Blk expression is not relevant for the 
migration process of immature B cells from the bone 
marrow into the periphery, or the initiation of surface IgO 
expression. 
A role for Blk in signalling at the stage bctween pre-B 
cells and B cells still remains puzzling. Moreover, the 
outcome of defcctive Blk function appears to be different 
between mice (which exhibit an impaired transition to 
immature B cells) and man (where an almost complete 
Inactivation of Blk by insertion of LacZ 
block is observed at this stage). These defects may well 
involve the same stage of B cell development. but with 
qllalltitative differences betwecn mice ,md man. In addi-
tion, a large variation ill the numbers of pre-B cells present 
in tht.: bone marro\\' of XLA p.uit.:nts (Pearler al .• 1978: 
Fu et 01 .• 1980: Campanu. ellll .. 1990) would point towards 
a role for Btk in the survival of pre~B cells in humans. In 
this context, it is interesting to note thnt mice and 
humans show differences in their expres"ion patterns of 
Ig surrogate lig.ht (SL) chains at the transition from pre-
B to immature B cells (Lassoued et al., 1993; K:uasuymua 
et 01., 1994). Allhough both murine and hUlllan pre~B cell 
lines express SL chains on the cell surface in n~sodlltion 
with Jill chain, the surface expression of this pH-SL 
complex on normal bone Illarrow cells can only be detected 
in humans (on late stage pre-B cells; Lassoucd et al., 
1993). This offers the possibility of:m interaction of the 
JIH-SL complex with an environmental ligand to promote 
the transition from pre-B to immature B celis in humans. 
In the mouse, the surtace expression of SL ceases once 
pH is produced; the small pre-B cells express JlH intm-
cellularly but do not express SL in either the surface or 
the cytoplasm. An attractive model for Blk function in the 
pre-B cell would be its involvement in signal transduction 
from the pH-SL complex. which in humans would be 
essential for the enhanced survival of pre-B cells and 
further differentiation into the immature B cell. In mice, 
the role for Btk appears to be less critical because immature 
B cells are generated at only moderately reduced numbers. 
In summar)" our BtldlacZ mouse model allows the 
novel detection in heterozygous fcmales of subtle defects 
that may only lead to minor selective disadvantages for 
Btk-dcficient cells. In future studies, such as transgenic 
rescue cxperiments or crosses with other knock-out strains, 
these mice will again offer the same possibility of the 
identification of defects which may not be recognized 
from the phenotype of only affected males. 
Materials and methods 
Constructfon of the targeting vector 
Blk-<:oolJining cosmid don~~ were isolated from;l 129 mou..;e genomic 
DNA llbnlI)" (Nva tI <>1., 1995) by ser""'ning I,ilh;l hUlllan [JI( eDNA 
J'ro~ (de \\'ccrs £1 al., 1993). A 1.0 )"b S"ll-Sud end fragmenl 
encomp~sing c:>;on' 7 and 8,;md J 1...1 kb BllmHJ (l""Jgment cnC{lmp~"ing 
e~on, 13-11, were doned into Blue,cript (6S). A 4.6 J..b [J'1'111 fragmenl, 
with the nlslu,Z g~ne Jod th;: 1ifO-~elecl.lhle !1lJ.Ika (Nua t"f <II .. 1995). 
\\as blunleJ and doned into a parti~lly digeswl .md hlunlcd Mw!1 
frJgrnenl at e\on R. The in-fl""Jllle in'erli"n of the fr/{"Z gene ~I Bit 
Lcu235 \\"JS writied by (I DNA ~e<luence ilJldl}'i •. A Kpllt-Spd fragment 
conlJining Ihe PyEn-HSV Ih)mhline J...inJ.'c (TK) gene \\"J, ,uh,cquenlly 
introduced in the BS po!)'!inJ..er up<lr<.'JIll of ",on 7. The ~~mc -1.6 )"h 
B'pHI n(,I",·Z-/1,." fmgmenl \13.> Jlso doned inlo Ih~ Sm,,1 ~ile of Ihe 
BS poJylinker at the 5' end orlh ... 7.4 J..h IIwlIlII (l"""'gm"n\. TIle tJrgeling 
welN WJS con'lrucled by combining Ihe 1"<1 pia,mids. onc conl<lin-
ing the TK gene", 5' BIl; homology and nl'/<lc7.ll<"'" ;lnd one 'onlJining 
n\,f,,<,Z--Il((I and 3' flil. homology. using <l uni,!u~ CI"I sitc in Ihe ("eZ 
gene and Kpl1r siles in Ih\' BS pol}'linker'i. 
Generation of mutant mice 
EI4 lOS ce"lIs were (uhurcd in BRL-<:ondilinn~d I1l~Jiul1l suppkmeoleJ 
with 1000 Ufml leukaemia inhitJilt)!)' ra((Or. The tar£eling w({or I\a.~ 
linearized Ililh ,voll Jnd de.:lmJ'orJled inlO ES cell, (8 j.1g 0;-':" per 
107 cells in 500 j.1\),:iS d~scriheJ prniou,ly (Zhou fI (If • 1995). Sekclion 
\Iilh 0.2 mgfml G418 and 0.2 jl~l HAU \\.1' 'lJrteJ 24 h after 
e1eclroporJlion. After 8-10 dll». doubk-rc<i<laTII d<>ne~ I\ere ,ckcled 
and e"\PJo<.kd, PJltly fmun in rfY~ dill1cthylsulfo\ide and pJ.!lly used 
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h. isolate ~enomk DNA. Sneening for homologous recombinants 
Wol!' ~rformed b}' Southern blolling of E<"oRI·dige;ted DNA and 
h}bridiz.l!ion to a human Bil eDNA fragment done (133-1153 bpJ 
h)bridizing to e.\OIlS 2-11 (de Weers et uf., 1993). Four mutant El4 
clone;; weee identilled and \'erilled by Southern blot analyses of EcoRI, 
DumHI ~nd IJindUI digests, using genomic pwbes spcdrk for BII; exon 1 
(1.8 kb mouse genomic £wRf fragment), ewn 2 (0.9 kb mouse genomic 
PJII fragment). e~ons 12-19 (1.0 I..b human 3' fragment eDNA P!"l.)be: 
M W.xrs ct <If., 19<}3) and a lucZ probe. 1\1'0 F-S clone; (JIl)"ing the 
Dlk-/{m-7. mutation were injeded into bla-'.tocysts of C57BU6 mice 
(Robertson, 1987) and transplanted into BL6ICBA fomr mothers. The 
resulting male (himadS tha! had >80'k agouti were mated to C57BU6 
female;;. Oerrnlinc tro1llImi,sion of the targeted Blk allele to femJle 
off'pring was wrified by a Southern blot analysis. The.<;e females II ere 
further bred [0 CS711U6 males: th~refore the mke ana!ysed had a mi,ed 
119lC57B1J6 background. 
Western blotting 
For the We;!em blotting analysis. l)"sJtes of 5x I()~ cells were separated 
on 10% SDS-PAGE gels under reducing condi!ioll.S and [rJnsferr~d to 
ni!rocellulose. Blots were blocked with 5'k non·M dl)' milk in 20 mM 
Tris-HCI. pH 7.6. 137 m.\[ NaC], 0.05\1 Tween 20 and in(uw!ed with 
fjPl{· ~nd ~ccond·~tep r~agen[s in the s~1lIe buffer Ilith Ilk- non· fat dry 
milk. The polydonal B[I.: antiserum I\;}.<; raised againlt fusion prouins 
of glutathione S·transferase and amino acids 163-218 of the human Btk 
protein (Katz el al .. 199..\). The antibody. \\hkh also detects murine B[k 
because amino ;\cids 163-206 are completely conser .... ed, was used in a 
1 :1000 dillltion Ilith hnr;efildish penl.\idase·conjugaled swine In[i.rabbit 
Ig ;l.' a second step and del·e!.)ped by enhanced chemiluminescence. as 
de"ribed previously (de Weers t'lll/., 1994b). 
Flow cytometrlc analysis 
Single·cell suspensions were prepared from lymphoid orgall.S in PBS. 
es"~ntiaHy ~<;. de,cribed preliou;;l}" (Slieker cl (II •• 19<}3). Peripheral 
blo..,J mononude.l! (ells were isolaled by demily gr.ldi~n[ centrifugJtion 
u,ing L)'mphoprep IN)'comed PhamlJ AS. O;!o. Noma)'). p-OalactosiJ-
ase activity W,lS anal)"sed by loading 2xIIJ'i cells in 50 VI Dnlbecco's 
modified Eagle's medium (D~lEM)/IO\1 fetal bolin.! serum (FBS) Ilith 
an equal volume of 2 m~l FDG (Mok(ular Probes Europe. l.eiden, The 
Netherland,) at 37'C for 60 s (Nolan eI al .• 1988). To stop th~ r(anion, 
I ml ice-<:old D~tE~lIFBS I\as Jdded. FDG·loJded cells were allo\\ed 
to react with the FDG substrate for 30 min (on ice). and subsequently 
~tained with monoclonal an[itxxiies. Wh~n kept on ke. FDO ,taining 
was found to be stable up to 7 h after lo~ding. 
Appro.,imatdy 1-1X IW cells were incubated \\ill1 antibodies in PBSI 
OYf bovine serum albumin (BSA}l20m.\I NaN) in 96-wel! U·bouomed 
plates for 30 min at ..\'e. Cells \\ere Ila\.tJed tllke in PBSIO.S~ BSM 
Na.t'l). For ea(h sanlple. 3xIW cell~ I\ere scoreJ using a FACScan 
JnalySef (Be(ton Dickinson, Sunn)\"ale. CAl equipped Ilith appropriate 
flite£5 for a Ihree·~olour analysis. For four-<:olour immunofluorescence 
oflhe bone marrow sanlple~. 1-3X 105 ('\ents were ~cored usin~ (I FACS 
Vantage dual laser (488 and 595 nm ewitation) fadlity Ji Be.:ton 
Dickinson (Erembodegem. Belgium). FACS data were anal~'sed using 
CdlQuest version 1.0 ;;omputer software: statistical el'aluations were 
perfonned with Insta[ l'e£5ion 2.0 (Gr.lphpad Software, Sill Diego, CAl. 
The follo\\ing monoclonal M[ibodie, wae purchased from PharM-
ingen (San Diego. CAl: PE-<:onjugated anti.CDSILy·l, Mli-CDIth/Mac. 
I, anti·HSAlM 1169 and anli·CD-t3/S7: blolinylated anli·HSAlM 1/6. anti-
BP-!/6CJ and In[i·lgM; and Cy-Chrome· Jnd APC·conjugated anti-
B220/RA3-6B2. Fluorescein isolhilXyanale-conjugated In[i·B220IRA3-
6B2 lIas obtained from Sigma (St louis. MO). and PE-c:onjngated anli· 
IgD lIa<; purchased from Southern Biotechnology {BimlingtJam. ALJ. 
PE·conjngated anli·CD-t Ivas purchased from Becton DicJ."inson. ,\nli. 
CD8/53-6. 7. anti ·Or·11R B6-8CS Md F:R·~tP20 were purified monoclonal 
antil:>oJies conjugated to biotin (de Bruijn ct (If., 199.JJ. Se.:ondary 
antibodie;; med were TriColor· or PE-c:..,njugated strep1avidin (Calr.ag 
LaborJlOri~s. CAlor streplJvidin-Red 613 (Bcc!lln Dickim;on). 
In vitro cultures and Ig ELISA 
Whole,spleen cell suspensioll.S from 5 lleek-old mke were prepared and 
(uhured with SO vglml E.coli lipopolysaccharide as described previollsly 
(Sal"dkoul cl al., 1988). The (ui(ure supt'matanlS \Iere as<;aycd for the 
production of Ig~l, IgO!, IgOla and Ig03 on day 7 in an isotype· 
specific ELISA using antisera purchased fwm Southern Biotechnology. 
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Mutations in the gene for Bruton's tyrosine kinase result in the B cell differentia-
tion defects X-linked agammaglobulinemia in man and X-linked immunodefi_ 
ciency in mice. Here we describ the generation of two yeast artificial chromo· 
some (YAC)-transgenic mouse strains in which high-level expression of human 
Blk is provided by endogenous regulatory cis-acting elements that are present on 
a 340-kb transgene. Yc340-hBrk. The expression pattern of the transgenic human 
Btk was found to parallel that of the endogenous murine gene. When the Yc340· 
hBlk~transgenic mice were mated onto a Blk-deficient background, the .tid B 
cell defects were fully corrected: conventional and CD5+ B-1 B cells were pres-
ent in normal numbers, serum IgM and IgG31eveJs as well as responses toTcell-
independent type II antigens were in the normal ranges. 111 ~'ivo competition 
experiments in Btk+J.- female mice demonstrated that in the conventional B cell 
population the Yc340-hBtk transgene could fully compensate the abscnce of 
expression of endogenous murine Btk. We conclude that in the YAC-transgenic 
mice Btk is appropriately expressed in the context of native regulatory sequences. 
1 Introduction 
Bruton's tyrosine kinase (Btk) is a non-receptor protein 
tyrosine kinase that is mutated in X-linked agammaglobu-
linemia (XLA) in man and X-linked immunodeficiency in 
the mouse [1-4]_ XLA is characterized by severe and 
recurrent bacterial infections. Affected males have very 
low serum levels of all Ig classes. In the periphery, surface 
Ig+ B cell numbers are severely decreased and plasma cells 
are virtually missing_ Because in BM of XLA patients pre-
B cells are present, the disease is manifested as an arrest in 
differentiation of pre-B cells to later B cell stages (for 
review see (5». Although Btk-deficient mice exhibit a less 
severe B cell deficiency, the first selective disadvantage of 
Btk-deficient cells was also found at the transition from 
small pre-B to immature B cells in the BM [6}. Both CDAI 
N mice carrying an Arg2S pleckstrin homology (PH) 
domain mutation, and mice with targeted disruptions of 
Btk in their germ line display the x-linked immunodefi-
ciency (.tid) phenotype. The disorder is characterized by a 
decrease of peripheral B cell numbers. specifically of 
mature surface IgM~gDhlg,h cells, an absence of perito-
[I 170841 
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neal CDs+ B-1 B cells, low levels of serum IgM and IgG3 
and severely impaired responses to T cell-independent 
type II (11-11) antigens [6-8]. 
The Btk gene encodes a 659-amino acid protein that con-
tains a single kinase domain, the src homology domains 
SH2 and SH3, and an N-terminal region with a PH domain 
and a unique proline-rich Tee homology (TH) domain 
[1-5]. Several molecules, including Src family kinases. 
protein kinase C, ~ysubunits of heterotrimeric G proteins, 
and the 120-kDa protcin encoded by the c-chl proto-
oncogene have been shown to interact with the individual 
domains of Blk, mainly by studies ill vitro (reviewed in 
[9]). Btk has been implicated in signaling events induced 
by cross-linking of the surface Ig receptor. IL-5, IL-6, 
CD38 and CD40 in B cells and FeERI in mast cells and 
basophils {5, 9]. 
The expression pattern of the Btk genc was investigated in 
mice and man using cultured cell lines [10, 11], as well as 
by analysis of p-galactosidase activity in ~'iyo in mice with 
a targeted in-frame insertion of a IncZ reporter in the Blk 
gene [6]_ Blk is expressed throughout B cell development, 
from the earliest identifiable pro-B cell stage 
(B220+CD43+HSA-Ig-j 12) up to maturc B cell stages. At 
the transition from mature B cells to plasma celis, expres-
sion is down-regulated. Btk is not expressed in the T cell 
lineage. Although Blk is also expressed in myeloid cells, it 
is not required for myeloid differentiation, since myeloid 
cells are not affected in XLA or in xid [5}_ 
The tissue-specific and differentiation stage+specific Blk 
expression may - at least in part - be accomplished by the 
Btk promoter region, which contains several binding sites 
for the transcription factors Spi and pu.t [13, 14]. 
Although transient transfection experiments implicate 
pu.t as a major regulator for Btk expression in B cells and 
myeloid cells, other elements may well be required, espe-
cially because Btk expression is not abolished in fetal liver 
of PU.1-deficient mice [14}. 
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To develop methods to investigate the effects of Blk muta-
tions i/l vivo and to analyze the developmental control of 
Blk gene expression, we generated Blk-transgenic mice. 
Because far upstream or downstream cis-acting regulatory 
elements arc essential for correct expression of genes 
[15-17], large DNA transgenes are needed to exclude any 
influence of the chromatin environment at the position of 
integration in the mouse genome (17.18]. We have used a 
340·kb yeast artificial chromosome (YAC) clone contain-
ing the human Blk gene to generate transgenic mice in 
which the expression of Blk is under the control of native 
regulatory sequences. By mating these Blk transgenic mice 
onto a Blk·deficient background, we show that the xid 
phenotype in the mouse is completely corrected byexpres· 
sion of human Blk from the YAC transgenc. 
2 Materials and methods 
2.1 Southern and Western blotting 
High molecular weight DNA was extracted and processed 
by Southern blotting analyses using standard methods [19]. 
The 340·kb YAC clone Yc340·hBlk was from the ICI 
human DNA YAC library (20] and was selected by hybrid-
ization to probes specific for the DXS178 locus. The 
DXSIOI. DXSI78. DXS26S. DXS366. DXS442. SD8IDDP 
and GLA probes and cDNA, for which the Ye340-hBlk 
YAC was screened, have been described [21, 22]. In addi-
tion, the following probes were applied: Blk.1 (human Blk 
eDNA bp 133-US3 [23]; Blk.2 (human Blk cDNA bp 
1049-2159), FTP-3, a 1.8-kb PCR fragment from position 
9373 to 10749 [24}, YcL (YAC left ann probe; a 2.3-kb 
PV/lll-EcoRI fragment of pBR322 [2S}) and YcR (YAC 
right arm probe; a 1.4 Pvull-Sall fragment of pBR322 
[2S». 
Western blotting was perfomled'as described [6}. 
2.2 Isolation ofYAC DNA and generation of transgenic 
mice 
Isolation of the YAC was performed essentially as 
described [18J, except that the agarose blocks of yeast cells 
were made in 1 % low·melting point agarose in SCE (1 M 
sorbitol, 100 mM sodium citrate pH S.8, 10 mM EDTA) 
and a final zymolyase concentration of 4 mglml. The aga-
rose blocks were incubated in SCE containing 10 mM 
DIT at 37°C for 2 h, followed by incubation in 400 mM 
EDTA pH 7.5,1 % sarkosyl and 2 mglml proteinase K at 
SO°C overnight. Size-fractionation of yeast chromosomes, 
isolation and preparation ofYAC DNA were as described 
[18J. Purified YAC DNA was micro·injected into pronuclei 
of FVB fertilized oocytes [26] at various concentrations 
(2-10 ng/ml). 
2.3 Reverse transcription polymerase chain reaction 
Isolation of RNA and eDNA synthesis have been 
described (27). PCR reactions were performed in 50 III 
PCR buffer (Life Technologies, Paisley, OD), 1 pmoU!1i of 
each primer and O.3IlCi of (a_JZP]dATP. Amplification 
was for 2S cycles with denaturation at 94°C for 30 s, foJ-
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lowed by annealing at S8°C for 30 s and extension at 72 °c 
for 45 s. PCR products were visualized by electrophoresis 
on a 6 % polyacrylamide IX TBE gel followed by autoradi-
ography. Quantifications were performed using IMAGE-
QUANT (Molecular Dynamics). Primers specific for 
human Blk (S'·OACfGCfOAACACATTGCCC-3' and 
5'-AOAAGTAGAACCAAGAAGCITAT-3') and murine 
Blk (S'-GACAGCAGAACACAITGCfCA-3' and 5'-
CfCAGGAAACATGGAATIAGGT-3') were in exons 18 
and 19. Murine hypoxanthine phosphoribosyl-transferase 
(HPRD primers have been described [27J. 
2.4 Flow c,)iometric analyses 
Preparation of single-cell suspensions,loading of cells with 
fluorescein·di,p·D·galactopyranoside to measure p. 
galactosidase activity and three·color flow cxtometry have 
been described [6]. Cells (3 x 1O'~S x 10 ) were scored 
using a FACScan flow cytometer (Becton Dickinson, Sun-
nyvale, CA). mAb obtained from Pharmingen (San 
Diego, CA) included PE·conjugated anti-CD4, anti-CDS, 
anti·CDllblMac-1 and anti·CD43; biotinylated anti-IgM 
and anti·CD8; FITC·conjugated anti·D220IRA3·6B2 and 
anti-CD3. PE·conjugated anti·IgD was purchased from 
Southern Biotechnology Associates (SEA, Birmingham. 
AL). niColor·conjugated streptavidin (Caltag Laborat-
ories, CA) was used as a secondary antibody. 
2.5 Serum Ig defection and immunizations ;" ~·itro 
Serum levels of Ig subclasses were determined by iso-
type-specific sandwich ELISA [28J. To measure TI-II 
responses, mice were injected i. p. with SO I'g DNP-Picoll 
in PBS and DNP-specific Ig subclasses were analyzed at 
day 7 by ELISA. To measure thymus·dependent (TD) 
responses, mice were immunized with 100 11g TNp·KLH 
precipitated with alum; after 3 months a booster dose of 
100 11gTNP-KLH was given andTNP-specific Ig subclasses 
were analyzed at day 7 after the booster. For DNPffNP· 
specific sandwich ELISA assays, plates were coated with 
isotype-specific antibodies and serum dilutions were 
incubated over night. Subsequent steps were biotinylated 
TNP-KLH, streptavidin·coupled peroxidase and azino·bis-
ethylbenzthiazoline·sulfonic acid (AnTS) as a substrate. 
Absorbance (A) was read at 419 nm. 
3 Results 
3.1 The Yc340.hBlk-fransgenJc mice contain the human 
Blk gene 
The YAC clone Yc340·hBlk was isolated from the ICI YAC 
library [20J on the basis of hybridization with the DXS178 
probe, which is 80-150 kb distal to Blk [1, 21]. Yc340-hBtk 
was found to contain the 40 kb human Blk gene, approxi-
mately 100 kb of 5' flanking DNA and 200 kb of3' flanking 
DNA (Fig. lA). The YAC also included several other 
genes, such as a·galactosidase A, the ribosomal protein 
IA4L, the RNA-binding protein FfP-3 and the deafness! 
dystonia peptide (DDP) [22, 24], as well as the poly-
morphic markers DXS178 and DXS265. The YAC was 
negative for more distant markers, including DXS366, 
Yc340~hBtk transgenic mice 
not shown}. Fluorescence ill situ hybridization of meta-
A 
phase chromosomes to human Blk sequences demon_ 
strated single integration spots at chromosome 14 for T9 
I ~ ... and chromosome 3 for TH. In the transgenic lines. no >--t~'b~XS~I'"1S.-_-+~'I-'~B~/~k"------lIr- developmental deCects or any increased susceptibility to infectious diseases or malignancies wcre observed on vari-G ~,"l.. ous genetic backgrounds (FVB, 129 or C57BU6) for over FTN 10 months of age. 
B 
<214.0 
+10.7 
<210.0 
<2 8.1 
1+ 5.8 
Figure 1. Generation ofYc340·hBtk·transgenic mice. (A) Map of 
the 340·kb YAC transgene construct, sho'Ning the location of the 
Btk gene (filled box). the L44L, {(·galactosidase A (OLA) and 
FTP-3genes (open boxes) and the polymorphic marker DXS178. 
Arrows indicate the direction of transcription. (8) Southern blot 
analysis of DNA from the two different Yc340-hBlk-transgenic 
mouse Jines 1'9 and TIl on various backgrounds, wild·type (Ble), 
knockout (Blk-). or heterozygous females (Blk'I-). as well as from 
human and mouse controls. DNA samples were digested .... ith 
EeoRI and probed with a hUman Blk cDNA fragment (Blk.I). 
The closed arrows indicate the 1O.7-kb and 5.8-kb Yc340·hBlk· 
transgenic bands. The open arrows indicate the endogenous 
murine bands, which are 8.1 kb and 14 kb (wild-type allele) or 8.1 
and 10.0 (knockout allele). The genotypes are indicated at the 
top. 
DXS442 and DXSIOI. In a comparison ofYc340·hBlk with 
other DXS178·positive YAC and genomic DNA, by pulse-
field gel electrophoresis, Southern blotting and Alu fin-
gerprinting, we did not find evidence that the Yc340·hBlk 
is rearranged, deleted or a hybrid clone (data not shown). 
The Yc340-hBlk YAC was isolated by pulse-field electro-
phoresis, purified and microinjected. Out of 50 offspring 
born. two hBlk-transgenic mouse lines, 1'9 and TH. were 
obtained (Fig. lD). In Southern blotting analyses using 
BamHI. EcoRI, Hil/dIlI. XbaI and PvltII and probes spe-
cific of the entire Elk gene, FTP-3andDXS178. all restric-
tion fragments present in the Yc340·hBlk YAC clone were 
also found in the transgenic lines; both lines contained left 
and right YAC arm sequences. Densitometric quantifica-
tions indicated that T9 and Til were low· copy transgenic 
lines. containing two to three copiesoC the hBlk gene (data 
3.2 The expression paUem of transgenic human Btk 
To investigate whether the expression of the transgcnic 
human Blk gene is comparable to that oC the endogenous 
murine Blk gene, RT-PCR experiments were performed 
on various tissues Crom Yc340·hBlk·transgenic mice 
(Fig. 2A). Both the human and the murine Btk gene were 
found to be highly expressed in spleen and BM. whereas 
A 
B 
19 
33 
7 
4 
0.4 0.5 <0.2 <0.2 <0.2 
1.0 J.S <0.2 <0.2 23 
Blk-/Y 
hBlk FA> IIprl) 
ntBtk (% Ifprl) 
II Y c340·hBlk transgenic 19 1"9 T9 Til Til 
Figure 2. E.xpression of the Yc34O-hBlk transgene. (A) RT-PCR 
analysis of cDNA samples from the indicated tissues from a 
Ye340·hBlk·transgenic Btk tlt mouse. Spleen from a non-
transgenic mouse was included as a control (NT). The human and 
the murine Blk·specifie amplified products were - 200 and - 230 
bp, respectively. Yields were nonnalized using HPRT RT-PCR 
products ( ..... 250 bp). At the bottom. the relative densities of the 
human and the murine Blk RT-PCR products are given as per· 
centages of the values of the HPRTRT·PCR products. (8) Wes-
tern blot analysis of Blk expression in total ceJlly'Sates (2 x lOS 
cellsflane) from spleen from 2·month·old .... ild·type (Btk+N), 
knockout (Blk-N) and Yc34O-hBtk-transgenic Blk-fY mice. The 
position of the 77·kDa Blk band is indic.ated. 
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Thble 1. Flow cytometric analysis of the lymphocyte compartments in Yc340-hBtk-transgenic mice') 
Non-transgenic Yc340-hBtk-transgenic 
TIssue Cell population Btk+fY Btk-fY B/k+fY Blk-N 
Bone marrow B220· eells. % 16 ± 3 15 ± 2 19 ± 4 19 ± 
Pro-B (CD43+). % 3± 1 3 ± 1 3± 1 3± 
Pre-D (CD43-IgM-). % 5± 2 5 ± 2 7± 1 6± 
Immature D (IgM'IgD-). % 4± 2 3 ± 1 4± 1 3± 
Mature B (IgM+IgD;t, % 4± 1 1.0 ± 0.4 4 ± 1 5± 2 
Spleen Nucleated eells, x 1 192 ± 33 82 ± 15 173 ± 28 155 ± 27 
D2l0+ eells, % 51 ± 10 29 ± 12 55 ± 3 55± 7 
IgM~gD\4It D eels, % 31 ± 5 6 ± 3 30 ± 3 31 ± 4 
CD3+CD4+Teells. % 20 ± 3 19 ± 5 19 ± 2 18 ± 1 
CD3+CD8+Tcclls. % 11± 4 10 ± 3 1O± 3 H± 3 
MLN D220+ cells, % 24± 4 12 ± 2 24 ± 4 23± 6 
IgM~gDlIp B cells. % 21 ± 2 3 ± 1 17 ± 4 18 ± 4 
CD3+CD4+ Tcells. % 48 ± 7 52 ± 9 45 ± 3 38 ± 8 
CD3+CD8+ Tcells, % 23 ± 3 27 + 6 23 ± 3 23± 4 
Peritoneum CDY De-ells, % 4± 2 0.3 ± 0.3 3± 2 9± 5 
CDS- B cells, % to± 6 2 ± 1 !O± 4 IS ± 9 
CD5+Tcells, % 4± 2 4 ± 2 3± 3 4± 2 
a) Mke were 6-10 weeks old. Numbers of mice anlyzed are: 7 for Yc340-hBtk·transgenic Btk+/Ymice and 4-7 for the other groups. 
low but detectable signals were present in thymus and 
lung. Quantification of the densities of the amplified prod-
ucts indicated that the expression levels of the human and 
the murine Blk genes were similar. Murine or human Brk 
RT·PCR products were not detected in liver, brain. kidney. 
intestine, ovary or heart (Fig. 2A, and data not shown), 
indicating the absence of additional. integration site-
dependent, expression of the Yc340-hBtk transgene. 
The Yc340-hBrk-transgenic mice were mated onto a Btk~ 
background, i.e. mice with a targeted inactivation of the 
Btk gene by an in-frame insertion of a LacZ cassette {6]. 
Btk protein expression was evaluated by Western blotting 
of total spleen cell Iysates from Yc340-hBtk-transgenic 
Brk-ty male mice (Fig. 2B). Using a polyclonal rabbit anti-
serum which recognizes both human and murine Btk. a 'n-
kDa band was obsen'ed in wild-type Bte ty mice and 
absent in knockout Blk-ty mice. In the two Yc340-hBrk-
transgenic lines 1'9 and Til on the Btk-ty background. Btk 
protein was detected at levels comparable to those in wild-
type mice (Fig. 23). In all further analyses described 
below. the two Yc340-hBtk lines did not exhibit any differ-
ences and, therefore. data from the two transgenic lines 
were combined. 
3.3 ltansgenlc Yc340·hBtk expression reslores B ceU 
numbers 
To investigate whether expression of the Yc340-hBtk trans-
gene could fully compensate the absence of the endoge-
nous murine Blk gene, we examined the lymphoid popula-
tions in four groups of 6-1O-week-old male mice: wild-type 
and Blk~/y mice, either non-transgenic or Yc340·hBtk-
transgenic (Thble 1; Fig. 3). Flow cytometric analyses of 
BM, spleen. mesenteric lymph nodes (MLN). thymus and 
peritoneum displayed the xid phenotype in the Btk-ty 
mice {6-8]. The numbers of B lymphocytes, in particular 
recirculating IgM+IgD+ B cells in the BM and mature 
IgM""'1gDhiJ/l B cells in the periphery. were significantly 
reduced and the population ofCDS+ B-l B lymphocytes in 
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the peritoneal cavity was missing. In contrast, the Btk~ty 
mice that expressed the Yc340-hBtk transgene had normal 
numbers of mature B cells in BM, spleen and MLN, and of 
CD5+ B-1 B cells in the peritoneum (Table 1; Fig. 3). The 
additional expression of the Yc340-hBtk transgene on the 
wild-type background did not have any effect on the B cell 
numbers. The four groups of mice analyzed did not show 
significant differences in the numbers of myeloid or T lin-
eage cells. 
3.4 ltansgenlc Yc340·hBtk expression reslores serum Ig 
1C\'els and responses 10 TI-lI antigens 
Although Yc340-hBtk-transgenic Btk-ty mice had normal 
B cell numbers, a possibility remained that B cell function 
was not fully restored. 
Serum levels of all Ig isotypes were detennined by ELISA 
in 2-month·old mice from the four genotype groups 
described in Sect. 3.3. The Blk-ty knockout mice had de-
cresed concentrations of IgM and Ig03 in the serum 
(Fig. 4A), whereas the levels of IgOl. IgG2a, IgG2b, IgA 
or IgE were in the normal range (data not shown). The 
Yc340-hBtk-transgenic mice, both on the wild-type back-
ground and on the Btk-ty background, manifested serum 
Ig levels that were in the nonnal range for all isotypes, 
including IgM and Ig03 (Fig. 4A). 
To analyze the responsiveness to 11-11 antigens ill vivo, 2-
month·old mice were injected i. p. with DNP·Ficoll, and 
after 7 days DNP-specific antibodies were measured by 
ELISA (Fig. 4B). In Btk-deficient mice, DNP-specific 
IgM or IgG3 was completely absent: absorbance measured 
did not direer from the values of unimmunized animals. In 
contrast. the TI-II responses of Yc340-hBlk-transgenic 
mice, both on a wild-type and on a Btk~ty background. 
were comparable to those of wild type mice. As a control, 
secondary responses were measured after immunization ill 
vivo with the T cell-dependent antigen TNp·KLH. The 
TNP-specific IgM, IgGI and IgG2a responses were not sig· 
Yc340-hBtk transgenic mice 
non-transgenIc ,co ---:cYc034::.cO-C"hBol='c"",=~,g<,=,,,,,'--, 
BI);+ fY Btk- fY Blk+ fY Blk- fY 
!~.-_~~.I~I_~ Bone marrow Figure 3. The effect of the Yc340-hBIk Iransgene on peripheral B lymphocyte populations. Three·color flow cytometric analysis of BM, spleen, MLN, and perito-neal cavity from 6-8-week-old non-transgenic and Ye340-hBlk-transgenic Blk+fY or Blk-fY mice. Spleen, MLN and BM cell suspensions were stained with bioti-nylated anti-lgM and streptavidin-TriColor, PE-
conjugated anti-IgD, and FlTe-conjugated anti-B220, 
and B220· cells are displayed. Percentages of total BM 
cells that are B220'IgM'IgD' are displayed in the 
boxes (Fraction F; (12, 29». For spleen and MLN the 
proportions of cells that are IgMI.'"··JgDhl¢ (Fraction I; 
(29», IgM~'!.-\lgDbt> (Fraction II), and IgMb;/JIIgDb .. 
(Fraction III) are shown. Peritoneal cells were stained 
\\ith anti-8220, anti-lgM anti-CD5-PE and 8220+ cells 
are displayed. The percentages of total cells (including 
peritoneal macrophages) that are B220'CD5+ D cells 
or conventional 8220+COS" B cells are indicated. Data 
shown are representative of the mice examined and 
shown as 5% probability contour plots. 
~:EiilJ~~ -L:iJ~LiJL:lJ Spleen 
t!J~f!EJffi 
~ 1:iJ~raIilJ 
MLN 
Peritoneum 
-------1,'1------_ 
nificantly different between the four groups of mice ana-
lyzed (Fig. 4C). 
In summary, these results show that transgenic Yc340-hBlk 
expression did not affect serum Ig concentrations ofTI-II 
or TD responses ;11 vi~'o in the presence of endogenous 
murine Blk. More importantly, the selective IgM and Ig03 
deficiency in the serum and the unresponsiveness ill vivo 
to TI-II antigens of Blk-fY knockout mice was restored by 
transgenic Yc340-hBlk expression. 
3.5 III lIi,'o compefilion between n cells expressing only 
Y1.'340-hBlk and n cells that also express endogenous 
murine Blk 
In the I1lk-lIacZ mice, expression of the disrupted Blk 
allele can be monitored by lacZ activity: in Blk- males, 
virtually all B220-l- cells, except for HSA-CD43-1- pro-B 
cells in the BM, express lacZ. Because of the process of 
random X-chromosome inactivaton, about half of the B-
lineage cells in female Hlel-- heterozygous mice will have 
the disrupted Blk allele on the active X chromosome. 
When these cells reach a developmental stage at which Blk 
is required, they are arrested in differentiation. We previ-
ously identified selective disadvantages of Blk- cells within 
B cell subpopulations by a reduction of the proportion of 
lacZ-I- cells below the value of 50% [6]. In the BM of Ble'-
heterozygous mice such selective disadvantages were 
absent up to the B220+C043- pre·B cell stage, but were 
first exposed at the transition to the immature IgMtIgO-B 
cell and, more markedly, in mature JgM-I-IgO+ B cells (6). 
In the Yc340-hBlk-transgenic mice, we used lacZ expres· 
sion anlysis as an ;11 vivo competition assay to compare the 
capacities of B cells that only express transgenic human 
Blk and B cells that express the transgenic human Blk in 
addition to the endogenous murine Blk. Cells from BM, 
spleen, MLN and peritoneum (rom BlkH - females, either 
non· transgenic of Yc340-hDlk-transgenic, were analyzed 
for laeZ expression by flow cytometry. Fluorescein di-P-D-
galactopyranoside was used as a substrate, in conjunction 
with surface markers that define various B cell popula-
tions. The proportions of lacZ-expressing cells in the non-
transgenic females decreased during B cell maturation 
CI~:CSJlSJ 
--Figure 4. Expression of the Yc340--hBtk transgene corrects serum 
Ig levels and responses ill ~'il'o to TI-II antigens. (A) Serum con-
centrations of IgM and IgG3 in unimmunized 2-month-old mice 
from the four different groups indicated. (0) ForTI-II responses, 
serum concentrations of DNP/INP-specific IgM and IgG3 anti-
bodies were determined 7 days after i. p. injection of DNP-FicoII. 
For each serum dilution, the A (00) are shown as mean values 
from 6 to 12 mice in each group. The values for pre-immune sera 
(II = 8, 2 from each group) were not significantly different 
between the four groups. (C) To determine secondary TD re-
sponses, serum concentrations of DNPfTNP-specific IgM, IgGl 
and IgG2a were measured 7 da)'s after an i. p. booster with TNP-
KLH. 
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Figure 5. The effect of the Yc340-hBlk transgene in female Blk'/-
mice. Cell suspensions of non.transgenic and Yc340-hBlk-
transgenic Btk'/- mice were loaded with FDG to asses LacZ activ-
ity, and subsequently stained with anti-B22()"FlTC. biotinylated 
anti-Igl-.1/streptavidin.1fiColor, and either PE-conjugated anti-
IgO. PE-conjugated anti-CDS or PE-conjugated anti-CD43. For 
the indicated de\'elopmental B ceU fractions in the BM and the 
peripheral organs [12, 29), the proportions of cells that express 
LncZ are shown. Data are gh'en as mean values and standard 
de\iations flOm three to nine non-transgenic mice and fi,'e 10 nine 
Yc340-hBtk-transgenic mice that were 7-10 weeks of age. 0 = 
B22~""~CD43- pre-n cells,. E = IgM+IgO- immature B cells, Fill = 
IgMb;!-\lgD1"", Fn = IgMIJ&I>IgD~"P., Fl = IgMio-.lgDl¢ mature B 
cells. 
from ~50% in CD43- pre-a cells (Fig. 5, fraction D), to 
-30% in immature IgM+ B cells (fraction E) in BM, and 
to almost undetectable levels in mature IgM!-O'i>IgDbiP. B 
cells (fraction F1) in BM, spleen and MLN, as previously 
reported [6]. In contrast, in the Yc340-hBlk-trangenic 
Blk+/- heterozygous females, IneZ-expressing cells repre-
sented 50 % of the a cell population at every developmen-
tal stage in the BM (Fig. 5). Likewise, no selective disad-
vantages of IneZ-expressing cells were observed in the var-
ious peripheral mature B cell fractions Fm(IgMhi&bIgDIa..), 
Fu(IgMbi&bIgDbl&h), and F1(IgMrnlgDbP.) in spleen and 
MLN. These findings indicate that the Yc340-hBtk trans· 
gene could fully compensate the absence of the endoge-
nous murine Blk gene. 
In the CDS+ B-1 D cells or the conventional CD5- B cell 
populations in the peritoneum from non-transgenic Blk+].. 
mice, laeZ+ cells were hardly detectable (Fig. 5 and [6)). 
In contrast, the Yc340-hBtk-transgenic mice manifested 
IneZ activity in significant proportions of their CD5+ B-1 B 
cells (16% ±7%) and conventional CDS" B cells 
(35% ± 11 %) (Fig. 5). These values did not appear to 
result from a down-regulation of Blk expression in a signif-
icant proportion of peritoneal B cells, because IneZ 
expression was found in 97% ± 0.4 % of the CDY B·l 
and in 98 % ± 0.3 % of the conventional peritoneal B cells 
ofYc340-hBlk-transgenic Blk-ty mice. 
4 Discussion 
Although Btk has been implicated in several receptor-
mediated signal transduction pathways, it is currently 
unknown which of these signaling functions account for 
the disease phenotypes of XLA and xid. Moreover, the 
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function of Elk in early pre-B cell stages or the molecular 
mechanisms that lead to an arrest of B cell development at 
the pre-B Cell level in XLA are unknown. The reported 
interactions of Etk with various proteins have mainly been 
studied in vitro «(9} and references therein). TIle signifi-
cance of these findings still has to be established ill vi.'o, 
e.g. by studies in transgenic mice using mutated Blk trans-
genes. For most genes, expression in transgenic mice is 
influenced by surrounding chromatin at the site of integra-
tion, leading to low expression levels of the transgene, or 
to expression in cell lineages that normally do not express 
the transgene. Therefore, transgenes should contain the 
essential regulatory sequences, such as transcriptional 
enhancers or suppressors that are located either in introns 
or at the 5' or 3' flanking regions of genes, to obtain 
position-independent copy number-related expression. 
'Ve have generated two transgenic mouse strains in which 
expression of human Blk is provided by the endogenous 
regulatory cis-acting elements present on the 340-kb YAC 
clone. Our results indicate that all relevant regulatory 
sequences that are required for high-level expression of 
Btk during a cell development are contained within the 
340 k~ of genomic DNA. 
The RT-PCR and Western blot experiments showed that 
the expression of the Yc340-hBlk transgene is similar to the 
expression of the endogenous murine Btk gene, providing 
evidence for the absence of position effects. 
When the Yc340·hBtk·transgenic mice were mated onto a 
Blk-deficient background, the Yc340-hBtk transgene could 
fully compensate the absence of the endogenous murine 
Blk gene. In BM and peripheral tissues, the numbers of B 
cells and their surface Igl\'flIgD profile were normal. In the 
peritoneum nonnal amounts of CD5 t B-1 B lymphocytes 
were present. Furthermore, the serum concentrations of 
IgM and IgG3, as well as the responses ill \'ivo to TI-ll 
antigens were restored. 
TIle ill vivo competition experiments in BlktJ~ female mice 
demonstrated that expression of human Btk from the 
Yc340-hBlk transgene completely eliminates the selective 
disadavantages of Btk-deficient cells at the transition from 
small pre·B cells to immature B cells in the bone marrow, 
as well as the severe arrest during maturation of com'en-
tional B cells from IgDla..lgMbiP. to IgDhl~IgMkr.· stages in 
the peripheral tissues. TIlese findings indicate the absence 
of any dominant negative effects of the expression product 
of the targeted Blk-lneZ allele, and also show that the 
human Blk can functionally substitute the murine protein. 
In this respect, the Yc340-hBlk transgenic rescue differs 
from the correction of the xid phenotype by transgenic 
expression of human Blk driven by the MHC class II Ea 
locus control region, which we previously reported {27]. In 
those mice, the fractions of IneZ-expressing cells in the 
MHCII-hBtk transgenic Bte'- females did not reach 50%, 
but only -10% in the most mature IgMJ'''''IgDhlP. B cells in 
the periphery. Although the xid defects were completely 
corrected, apparently there were some minor insufficien-
cies in the expression of the MHCII·hBlk transgene that 
were only detected by competition ill vb'o in heterozygous 
females. The native regulatory sequences present on the 
Ye340·hBlk transgene, however, appear to provide appro· 
priate expression of Blk in conventional B cells. 
In contrast, within the peritoneal CD5+ B-! B cell popula-
tion ofYc340-hBtk-transgenic Btk+1- mice, the fractions of 
JacZ-expressing cells still only reached 10-20 0/0. This find-
ing implies that the human Btk protein has a slight intrinsic 
inability to substitute for murine Btk in peritoneal B cells. 
'IWelve out of 659 amino acid residues are different 
between murine and human Blk, three of which are clus-
tered at positions 207-214 in theTH domain thought to be 
involved in the interaction of Btk with SH3 domains of 
other tyrosine kinases (1, 2, 27, 30). The alternative 
explanation of a selective down-regulation of Blk expres-
sion in a major fraction of CD5+ B-1 B cells seems 
unlikely, because in the Yc340-hBtk-transgenic Btk-IY 
mice,lacZ was found to be expressed in nearly all CD5+ B 
cells. 
The finding that in the Yc340-hBlk-transgenic mice Btk is 
appropriately expressed in the context of native regulatory 
sequences, is a starting point for the identification of the 
elements involved in the regulation of Blk expression in 
the hematopoietic system. Using the inherent homologous 
recombination system of yeast, various deletions within 
the Blk locus or its flanking regions can be readily intro-
duced in the Yc340-hBtk YAC. After transfer of these 
modified YAC into transgenic mice, functional analyses 
should allow the identification of essential regulatory 
elements. Using similar methods, precise site-specific 
mutations can be introduced into YAC [31, 32), enabling 
the analysis of the effects ill vivo of Blk gain-of-function 
mutations [34), or Blk variants that lack the function of 
specific domains. In these mouse models, Blk lransgenes 
should be expressed at natural levels, with a slage and tis-
sue specificity that parallels the endogenous Blk locus. 
Knowledge of the regulatory elements involved in Blk 
gene expression would not only help to explain XLA cases 
without mutations in Blk coding region (;341, but would 
also be essential for the development of gene therapy stra~ 
tegies for XLA: the constructs that will eventually be used 
to express an intact Blk gene in pre-B cells of XLA pati-
ents should preferably contain regulatory sequences from 
the Blk gene itself. For restoration ill vivo of B cell func-
tion in XLA, a Blk mini-locus could be designed that con-
tains genomic Blk sequences and the major regulatory 
elements. The development of gene therapy vectors with 
less strict size limitations, e.g. based on receptor-mediated 
delivery [35], would make such a Blk mini-locus DNA con-
struct applicable for use in gene therapy to achieve physio-
logical levels of Btk expression during B cell development. 
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Abstract 
Defects in the gene for Bruton's tyrosine kinase (Btk) result in X-linked 
agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Btk is 
expressed throughout B cell development, but not in plasma cells. Blk is also expressed in 
other lineages of the haematopoietic system, except in T cells. In this chapter we addressed the 
question how this unique expression pattern is accomplished. Using intracellular flow 
cytometry we show that Btk is already expressed at significant levels early in B cell 
development. 'Ve describe the generation of yeast artificial chromosome (YAC) transgenic 
mouse strains in which the human Btk (hBtk) expression is provided by endogenous regulatory 
cis-acting clements that are present on a 240 kb YAC transgene, Yc240-hBtk, which contained 
the Blk gene and -{j kb 5' flanking DNA and -200 kb 3' flanking DNA, When the Yc240·IrBlk 
transgenic mice were mated onto a Btk-deficient baCkground, B cell numbers were fully 
restored. The expression pattern and levels of tbe transgenic hBtk were found to parallel the 
endogenous murine Btk gene. The expression level of Btk did not change significantly during 
the subsequent stages ofB cell development. To identify cis-acting regulatory elements, within 
the Btk locus itself, DNAseI hypersensitive site (HSS) mapping was performed. Nine HSS were 
identified, one of which was found to be B cell specific and conserved between mouse and men. 
Furthermore we show that although Spl, Sp3 and PU.1 are able to trans activate the Btk 
promoter synergistically in 111 vitro transfection assays. However, targeted deletion of Spl or 
Sp3 does not result in decreased Btk expression ill vivo. 'Ve conclude that not only the Btk 
protein itself is conserved between mice and men, but also the regulatory elements tbat drive 
Etk expression. This study provides a foundation for the development of a Btk'mini-Iocus to 
develop strategies to manipUlate Btk expression ill vivo. 
Introduction 
Bruton's tyrosine kinase (Btk) is a cytoplasmic protein tyrosine kinase that plays a crucial role in 
B lymphocyte development and function. Mutations affecting the Blk gene lead to X-linked 
agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice (Tsukada et 
ai" 1993, Vetrie ef ai" 1993, Rawlings el al., 1993, Thomas ef al., 1993). Affected patients display a 
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large variety of mutations in the Blk gene (Vihincll et al., 1998). XLA is characterized by an almost 
complete block in B cell development at the pre-B cell stage. Both CBNN mice with a R28C 
mutation in the PH domain as well as mice with a targeted disruption of the gennline Blk locus 
display the xi" phenotype (Khan ef al., 1995, Hendriks et al., 1996), which is a less severe B cell 
disorder than XLA. 
The Btk gene encodes a 659-amino acid protein that contains a single kinase domain, the src 
homology domains SH2 and SH3, and a N tenninal region with a PH domain and a unique proline-
and cysteine-rich Tee homology (TH) domain (see for review: Sideras and Smith, 1995, Desiderio, 
1997). 
Blk expression has been investigated in human using cultured cell lines, leukemias and 
peripheral blood samples (de Weers e/ al., 1993, Genevier e/ al., 1994, Smith e/ al., 1994, Futatani, 
et al., 1998). In the mouse, Btk expression has been analyzed in cultured cell lines as well as ill vivo, 
by flow cytometric analysis ofLacZ activity in a mouse with a targeted insertion in frame of a LaeZ 
cassette in the Bfk gene (Tsukada ef al., 1993, Hendriks ef 01., 1996). Btk is expressed throughout B 
cell development, from the earliest pro-B cell stage up to mature B cells, except in plasma cells. Btk 
is also expressed in cells of the myeloid lineage, but is not required for myeloid differentiation, since 
cells from the myeloid lineage are not affected in XLA nor in xi" (Sideras and Smith, 1995). Btk 
expression is not found in T-lineage cells. 
It is not clear to date, how the tissue-specific expression pattern of Blk is accomplished. 
Knowledge of the regulatory elements involved in Blk gene expression would not only help to 
explain XLA cases without mutations in Blk coding region, hut would also be essential for the 
development of gene therapy strategies for XLA: the constructs that will eventually he used to 
express an intact Blk gene in pre-B cells of XLA patients should preferably contain regulatory 
sequences from the Blk gene itself. 
Sequence analyses of the ...... 280 bp Blk promoter region revealed no obvious TATA box, but 
several E boxes and PU.l, Spi and Sp3 binding sites were found (Sideras el al., 1994, Himmelmann 
et al., 1996). Spl, Sp3, Spi-B and PU.I were shown to bind ill vitro to this part of the promoter 
region (MUlier et al., 1996, Himmelman et al., 1996). A construct, containing the first 450 bp of the 
Blk promoter showed high activity in Blk expression in B cell lines and the erythroleukemia line, 
K562, but not in Btk negative Rela cells or various T cell lines. Moreover, PU.l and Spi-B can 
transactivate the Blk promoter in the T-cell line Jurkat which does not contain these factors 
endogenously. However, in fetal liver of PU.l homozygous mutant mice, Btk was still expressed, 
albeit at a slightly reduced level (MUlier et al., 1996). The transcription factors Spl and Sp3 are 
closely related members of a gene family of zinc finger proteins with similar structural features. 
They share a highly conserved DNA binding domain and recognize a GGGCGGGG- or 
GGGTGGGG-box with identical binding affinities (Hagen et al., 1992). Like Sp I, Sp3 is 
ubiquitously expressed (Hagen ef al" 1992, Supp et al., 1996). The transcription factor PU.I belongs 
to the Ets family of sequence specific DNA binding proteins which specifically bind to purine-rich 
sequences characterized by an invariant GGA core sequence (Klemsz el al., 1990, Moreau-Gachelin 
1994 and references therein). PU.l is expressed in haematopoietic cells, with the highest expression 
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in B-cells, myeloid cells and erythroid cells but PU.1 is absent in T-cells (Su et al., 1996). Numerous 
target genes for PU.I have so far been identified in the B cell and monocyte lineages, such as mb-l, 
Ig J chain and Ig ~l, K and'}.. chains (Eisenberg et al., 1995, Pongubala et al., 1997, Mittmcker et al., 
1997). 
Besides the promoter region, additional far upstream, downstream or intragenic cis-acting 
regulatory elements, such as enhancers and locus control regions are often essential for correct 
expression of genes (Carson et al., 1993, Grosveld el al., 1989, Graeves et al., 1989, Yannoutsos et 
al., 1996). Multiple regions in Blk introns showed extensive conservation, to over 95% identity, 
between mice and men (Oeltjen et al .• 1997), which suggests that these regions may contain cis-
acting regulatory sequences. As a first step in the characterization of the regulation of Blk gene 
expression, we have previously described the generation of yeast artificial chromosome (Y AC) 
transgenic mice strains, Y c340-hBlk, in which human Blk (hBtk) expression is provided by 
endogenous regulatory cis-acting elements present on a 340 kb YAC transgene (Maas et al., 1997). 
\Vhen the Yc340-hBlk mice were mated onto a Btk - background, all features of the xid defect were 
fully corrected. We have now shortened the 340 kb YAC by homologous recombination in yeast and 
reduced the -100 kb flanking the 5' end of the Elk gene to ~6 kb. The shortened 240 kb Y AC was 
used to generate transgenic mice. By mating these Blk-transgenic mice onto a Btk-deficient 
background, we show that the xid phenotype in the mouse is corrected, and that the ill vivo 
expression patterns and levels of the transgenic hBlk are similar to that of the endogenous murine 
Elk. 
The chromatin stmcture of promoter and enhancer regions of actively transcribed genes is often 
hypersensitive to DNAse! endonucleases, which reflects the accessibility of the DNA ill vivo for 
interaction with proteins, like transcription factors and nucleases (Gross, 1988). \Ve perfonned 
DNAseI hypersensitive site analyses to identify any cisMacting regulatory sequences within the Blk 
region. 
To elucidate the role of the transcription factors binding to the Btk promoter we have perfonned 
transfection experiments with expression vectors for Spl, Sp3 and PU.1. In addition, the effect on 
Blk expression by targeted deletion of Sp 1 and Sp3 was studied. 
7t 
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Results 
1. III vivo expression of murine Blk 
We have previously described the generation of a Btk-deficient mouse model by inactivating the 
Elk gene through an in-frame insertion of a LacZ reporter gene (I-Iendriks et al., 1996). Expression 
of LacZ activity. driven by the endogenous Blk promoter and regulatory elements, allowed us to 
detennine the Blk expression patten! in affected male mice. Expression ofthe Elk gene was found to 
be restricted to cells of the myeloid and B cell lineages. In the bone marrow, the ER_MP20high 
precursor cells of the monocyte lineage (De Bmijn e/ al., 1994) showed lacZ activity, whereas the 
ER_MP20med fraction of granulocyte precursors manifested heterogeneous levels of LacZ 
expression (Hendriks e/ at" 1996, and Fig. I). In the erythoid lineage (Ter-119+), LacZ activity was 
only detected in the inunature population of large erythroid precursors, representing the 
(pro)erythroblasl stages. 
To study the ill vivo murine Btk protein expression, we applied intracellular flow cytometry. 
using a rabbit polyclonal antibody to a recombinant Btk-fusion protein, containing aa 25-173. Cells 
from Btk-deficient mice served as negative controls (Fig. 2A and C), As shown in the upper panel of 
Fig. 2A, in the bone marrow, Btk is expressed throughout B cell development from the pro-B cell 
stage up to the mature IgM + IgD + B cell stage. From the intensities of the fluorescence signals, it 
was clear that Blk was already expressed at significant levels in early B cell development. During B 
cell differentiation, only minor changes in the Elk expression levels were observed. In the spleen and 
mesenteric lymph node Btk expression is found from the immature IgMhighIgDiow up to the mature 
IgMloWlgDhigh cell stages as well as in activated B lymphoblasts, as identified by large FSC B220+ 
cells (shown for spleen in Fig. 2A, middle panel). In the peritoneum Btk was found to be expressed 
in conventional CDngM+ B cells and ill CD5+lgM + B-1 B cells. For the B-1 B cell population, 
the fluorescence signals in wild~type could not be compared with knock-out cells, since these cells 
are absent in Btk-deficient mice (Hendriks et al., 1996).' 
In the BM, very low levels ofBtk expression were observed in the ER_MP20high monocyte and 
the ER_MP20med granulocyte precursors (Fig. 2B, upper panel). Btk could not be detected in the 
Ter-119+ erythroid lineage of the bone marrow. In the periphery (Fig. 2B, lower panel), Btk was 
found to be expressed both in the Gr-}- Mac-l + monocytes in the spleen as well as in the peritoneal 
Mac~ I + macrophages. In the Gr-} + Mac-l + granulocyte popUlations, the expression level was found 
to vary between different mice (shown for two wild-type mice in Fig. 2B, lower panel). 
Btk could not be detected in any of the thymocyte subpopuiations, nor in T cells or NK cells in 
Ihe spleen (Fig. 2C). 
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Figure 1. SlIIface profile oflhe ER-MP20 alld Ter-119 markers of cells ji-om Ihe bOlle marrow (lOp). 
The gated (R) subpopulatioJ1s were analyzed for LacZ ey!ression aJ~d the results are displayed as 
histograms. NK cells were Mac_l 1ow, The Tel'-119 -ER-MP20 erythroid cells (R4) were 
subdivided. usillg fonvard side scat/er profiles (FSC) illlo small (Ml) alld large (M2) elylhroid 
cells. Subsequently, LacZ activity was analyzed in these subpopulatiol1s and displayed as 
histograms, Solid lines represent cell populations of Btk-/LacZ -mice, dashed lilies represent the 
background staining as determined ill wild-type mice. 
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A a·lymphoid 
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Figure 2. Intracellular expression of the endogenolls murine Elk and transgenic humall Blk ill 8-10 
week·old wild·lype or Blk' mice alld Yc240·hBlk lrallsgellic mice 011 Ihe Blk' backgrolllld. The 
indicaled populations were gated alld analyzed for Btk expressio1l. The results are displayed as 
histograms, cell populatioJ/s are given at 'he top, originating tissues at the left. Pro-B cells were 
defined as B220+CD43+, pl'e-B cells as B220+CD43-, ER-AfP20higlz cells are mOllocytes 
(precursors) alld ER_MP20medium cells are granulocyte (precursors). I7,e peripheral G,.-/+-
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D B·lymphold 
Counts 
LB!k 
E Non·lymphold 
ER'MP~~I~:9h exER'MP20 medium [KJTe'.1t9+ 
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F T·lymphold and NK cells 
Thymus 
Spleen 
Mac-1+ populatioll represents the granulocyte /raction and the Gr-J-Mac-1+ population the 
macrophage fractioll of the spleen. Data are obtaiued from 105-106 total events. (A-C) Blk 
expression ill wild-type (solid lilies) alld background Btk staining as determined ill Btk- mice 
(dashed lilies), (D·F) Blk expressioll frolll Ihe Yc240,hBlk lrallsgelle (solid lilies) alld backgrolllld 
slaillhJg (dashed lines). 
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2.111 ,!;,!O expression of human Etk from a 240 kb Yc240-hEtk transgene 
2.1 Generation ofYc240-hBtk YAe transgenic mice 
The 340 kb Y AC clone 9DA6, containing the human Blk gene and -100 kb 5' flanking and -200 
kb 3' flanking DNA (Maas el al., 1997) was shortened by homologous recombination, using a 7.5 
kb HbulIIT genomic DNA fragment encompassing the first exon of the Blk gene (Fig. 3A) The 
obtained 240 kb Y AC, Y c240-hBlk was isolated by PFGE, purified and micro-injected. Out of 50 
offspring bom, three independent hBlk-transgenic mouse lines, Yc240-hBlk S2, S3 and 830 were 
generated. In Southern blotting analyses, using HindUI, PvuII, XbaI and BamHI and probes specific 
for the entire Blk gene and Yc240-hBlk itself, all restriction fragments present in the Yc240-hBlk 
Y AC clone were also found in the Y c240-hBlk transgenic lines. Densitometric estimations indicated 
that S2, S3 and S30 contained 1-3 copies of the transgene (data not shown). Fluorescence ill situ 
hybridization of metaphase chromosomes to human Blk sequences demonstrated single integration 
spots at chromosome 2 for S2, chromosome X for S3 and chromosome 8 for S30. As the transgene 
was integrated on the X chromosome in line S3, we did not use this line for further analyses. 
The two other lines manifested expression of the Blk transgene as was evaluated in cells from 
spleen and peritoneal cavity by RT -peR using a range of cDNA concentration dilutions (shown for 
spleen of line S2 in Fig. 3B). In the transgenic lines S2 and S30, neither developmental defects nor 
any increased susceptibility to infectious diseases or malignancies were observed on various genetic 
backgrounds (FVB, 129 or C57BLl6) for over 12 months of age. 
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Figure 3. Generation oJYc240-hBtk-transgenic lIIice (A) Map oJthe 340kb Yc340-hBtk YAe (top). 
showing the location of the Btkgene (filled box) the L44L, -galactosidase (GLA) and FTP-3genes 
(open boxes) alld the polYIIIOJphie marker DXS178 (Maas et al., 1997), III the middle section, the 
genomic organization of the murine Btk gene, inclllding the position of the 19 exOIlS (Sideras et al., 
1994) and the retrofittillg vector are showl/. At the bot/om, the targeted construct Ye240-hBlk is 
shoWI/, illdkatillg the loeatioll of the Blk gene. E, EcoRl; H, HilldIII. (B) RT-PCR analysis of eDNA 
samples from spleen ofYe240-hBlk transgenic line S2 and wild-type. Shown is a PCR COJlcellfratioll 
range using 0.3-1-3 I eDNA, for wild-type (lalles 1-3) and Yc240-hBtk transgenic mice (Ialles 4-6). 
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2.2 Trallsgenic Yc240-hBtk expression restored B cell numbers and pm'alleled endogenous Btk 
expression 
To investigate whether expression of the Yc240-hBtk could fully compensate the absence of the 
endogenous murine Btk gene, transgenic mice were bred onto a Btk-deficient background (Hendriks 
et al., 1996). As shown in Table 1, flow cytometric analyses of spleen, mesenteric lymph nodes, 
peritoneum and bone Illarrow of Btk-deficient mice displayed the xid phenotype (Hendriks et 01" 
1996, Scher, 1982, Khan el at., 1995), characterized by a reduction ofIgMloWIgDhigh peripheral B 
cells and a lack of CD5 + B cells in the peritoneum. Expression of Y c240-hBtk on the Btk-deficient 
background resulted in correction of the B cell numbers to levels comparable to those of wild-type 
(Btk + N) mice. No differences between the two lines were observed and. therefore, data of the two 
transgenic lines were combined. 
Table 1. Freguencies of lymQhocyte QOQulations 
Compartment Cell population Non-transgenic Yc240-hBlk 
Btk +ty Btk -ty Btk -ty 
Spleen 
Nucleated cells, x 106 200±37 128±11 160±29 
B220 + cells, % . 51±5 33±5 57±4 
Of which, IgM~,~ghIgDI~w B cells, % 8±3 32±7 10±3 
Of which, IgMhlghIgDhlgh B cells, % 25±4 39±5 26±S 
Of which, IgMloWIgDhlgh B cells, % 67±6 30±3 64±7 
CD3+ T cells, % 35±5 48±0.3 35±1 
Lymph Node 
+ 28±4 7±1 21±4 B220 cells, ~ . 
Of which, IgM llghIgDI~w B cells, % 7±1 15±1 5±1 
Of which, IgMl11ghIgDhlgh B cells, % 45±3 67±1 51±2 
Of which, IgMloWIgDl11gh B cells, % 47±2 19±2 44±1 
Peritoneum 
CD5+IgM+ B cells, % 5±1 <1 12±4 
CD5-IgM+ B cells, % 35±16 28±3 49±7 
CD5+IgM- T cells, % 33±11 44±8 20±8 
BOlle Marrow 
B220+ cells, % 35±IS 34±4 40±4 
Of which, IgM- pre-B cells, % 18±1O 22±2 24±S 
Of which, IgM+IgD- B cells, % 7±3 8±1 8±1 
Of which, IgM+IgD+ B cells, % 9±1 2±1 7±2 
The phellotype of lymphocyte population Was determined by flow cylometry; dead cells 
alld high side scaifeI' cells were excluded by gating. Data are mean values ± standard 
deviatiollsfrom 2-6 mice analyzed per group. Mice were 8-10 weeks of age. 
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Using intracellular flow cytometry, the expression of human Btk from the Y c240-hBtk transgene 
was evaluated in cells of the hone marrow, spleen, thymus and peritoneum. (Fig. 2E-F). The 
transgenic human Elk expression pattern was similar to the murine endogenous Btk expression 
pattern and, moreover, expression levels were in the same range. As was found for the endogenous 
murine Btk (Fig. 2A), the levels of transgenic human Btk were found to be similar in the individual 
stages ofB cell development. 
3. The role of transcription factors SpI, Sp3 and PU.1 in activation of the human Etk 
promoter 
3.1 Sp1, Sp3 and PU.1 activate the Btkprol1loter ill SL2 cells 
To assess the individual role of transcription factors binding to a 280 bp fragment containing the 
Btk promoter (-280-Btk-Luc, Fig. 4A) we perfonned cotransfection experiments in Drosophila 
Schneider (SL2) cell. which are devoid of endogenous Sp factors or PU.l-like activities (Courey and 
Tjian, 1988). Nuclear extracts prepared fonn SL2 cells transfected with either Sp I, Sp3 or PU.I 
expression plasm ids contained complexes that were able to bind to sites in the Btk promoter, 
specific for these transcription factors, as was verified in electromobility shift assay (EMSA, data 
not shown). This binding was specific since it could be competed with specific oligonucleotides but 
not with unspecific oligonucleotides. 
To detennine the range in which expression of SpI, Sp3 and PU.I were in a linear range as 
referred to the amount of transfected plasmid, 2 ng to 2 J.tg of the expression vectors were 
transfected into SL2 cells, and luciferase activity was detennined (Fig. 4B). Transactivation was 
clearly detected with 200 ng of each of the expression vectors. For Spi and Sp3 a plateau was 
reached with about 1 J..lg expression plasmid. 
3.2 PU.l, Sp1 and Sp3 activate the Btk promoter sYJlelgistically. 
We perfornled cotransfection experiments using the Spi, Sp3 and PU.I expression plasm ids 
either alone or in combination. Although relative luciferase activity were found to vary between the 
individual experiments, consistent effects of cotransfection of individual plasmids were observed. 
Using different amounts of the Sp3 and Spl vectors, it was shown that the two transcription factors 
had additive stimulatory effects (Fig. 4C). Transfection of 200 ng of the PU.l expression plasmid 
resulted in about five-fold activation of the Btk promoter, whereas the same amount of expression 
plasmid for Spl and Sp3 was able to transactivate the Btk promoter six-fold and 2.5-fold, 
respectively (Fig. 4D). Cotransfection of PU.l with either the Sp I or Sp3 vectors, activated the Btk 
promoter 62 fold and 32 fold, respectively. Transfection of all three expression plasmids together 
activated the Btk promoter 124-fold (Fig. 4D). These data show that PU.I is able to act 
synergistically with Sp I and Sp3. 
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The contribution of each of the two individual Sp~binding sites (GC-, and OT-box, Fig. 4A) to 
the transcriptional activation of Btk, was investigated by mutating them 
separately. When 200 ng of the respective expression plasmid was transfected, mutation of either 
Sp-binding site rednced the inducibility of--280-Btk-Luc by Spl or Sp3, indicating that both Sp 
binding sites are functional in SL2 cells (Fig. 4D). The effect was more prominent when 400 11g of 
the expression plasmids were used (data not shown). To address the question if the two Sp-binding 
sites could contribute equally to the synergistic effect with PU.l, the Spl~, Sp3~ and PU.l-
expression plasmids were cotransfected with either wild~type or mutant reporter constructs. Upon 
coexpressing PU.l with either Spl or Sp3, the mutation of the GT-box had a more pronounced 
effect than the mutation ofthe GC~box. Since the GT-box and the PU-box are in close proximity in 
the Btk promoter (see Fig. 4D), these findings suggest a functional interaction between PU.l and Sp 
factors binding to the OT -hox. 
Figure 4. Btk promoter studies. (A) Schematic representati01l of the human Btk promoter. Shown is 
the promoter area from -250 to +30 and cis-acting regulatory elements that have been identified ill 
this region. The mcy'or transcription initiation site is determined as + i, GC and OT represent the 
two Spl/Sp3 binding sites, PU the binding site for Pu'l and E represents an E~box. Black bars 
indicate the position of the bindi1lg sites for Spil3 and Pu'l. (B) pu, J, Spi alld Sp3 activate the Btk 
promoter. SL2 cells were transielltly trausfeeted with 8 g of the 280~Btk-Llic cOllstruct aud variable 
amounts afthe Spi, Sp3 or PU.l expression plasmids, as illdicated. (C) Sp1 alld Sp3 have additive 
stimulatOJY effects. 8 g of the 280~Btk-Luc cOllstruet was trallsfected together with variable 
amollnts ofSp1 alld Sp3 ,'ectors, as indicated. (D) Cottallsfectioll ofSpl, Sp3 and PU.1 in SL2 cells. 
8 g of a reporter COllstruct was ttal/sfected together with 200 IIg of the Spi, Sp3 and PU.I 
expression plasmids, respectively, as indicated. Filled bars represent data obtained by trans/eclillg 
the reporter cOllstmct 280~Btk-LIlC, opell bars by trallsfectillg 280-Btk-GC-M-Luc, alld shaded bars 
by trallsfectillg 280~Btk~GT-M-Ltic. (B-C) The relative activity measured after trallsfection of the 
empty expression vector was set 1. Data represent the mean and the standard deviation of a 
representative experimelII. 
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3.3 Etk expression ill the absence ofSpl or Sp3 in vivo. 
To study the functional importance of Spl for ill vivo Btk expression, Spl+l+ and Spl-I-
embryonic stem (ES) cells were examined using RT -peR (Fig. SA). In these experiments, 
densitometric values were nomlalized to the HPRT RNA content, since the expression levels of this 
gene were shown to be indistinghuisable between wild-type, Spl+l- and Spl-I- mice (Marin et al., 
1997). As shown in Fig. SA, the expression of Btk was not affected in Sp 1-1- ES cells. Due to 
lethality of Spl-I- mice at embryonic day 9-10 (Marin ef (fl., 1997) no lymphoid tissues of Spl-I-
mice can be analyzed. The low expression of the Blk gene in day 8.5 embryos, which was at the 
borderline of detection, precluded a quantitative comparison of Btk levels in Spl+I+, Spl+l- and 
Spl-I- total embryo's. However, in at least one Spl-I- day 8.5 embryo we detected significant levels 
ofBtk (data, not shown). Subsequently, we analyzed day 11.5 embryos at which time point, due to 
the lethality of Spl-deficient embryos, no Spl-I- mice can be found. Densitometric analyses 
demonstrated that expression levels of Btk were similar in wild-type and Spl+l- heterozygous 
embryos (Fig. 5B). We also did not detect differences in Btk expression between Spl+l+ and Spl+l-
day 14.5 fetal liver samples (data not shown). These results demonstrated that Spl is not absolutely 
essential for Btk expression ill vivo and can be compensated for by other factors. 
One of these compensating factors might be transcription factor Sp3. As Sp3-1- mice die 
perinatally (peter Bouman, unpublished data), we analyzed fetal livers of day 19 dpc Sp3+1+ and 
Sp3-1- embryo's to study the functional importance of Sp3 for ill vivo Btk expression. As shown in 
Fig. 5C, Btk was expressed at comparable levels in fetal liver cells of both Sp3+1+ and Sp3-1- mice, 
as detected by Western blotting experiments. 
A B 
Transcript 'Sp1· ... Sp1+ Transcript Sp1'Ii Sp1· ... Sp1· ... 
Spl 
-
Spl 
1.0 0.68 0.51 
BIk 
--
BIk 
-
10 1.19 0.69 
HPRT •• HPRT I 
Figure 5. Effect ofSpi alld Sp3 011 Blk expression. (AJ RT-PCR alia lysis of the illdicated transcripts 
in Spi+l+ and spr
'
- ES cell clones. (B) RT-PCR analysis of the indicated transcripts ill day 11.5 
embl)'os. Genotypes are given at the top. Under the transcripts, the relative densities of the yield are 
given. Using HPRT, the relative densitometric vailies of Spi and Btk transcripts of the 5jJi+l+ 
embl)'O were set to 1.0. (C) Western blot analysis of Btk expression ill total celllysates (2 x io5 
cellsllalle) from spleens of day 19.5 emblYos. Genotypes are indicated at the top. 
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4. DNAseI hypersensitive site mapping of the human Btk gene 
To identify regions within the human Btk gene that are possibly involved in regulation of Btk 
expression, we perfonned DNAseI hypersensitivity experiments on human tonsil cell suspensions. 
Nuclei of these ceHs were incubated with DNAseI and, DNA was subsequently extracted, and 
digested with restriction enzymes, and fragments were separated on agarose gels. Digests of EcoRl, 
Bgffi, BamHI, PstI and HindIlI were hybridized to a large series of single-copy probes from the Etk 
region. Fig. 6A shows the genomic organization of the human Btk locus and indicates the 9 DNAseI 
hypersensitive sites (HSS) that were detected. The localization of the identified HSS was compared 
to the regions identified by Oeltjen et al. (1997), in which there is strong conservation of intronic 
DNA sequence between mice and man (Fig. 6A). Five of the HSS were strong, and representative 
blots, showing hypersensitive fragments, hybridizing to the indicated probes pi, p2 and p3 are 
shown in Fig. 6B-F. Using probe pi, two HSS could be detected in a 7.5 kb HindUI fragment 
encompassing exon 1 (I and II in Fig. 6A and B). \Vith probe p3 a HSS site 3' of ex on 19 in a 3.0 
kb Bglll fragment could be detected (IX in Fig. 6A and C). Two additional HSS could be detected in 
a 19 kb BamHi fragment with probe p2 (V and VI in Fig. 6A and D). The localization of these HSS 
was confinned in genomic digests of multiple restriction enzymes, using probes located both at the 
5' end and at the 3' end of the restriction fragments (data not shown). To test B celt specificity of the 
strongest HSS, we isolated Band T cell fractions from human tonsils, using standard E-rozetting 
techniques. HSS V and VI appeared to be B cell specific, as DNA isolated from. tonsilar B cells was 
very sensitive to DNAseI, whereas DNA isolated from tonsilar T cells was much more resistant to 
DNAseI treatment (Fig. 6E and F). When we analyzed the B cell specificity of the other HSS, only 
minor differences between the Band T cell fractions were detected (data not shown). HSS VI was 
found to co-localize to a 229 bp intronic region that showed strong conservation between men and 
mice (Oelljen et 01., 1997) (Fig. 6A). The region contained binding sites for PU.I and transcription 
factor CIEBP (Lee et al., 1997) that were conserved between men and mice. 
Figure 6. DNAse 1 hypersellsitive site assays 011 humall tOl1silar B alld T cells. (A) Alap showing the 
genomic organization o/the Btk gene, illcluding the position o/the 19 exol/S (Sideras el al., 1994) 
and bllrollic regions 0/ more thall 80% conservation between human and mouse (open boxes). 
Restrictioll/ragments and the position o/the probes (p) are indicated at the bottom. Roman numbers 
represellt the HSS detected. E, EcoRl; H, HilldI1l; B, BamllI; Bg. BglII. (B-F) SOllthem blot 
0110 lysis oj the DNAseI treated DNA ji'om tOllsi/ar lymphocytes (B-D), B ce/ls (E) alld T ce/ls. (F). 
Black triangles above the blots illdicate the illcrease ill DNAse/-concentratioll (0-6 Imitslml). The 
restriction emymes alld probes used are indicated at the bottom. The size 0/ the III/cleaved 
restrictioll jhlgmelll alld the HSS (romallllllmbers) are given 011 the right. 
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Discussion 
Btk expression patterns ill vivo 
Although Blk has been demonstrated to be expressed throughout the B cell devclopment, with the 
exception of plasma cells, and in other cells, such as 11l0nocytes, granulocytes and megakaryocytes 
(De Weers elal., 1993, Smith elal., 1994, Genevier el al., 1994, Tsukada el al., 1993) these studies 
were mainly done in cultured cell lines or leukemia samples. Therefore, data on the expression 
pattern ill vi\'O or the levels ofBtk in the individual stages ofb cell development were not available. 
To study murine Blk expression ill vivo we used the Blk-! LacZ mutation (Hendriks et at., 1996), 
intracellular flow cytometry and RT-PCR. Consistent with published data in the mouse and in 
human, we found that Blk was expressed throughout the B cell differentiation, from the early pro-B 
cell stage up to the activated B lymphoblasts. In contrast to the enonnous differences in expression 
levels of the BCR on the cell surface (e.g. between IgM!OW and IgMhigh inunature B cells) the 
expression of Btk appeared to be constant during B cell development. In the myeloid cell lineage, 
Blk was found to be expressed in the different stages of monocyte/macrophage development, 
whereas Btk expression in granulocytes and their precursors in the bone marrow was low or 
variable. In contrast to the LacZ activity observed in the Ter-119+ (pro·)erythroblast population in 
the bone marrow of Blk'/y mice (Fig. 1), indicating the expression of Blk, we could not detect Blk 
expression using flow cytometry in this cell population. Although it can not be excluded that there 
are erythroid-specific negative regulator sequences present in the region encompassing exon 8 to 13, 
which is deleted in Btk-IY mice (Hendriks el al .• 1996), the discrepancy is very likely to reflect 
differences in sensitivity between the two methods. 
Regulatioll of Blk expression 
Surrounding chromatin at the site of integration influences the expression of most transgenes, 
leading either to low expression, or to expression in cell populations that nonnally do not express 
the transgene. Therefore, to obtain position-independent and copy-number related expression, 
trans genes should contain the essential regulatory sequences, such as transcriptional enhancers or 
suppressers that are located either in introns or at the 5' or 3' flanking regions of genes (Carson et 
al., 1993, Grosveld el al., 1989, Graeves el al., 1989, Yallloutsos el al., 1996). We have previously 
reported that the human Blk gene was appropriately expressed in transgenic mice from a 340 kb 
YAC transgene, Yc340-hBlk (Maas el al., 1997). We have now generated a YAC clone, Yc240-
hBtk, by homologous recombination in yeast, in which ~ I 00 kb upstream of the human Blk is 
deleted. With this ..... 240 kb Yc240·hBlk clone we have generated two transgenic mouse strains. 
When the Yc240-hBlk transgenic mice were mated onto a Btk·deficient background, the Yc240-hBtk 
could fully compensate the absence of the endogenous murine Blk gene. B cell numbers in the bone 
marrow and peripheral tissues were in the same range as compared to the wild-type littennates. The 
intracellular flow cytometric experiments showed that the cxpression pattern and expression levels 
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of the Yc240-hBtk transgene were similar to the endogenous murine Blk. Our results indicate that 
native regulatory sequences present on the 240 kb Y AC are sufficient for appropriate expression of 
the human Blk gene and that cis-acting elements, which detennine the cell lineage specificity ofBtk 
as well as the expression level of Btk during the different stages of B celt development are highly 
conserved between mice and humans. 
\Ve furthennore studied the effect of SpI, Sp3 and PU.1 binding on Elk expression. Although 
each individual transcription factor was able to transactivate the reporter constmct, we have 
furthermore shown that transcription factor PU.l is able to act synergistically with either Spi or Sp3. 
This synergistic effect is mediated mainly through the PU~box and the adjacent GT~box since 
mutation of the GT -box, resulted in a much greater reduction of activation than mutation of the GC-
box, which is located about 100 bp further upstream. It has been shown that an exchange of cytosine 
in a typical GC-box (GGGCGG) for a thymidine, creating a GT-box (GGGTGG) weakens the 
binding of Spi (Letovsky et al .• 1989). It seems therefore that the position of the Sp~site is more 
important than the affinity. It is interesting to note in this context that the PU-box and the adjacent 
GT-box are highly conserved between the human and the mouse promoter whereas the more distant 
GC~box in the human promoter is replaced by a GT-box in the mouse promoter (Sideras et al., 
1994). The functional importance of the PU-box was recently confinned by the finding that a point 
mutation (agggaac .... aggggac) in this site leads to XLA (Holinski-Feder e/ al" 1998). The 
synergistic effect can be mediated by several different mechanisms. One possibility is that Spl and 
Sp3 interact directly with PU.I, as was shown for Spl with several transcription factors (perkins et 
al., 1994, Li e/ al" 1991, Lee e/ al., 1997, Sif e/ al" 1996). This is possible through the different 
functional domains ofSpl, such as the DNA binding domain, as described for the interaction with 
E2F and p65 (Karlseder et al., 1996, Perkins et a/., 1994) or the activation domains, as shown for the 
interaction with C/EBPP (Lee el al., 1997). Also for PU.I interactions with several other 
transcription factors have been described (Nagullapalli et al., 1995, Pongubala et al., 1992, 
Hagemeier et al., 1993). Even though a direct interaction between Sp 1 and Ets~ 1, another member of 
the Ets family of proteins, has not yet been demonstrated, it has been shown that Spl can act 
synergistically with Ets-I. Both proteins are able to form a temary complex in the presence of DNA 
and bind cooperatively to their cognate sites (Gegolme e/ al., 1993, Dittmer ef al., 1994). Further 
analysis will be necessary to reveal the nature of the synergism in the Btk promoter. 
Although Sp 1 and Sp3 are clearly able to transactivate the promoter construct in transfection 
assays, Blk expression is not abolished in mice with targeted deletions of the genes coding for Sp 1 
(Marin et al., 1997) or Sp3, suggesting they can compensate for each other. It will therefore be 
interesting to analyze Btk expression in Spl-!-Sp3..f- double knock-out mice. 
Large scale comparative sequence analysis of the human and murine Blk loci revealed highly 
conserved clusters within intronic regions (Oeltjen el. al., 1997). It is very likely that these 
conserved regions contain transcription control elements, as has been shown for introns of several 
other lymphoid genes, including the immunoglobulin (Staudt el al., 1991), T~cell receptor (Leiden et 
al., 1992), IL-4 (Henkel e/ al., 1992) and CD4 genes (Sawada e/ al., 1994). Recently, a negative 
regulator for Btk expression in pre~B cells and two Spl binding sites were identified within the first 
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500 bp of intron I of Blk that may account for the fine tuning of Blk expression (Rohrer and Conley, 
1998). Furthennore, intron 10 contains two E-boxes, a silencer element and methylated site in pre-B 
cells that becomes specifically demethylated in B cells (Parolini e/ al., 1995). However, a regulatory 
role in Btk expression in B cells is not supported by our HSS analysis, since we did not find any 
HSS in this intronic region. 
Using the homologous recombination system of Yeast, further regions can be deleted from the 
240 kb Y AC and precise site specific mutations within the Blk locus or its flanking regions can be 
introduced (Kaiser et al., 1994). After transfer of these modified YAC into transgenic mice, 
fUllctional analyses should allow the detenllination of the ill vivo importance of these mutated sites. 
Knowledge of the complex regulation of the expression of Blk would be essential for the 
constnlction of a Blk mini loclls, containing endogenous regulatory sequences, to develop further 
strategies to restore in vivo the B cell function in XLA patients. 
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Materials and Methods 
COllstructioll a/targeting vector alld shortening of YAC by homologous recombillatioll 
A 7.5 kb HindITI fragment encompassing the first exon ofthe Blk gene was isolated from a Btk + 
cosmid (De \Veers e( al., 1997) and cloned into the HillllIll site ofpBluescript (BS). Subsequently, 
this 7.5 kb fragment was excised from pBluescript, using a EcoRV/Sall digestion and cloned into 
the CiaI (biunted) and SaT! site of pCGS990HIS5-I-SceI retrofitting vector. The constmct was 
linearized by a San digestion and transfornled into Yeast strain AB 1380 containing the 9DA6 Y AC 
(Trp and Ura seiectable) (Maas et ai., 1997) using the lithium acetate method (Kaiser et ai., 1994). 
Colonies were plated out on Ura ~, His ~ selective plates and after five days colonies were picked. 
DNA was isolated from these colonies and checked for the presence of a shortened Y AC using pulse 
field gel electrophoresis (PFGE). Out of20 colonies picked, one colony contained a ...... 240 kb YAC, 
Y c240*hBtk, positive for the Btk gene and was chosen for further analyses. No abnonnalities in 
restriction enzyme pattern ofYc240~hBtkwere observed with PstI, BglI, HiIllIIII, EcoRI, BamHI and 
PvuI, compared to Y AC clone 9DA6 and human genomic DNA using Btk~cDNA and the Y AC anllS 
(Maas et ai., 1997) as probes. The following probes were applied: Btk-cDNA (human Btk cDNA), 
Btk.i (human Blk cDNA bp 133-1153) and Blk.2 (human Blk cDNA bp 1094-2159) (De Weers el 
ai., 1997, Maas el ai., 1997). 
Isolatiou o/YAC DNA alld gel/erattoll a/transgenic mice 
Size~fractionation of yeast chromosomes and preparation of YAC DNA was essentially 
perfollned as described previously (Maas et ai., 1997). Yeast DNA, embedded in agarose blocks 
were digested with meganuclaese I~Sce~I according the manufactures protocol (Boehringer 
Mannheim, Mannhein Germany) before size~fractionation of the yeast chromosomes. Purified YAC 
DNA was micro*injected into pronuclei ofFVB fertilized oocytes (Hogan et al., 1994) at ~ 8 ng/ml. 
Docytes were implanted into pseudopregnant CBAIN x C57/BL6 female mice. Tail DNA was 
analyzed by Southem blotting and transgenic offspring was crossed with Btk -/LacZ mice of mixed 
I 29/Sv x C57BLl6 background (Hendriks el ai., 1996). 
Flow cytoJlletric analyses 
Preparation of single~cel1 suspensions, loading of cells with fluorescein-dH3-D-
galactopyranoside to measure p-galactosidase activity, intracellular flow cytometric detection of 
cytoplasmic Btk protein, and three- or four-color flow cytometry have been described (Hendriks et 
ai., 1996, Dingjan el ai., 1998). 
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Plasmid construction 
Luciferase constmcts -280-Btk-Luc, -280-Btk-GC-M-Luc, -280-Btk-GT-M-Luc and -280-PU-
M-Luc have been described previously (MUller el al., 1996). The plasmid pPACSp I, PACUSp3, 
pPAC and the p·galactosidase expression plasmid p97b have been described (Hagen et al., 1994, 
Dennig et al., 1996). For the expression in Drosophila Schneider cells we generated the PU.l 
expression plasmid pPACPU.l. 
The PU.I eDNA from t>EB Spi-I (a kind gift from Dr. Dominique Ray-Gallet) was cloned into 
pBlueseript II KS. A 1.4 kb Bamlf1lXhoI fragment was subsequently subcloned into pPACSpl 
plasmid front which the Spl cDNA was removed by BamHUXlIoI cleavage. To achieve an in frame 
protein a PCR product was generated between the following primer pair: 5'· 
GCGGGATCCATGTTACAGGCGTGC-3' and 5'-CTCTGGAGCTCCGTGAAG T-3' and cloned 
between the BamHI and SstI sites (translational fusion). The stmcture of the constmct was verified 
by nucleotide sequencing (Sanger, 1977). 
Cell culilire and lralls/ecliolls 
The human B·cell line DG75 (Epsteiu·Barr virus.negative Burkitt's lymphoma) was cultured 
under conditions previously described (Sideras el al .• 1994). Drosphila Schneider (SL2) cells 
(Schneider 1972) were maintained in Schneider medium supplemented with 10 % fetal bovine 
serum and 2 mM glutamine at 25°C. One day prior to transfection cells were plated at a density of 
3.6 x 106 cells in 6 cm dishes. Cells were transfected by the calcium phosphate method. (DiNocera 
el al .• 1983). Each plate received 14 J.lg of plasmid with 4 J.lg of the p-galaetosidase reporter plasmid 
p97b as intemal control. DNA amount was kept constant by adding the empty expression vector 
pPAC. After 14 h the medium was changed and cells were harvested 48 h post transfection. 
Lllci/erase alld -galactosidase assays 
Cells were harvested after 2 washes in phosphate buffered saline in 200 ~llysis buffer (25 mM 
Tris-Acetate pH 7.8, 2 mM DTT, I mM EDTA, IO % Glycerol, I % Triton-X-tOO). 100 J.lllysate 
was mixed with 400 J.lI Luciferase reagent (20 mM Tris-Acetate pH 7.8, 33 mM DTT, I mM EDTA, 
3.74 mM MgS04. 0.27 mM Coenzyme A, 0.47 mM lueiferin, 0.53 mM ATP) and assayed using 
standards procedures (Maniatis el al., 1989). Transfections were carried out in duplicates which 
were repeated three times and nonnalized to the p·Galactosidase activity. p·Galactosidase activity as 
detennined according to Hall et al. (1983). 
Reverse transcription (R1)-PCR and Weslem blotting 
Sp 1-/- ES cells and embryos have been described (Marin el al .• 1997). Isolation of RNA, eDNA 
synthesis and PCR reactions were essentially perfonned as described previously (Maas el al., 1997). 
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Amplification was for 25, 33 or 35 cycles with denaturation at 94°C for 1 min, followed by 
annealing at 56°C for 1 min and extension at 72°C for 45 s. The PCR products were visualized by 
electrophoresis on a 6 % polyacrylamide 1 x TBE gel followed by autoradiography. 
IMAGEQUANT (Molecular Dynamics) was used for quantifications. Specific primers for murine 
Btk, human Btk, HPRT and Spl have been described (Maas e/ al .. 1997, Marin e/ al., 1997). 
Western blotting was perfornled as described (Hendriks et al., 1996) using 2 x 104 spleen cells 
per lane. 
Alapping of DNAsel hypersensitive sites 
Human tonsilar lymphomononuclear cells (MNC) were isolated by standard Ficoll-isoplaque 
gradient centrifugation. T-cells were separated from non-T cells by incubating 2 x 107 cells/ml on 
ice for 40 minutes with 2-aminoethylisothiouroniumbromide (AET)-treated sheep erythrocytes and 
elythrocyte free fetal calf semm (FCS). The T-cell-AET- rosettes were separated from the non-T 
cells by centrifugation on a Ficoll-isoplaque gradient (Schuunnan el al., 1980). B-cells were isolated 
from the interphase and washed twice with PBS. T-cells were isolated by resuspending the cell-
pcllet inlysisbuffer (0.155M NH4CL, O.OIM KHC03, 0.1 111M Na-EDTA pH 7.4) on ice to lyse the 
erythocytes, followed by washing with RPMI medium supplemented with 10% FCS. 
Nuclei ofT and B cells were isolated by incubating 5 x 108 cells in HS-buffer (15 mM Tris-HCI 
pH 7.4, 60 111M KCI, 15 mM NaCI, 0.2 mM EDTA, 0.2 mM EGTA, 5% glycerol, I mM DTT, 0.15 
mM Spernline, 0.1 111M Spennidine, 1 111M PMSF) on ice. Nonidet NP40 was added to a final 
concentration of 0.1 % and the cell suspensions were transferred to an aU glass Dounce 
homogenizer. The lysis of the cells was monitored by visually examination of samples. Nuclei were 
collected by centrifugation at 1500 rpm at 2°C and resuspended in ice-cold HS-buffer at a 
concentration of3 x 107 nuclei/ml. 
DNAseI treatment was perfonlled in a total volume of 2 1111 of HS-buffer, containing 3 x 107 
nuclei, supplemented with 20 111M MgCl2, ImM CaCI2 and various amounts (0-6 units/ml) of 
DNAseI (Boehringer Mannheim) and incubated on ice for 30 minutes. Reactions were stopped by 
adding equal volumes of 2x proteinase-K buffer (0.2 M Tris-HCI pH 8, 0.4 M NaCI, 1% SDS) and 
200 f.lglml proteinase K, followed by an incubation ovemight at 45°C. DNA was isolated and 
digested with restriction endonucleases followed by agarose gel electrophoresis and southern 
blotting. Southern blots were hybridized with variolls probes covering the Blk. Probe pI (Fig. 1) is a 
2.4 kb PstI-HindIII genomic fragment containing exol1 I, probe p2 is a 1.6 kb genomic peR product 
from exon 8 to exon 10 and probe p3 is a genomic 2.1 kb EcoRI fragment including exon 19. 
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To identify B·cell signaling pathways acll\'ated by 
Bruton's tyrosine kinase (Btk) ill )';)'0, we generated 
transgenic mice in which Btk expression Is drjnn by 
the MHC class II Ea gene locus control region. ntk 
overexpresslon did not ha\'c significant adverse effects 
on B cell function, and essentially corrected the X-li"ked 
imllulIlodeficiellcy (xid) phenotype in Btk- mice. In 
contrast, expression of a conslllulh'ely activated form 
of Blk carrying the E41K gain.of·function mutation 
resulted in a B cell defect that was more se\'ere than 
xid. The mice showed a marked reduction of the B cell 
compartment in spleen, lymph nodes, peripheral blood 
and peritoneal cavity. The lc\'els in the serum of most 
immunoglobulin subclasses decreased with age, and 
B cell responses to both T cell.independent type II 
and T cell·dependent antigens were essentially absent. 
Expression of Ihe E41K Brk mulant enhanced blast 
formation of splenic B cells ill vitro in response to anti· 
IgJ\l stimulation. Furlhenllore, the mice manifested a 
disorganization of B cell areas and marginal zones In 
the spleen, Our findings demonstrate that expression 
of constitutively activated Dtk blocks the development 
of follicular- recirculating B cells. 
Ke}words: B cell antigen receptorlB lymphocyteslBtkl 
xidIXLA 
Introduction 
Bruton's tyrosine kinase (Btk) is a non-receptor protein 
tyrosine kinase that is crucial for B lymphocyte de\'elop~ 
ment and function. Mutations in the Blk gene are the 
genetic basis for X·linked agammaglobulinemia (XLA) in 
man and X-linked immunodeficiency disease (:rid) in the 
mouse (Rawlings el af., 1993; Thomas et af., 1993; 
Tsukadn el al., 1993; Vctrie et af., 1993). Blk encodes a 
659 amino acid protein that contains. in addition to the 
Src homology domains SH2 and SH3 and a single catalytic 
domain, a unique pleckstrin homology (PH) domain at 
the N·tenninus and an adjacent proline- and cysteine-rich 
Tee homology (fH) domain (for review see Sideras and 
Smith, 1995; Desiderio, 1997). 
XLA patients displaying a large variet), of mutations in 
the Blk gene (Vihinen et af., 1998) are very susceptible 
to bacterial infections. XLA is characterized by an almost 
complete block in B cell development at the pre·B cell 
stage, resulting in a severe decrease of circulating B cells. 
Plasma cells are virtually absent and serum lewis of all 
Ig classes are \'ery low. TIle B cell defccts in Ihe CBAIN 
.tid mice which carry an R28C mutation in the Blk PH 
domain are less severe (Wicker and Scher. 1986). These 
mice have ~50% fewer B cells in the ~riphery and the 
residual cells exhibit an unusual IgM 'ghlgDlow profile. 
They lack Ihe CD5+ B·I B cell population and have low 
levels of IgM and Ig03. Although .lid mice are generally 
able to respond to T cell-dependent (TD) antigens. they 
cannot make antibodies to Ihymus-independent type 2 (TI-
ll) antigens. Detection of a similar PH domain mutation, 
R28H, in a patient with classical XLA suggested that Ihe 
distinction between the two phenotypes did not result 
from an allelic difference (DeWeers el al., 1994a). This 
was confirmed by the construction of null mutations in 
the mouse Btl. gene, which also resulted in .rid phenotypes 
(Kahn el af., 1995; Kerner el al., 1995; Hendriks et af., 
1996). By analysis of competition ill 1'/1'0 between wild~ 
type and Btk- cells. it was shown that the first selective 
disadvantage of Btk-deficient cells in the mouse is also at 
the transition from pre·B to inlmature B cell (Hendriks 
et al., 1996). 
Blk is expressed throughout B cell development, from 
the earliest pro·B cell stage up to malure B cells. and 
expression is downregulated in plasma cells (DeWeers 
el al., 1993; Sideras and Smith et al., 1995; Hendriks 
et al., 1996). Blk is also expressed in cells of the myeloid 
lineage. but not in T cells. Blk has been implicated as a 
mediator of signals from various receptors, including the 
antigen receptor, interleukin 5 receptor (IL~5R), IL-6R, 
and CD38 in B lymphocytes. and the FaRI in myeloid 
cells (reviewed in Desiderio. 1997). Btk activity is regu-
lated by Src family kinases, phosphalidylinositol (PI) 
3·kinase·y and the (X·subunit of the Oq class of G proteins 
(Rawlings et af., 1996; Bence el al., 1997; Li et af., 1997). 
After stimulation of the antigen receplOr or IL~5R in 
B cells and the Fc£RI in mast cells, Src family kinases 
rapidly induce phosphorylation of Y551 in Ihe Btk kinase 
domain, followed by Btk autophosphorylation at Y223 in 
the SH3 domain (Wahl el af .• 1997). These concerted 
phosphorylation events were shown to be enhanced by a 
Glu-to·Lys mutation, E4IK, in the PH domllin of Btk 
(Park et af .• 1996). The E4IK mutant, which was isolated 
using a retroviral random mutagenesis scheme. was shown 
to induce transfomlation of NIH 3T3 fibroblasts in soft 
agar cultures and factor·independent growth of the IL~5· 
dependent pro-B cell line Y 16 (U et af., 1995). The 
transfomling activity of Ihe E41K mutation is associated 
with increased membrane locali7.ation and tyrosine 
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phosphorylation of Btk in transfected NIH 3T3 fibroblast 
cells. PH domains recruit signaling molecules to the cell 
surface through specific interactions with phospholipids 
and proteins (reviewed in Lemmon et af., 1996). Bjnding 
of the Blk PH domain to various {phosphutidyl)-inositol 
phosphates. ~y-subunits of heterotrimeric G proteins and 
protein kinase C isofonns has been described (Tsukada 
et 01., 1994; Yao el of., 1994; Fukuda et of., 1996; Salim 
et at"~ 1996). The activating nature of the E41K mutation 
might be explained by its close proximity to the predicted 
inositol-phosphate binding site, as was indicated by X-ray 
crystallography studies (Hyvoncn and Sarasle; 1997). In 
this context, the E41K mutant binds inositol 1,2,3,4,5,6-
hexakiphosphate with a 2x higher affinity than wild-type 
Btk (Fukada et al .• 1996). 
We have previously described the generation of trans-
genic mice that express human Elk (hJJlk) under the control 
of the class H major histocompatibility complex (MHCII) 
Ea gene locus control region, which provides gene expres-
sion in myeloid cells and in B·lineage cells from the pre-B 
cell slage onwards (Drabek el al., 1997), When the MHClI-
hBlk mice were mated onto a Btk- background, Btk protein 
expression was restored to apparently nonnallevels in the 
spleen and the Btk- phenotype was corrected, B cells now 
differentiated to mature IgMlo""IgD~igh stages, peritoneal 
CD5+ B cells were present and serum Ig levels and ill ~'im 
responses to TI-II antigens were in the nonnal ranges 
(Drabek el af., 1997), These results indicated that in this 
system the hBlk gene was appropriately targeted to both 
conventional and CDS + B-1 B cells, 
The activation of Btk by B cell antigen receplor-
mediated phosphorylation (Aoki et al .• 1994; DeWeers 
et ai"~ 1994b; Saouaf el al., 1994; Wahl er al., 1997) raises 
the question about the nature of specific events that are 
controlled by Btk in developing B cells. To be able to 
identify signaling pathways that are activated by Blk 
itl )'il'O, we have now modified the MHCll·hBtk transgene 
construct and generated two different types of transgenic 
mice, which either overexpress wild-type hBlk, or express 
various levels of the E41K gain·of-function Blk mutant, 
These transgenic cilodels would indicate whether over-
expression or constitutive activation of Btk leads to 
proliferation of cells in the B cell lineage, immunodefici-
ency caused by elimination of B cells from the circulation, 
or induction of B cell anergy. 
In this report we show that overexpression of hBrk had 
only minor effects on B cell development and function. 
In contrast, E41 K hBtk mutant mice manifested an 
immunodeficient phenotype that is more severe than xid 
and is characterized by very low numbers of circulating 
B cells, an almost complete absence of B cell responses 
ill vim and a disruption of the cellular architecture of 
the spleen. 
Results 
Generation of WT·hBtk and E41K·hBtk transgenic 
mice 
The constructs used in this study containing either the 
wild·type (\VT-hBlk) or the E4IK mutant (E4IK-hBtk) 
Blk gene, as well as the MHCfl-hBtk construct previously 
used to obtain transgenic Btk expression (Drabek et ai"~ 
1997), are shown in Figure IA. The E41K mutation was 
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E4IK 
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MHCII-hBlk transgene: 
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Fig. 1. Structure and protein e~pression of the hElk transgencs_ 
(A) Map of the trartSgeIl¢ corutru(ts, showing the ilxatio/lS of thc fixc 
DNase I hyper>ensitivity sites present in the 10.6 Kplll-Pml mouse 
MHC class II upstream Ea fragment. The WT-hBlk and E4IK·hBlk 
transgenes CQntain a 21.4 kb hBlk eDNA-genomic DNA fusion 
segment with uons 1-19. as well as a ImP sequence. The MHCII· 
hBlt transgene contains a 2.1 kb hBlt cDNA fragment (hatched box) 
and a 2.8 I;h human j3-globin fragment with p.lrt of exon 2, exon 3 
and the 3' untranslated region. E, EC(TRI: K, Kpnl; M, MM; P. Prill; 
S. SW(l1. (8) Westero blot analysis of Btk protein e_lpression in total 
spleen cdl lysates (2X lOS celhAanel from the indicated mice, 
Transgenic mice were on the Btl;- bad.:ground, A polyclonal rabbit 
antiserum was used, .... rueh was raised against fusion proteill5 of 
gluthatione S·transferase (GST) and amino acids 163-218 of hBtl; and 
also recognized E41K hBtl; or murine BIk. Ranges of the relative 
densities of the 17 kDa Btl; signals as compared with the control Btl;-+ 
mice are given allhe bottom. Values were rorrected for <.lifferences in 
the proportion of B cells in the spleen, .... hich were determined by flow 
cytometry, {e, Intracellular Btl; e.lpression <.luring B cell maturJtion in 
the spl<"'.n. Sinfle splenic ~ell suspen,ions from J-month-old 1'101'1-
transgentc Bik or Btk- mIC~, a, well 3-<; WT·hBlk or E41 K-hBlk 
transgenic mice on the BIk- background we~ ~tained for surface B220 
and IgM and subsequently for intracellular Btk, Data are shown a, 5% 
probability B22011gM contour plots of total lymphocytes, .... hieh were 
gated by forward and side scaner characteri,tics (top). The indicated 
IgMhi~ and IgMIow B220-+ B cel[ populations were gated and 
analyzed for BIk e_lpressJon (bottom), The results arc displayed as 
histograms of the indicated mice (solid Jines). together with the 
background staining as determined in Btl;- mice (broken lines). 
introduced by a G to A replacement at position 257, using 
ill ~,itro sitc·directed mutagenesis, Since only high copy 
number MHCII-hBrk transgenio ,mice (two out of fivc 
lines) expressed hBlk levels ~i.mi1ar to those found in 
normal mice (Drabek el af .• 1997), we attempted to 
increase hBlk exprcssion levels by including more hBlk 
genomic DNA, as well as the endogenous 3' untranslated 
region, in the transgene constmct. The transgenes con-
tained a 10.6 kb MHC class 11 genomic DNA fragment, 
a 0.3 kb fragment with the first three cxons of hBtk as a 
eDNA sequence, as well as a 27.1 kb genomic DNA 
fragment, encompassing the hBtk exom; 3-19 (Figure JA). 
The transgene constructs were microinjected into fertilized 
oocytes and four independent E41K·hBtk transgenic lines 
(#8,#10. #11 and #14) and three \VT·hBlk transgenic Iincs 
(G5, F2 and A5) were obtained. Fonnder mice werc mated 
to BII\llacZ mice, in which the Btk genc is inactivated by 
a targeted in-frame insertion of a /acZ reporter in exon 8 
(Hendriks e/ a/., 1996). 
Expression levels of the E41K and WT hBtk 
proteins 
Btk protein expression was evaluated in transgenic mice 
on the Btlc backgronnd by Western blotting of total spleen 
cell Iysates (Figure JB). The mice exhibited a wide range 
of transgenic Dtk expression levels in the spleen, which 
were directly correlated with the transgene copy number 
as estimated by genomic Southern blotting analyses. 
To estimate the Btk expression levels of the individual 
transgenic mouse lines, the densities of the Western blot 
Btk protein signals were quantified and corrected for the 
proportion ofB cells in the spleen (which were significantly 
lower in thc E4IK-hBtk transgenic mice; see below). In 
contrast to the r-,'fHCII-hBtk transgenic mice which showed 
approximately endogenous Btk levels, the \VT- and E4IK-
hBtk mice manifested up to 14X overexpression ofhBtk in 
their splenocytes (Figure IB). P1e experiments described 
below were mainly pe.rformed on WT-hBtk line A5, and 
on E4IK-hBtk line #8. Except where specifically indicated, 
no differences were detected between independent lines 
in the perfonned analyses, either for the WT-hBtk or the 
E41K-hBtk transgenic mice. 
Using intracellular flow cytometry. we compared the 
expression levels of transgenic WT and E4IK hBtk with 
the endogenous murine Btk during B cell differentiation. 
The individual subpopulations of developing B cells in 
the bone marrow or spleen showed equivalent expression 
levels of the endogenous Dtk (shown for spleen in Figure 
IC). In constras!, a significant increase in WT or E4IK 
transgenic hUtk protein was found as B cells maturated 
from IgMhigh to IgM!oW cells in the spleen (Figure 1 C). III 
the bone marrow. transgenic Btk was only detected in 
recirculating IgM+lgD+ cells. Additional fiow cytometric 
analyses demonstrated that transgenic Dtk was also 
expressed in peritoneal U-I U cells, in <10% of the 
Mac-I+ myeloid cells in the spleen and peritoneum, but 
not in T cells or NK cells (data not shown). 
When transfected into NIH 3T3 fibroblasts, the E41K 
Btk mutant manifested enhanced auto-phosphorylation 
and increased membrane targeting, while the ill vitro 
kinase acth'ity was similar to wild-type Btk (Li et ai., 
1995). Ho\\'\(ver, ·Whell Wt;:allill)'Zed unstimulated .splcno-
cyte~, whetiler froiniiormal riiice,:"\VT-hB/~ or E41K-hBik 
E41K Btk transgenic mice 
transgenic mice. the majority of Btk protein was found in 
the cytosolic fraction. Also. ill vil·o tyrosine phosphoryl-
ation or ill vitro autokinase activity of the hBtk protein in 
these cells did not appear to be enhanced by the E41K 
mutation (data not shown). 
Depletion of peripheralS cells In E41K-hBtk 
transgenic mice 
The B cell popUlations in bone marrow, peripheral blood. 
spleen. mesenteric lymph nodes and peritoneal cavity from 
E41K-hBtk and WT-hBtk mice on the Btk+ or Btk-
background were examined by flow cytometry in 6- to 
8-week-old mice (Table J; Figures 2 and 3). Cells from non-
transgenic Btk+ and Btk- IiUernlates served as controls, 
showing that the Dtk-deficient mice had fewer mature B 
cells (~30--50% of normal) in peripheral blood, spleen, 
mesenteric lymph node (Figure 2A) and bone marrow 
(lgM+IgD+ fraction), and a specific deficiency of mature 
surface IgM!O\\lgDhlgh B cdls (Figure 3A) as previously 
described (Hendriks et aI" 1996). In the peritoneal cavity 
of Btk- mice, the numbers of conventional B cells were 
reduced and CD5+ cells were Jacking (Table I; Figure 2D). 
Correction of the .rid B cell deficiency, although not 
complete, was obtained by WT-hBtk transgene expression 
on the Btk- background. III the peripheral blood, spleen, 
mesenteric lymph node and bone marrow the B cell 
numbers only reached values similar to those of Dtk-
mice, but the numbers of peritoneal CD5+ cells were in 
the nomlal ranges, and the peripheral B cells exhibited a 
nonnal surface IgM/IgD profile (Table I; Figures 2 and 
3A). The effect of Btk overcxpression on the Btk+ 
background was limited; the numbers of B220+ cells were 
slightly reduced in peripheral blood, but were in the 
nornml ranges in the other organs analyzed (Table J). 
In contrast, when E41K-hBtk mice on the Dtk- back-
ground were compared with Btk- mice, a further depletion 
of B cells was observed in all lymphoid tissues analyzed 
(Table I; Figure 2). Also in the mesenteric lymph nodes 
from the three other independent E4IK-hBtk transgenic 
lines, the proportion of B cells was 1-5%. Expression of 
the E41K-hBlk transgene on the Btk+ background resulted 
in an analogous reduction in the numbers of circulating 
B celis, although the effect was less severe than on the Dtk-
background (Tablc I). The reduction of the proportions of 
circulating B cells in the E4IK-hlJtk transgenic mice was 
accompanied by a relative increase of Ihe percentages of 
CD4+ and CD8+ T cells (Table I). The six groups of mice 
did not manifest significant differences in the numbers of 
Mac-1 1o"DX5+ NK cells or Mac_lhigh myeloid cells in the 
spleen cell suspensions (data not shown). In the bone 
marrow of E41K·hBtk mice. pro-D, pre-D and immature 
B cells were present in nonnal proportions, whereas 
mature recirculating Ig~'f+IgD+ B cells were virtually 
absent (Table I). Additional analysis of the three pro-B 
cell subfractions, as defined by expression of surface 
markers B220, heat-stable antigen (lISA) andBP-1 (Hardy 
et al .• 1991) in E4IK-hBlk mice revealed no detectable 
alterations from the distribution in nonnal or WT-hUtk 
mice (data not shown). 
In strong contrast to the restored IgMlIgD expression 
profile found on peripheral B cells from WT-hBrk trans-
genic Btk-.inice, B cells in spleen, mesenteric lymph node 
and peritoneal cavity from--E4IK-hlJtk transgenic Btk-
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Table- I. Frequencies of lymphocyte populations in WFhBlk and E41 K·hBlk transgenic mice 
Compartment Cell population Non·transgenic WT·hM E-HK-hBlk 
'BI);+ Hlk- Btk-t Btk- Btk+ Blk-
Splren~ Nuc1e.'ltoo cells (X JO.{i) 190 ± 50 
" 
±22 16J ± 3-l- 112 ± [7 19-1 ± 20 191 :!: JS 
8220+ cells (%) 38 ± 9 IS ±5 3-1 ± 10 n ± 5 20 ± 6 10 ± J 
Cm+CD--I+ (%) 20 ± 3 22 ±5 26 ± 4 23 ± 8 26 ± 7 17 ±5 
C03+CD8+ (%) 11 ± 2 12 ±3 12 ± 3 12 ± 3 15 ±..\ IS ±4 
L)mph node 8220+ cells (%) l·U:::4 8 ±2 21 ±.5 7 ±:2 5 ± 004 , ± 1 
CD3+CD-I+ (<:t) 46 ± 5 53 ±2 50 ±-I 56 ± I 60 ±.5 62 ±3 
CW+eDS+ (%) 22 ± I 31 ±2 25 ± 2 27 ±.1 28 ±-I 29 ± J 
Blood 8210' cells (%) 3-1 ± 9 12 ±4 19 ± 6 10 ±-I 7 ± 2 4 ± I 
of I'.hkh B220'~'·lgDl.:>w (%) 10 ± of 41 ± 16 10 ± 5 23 ± 7 25 ± 1-1 51 ± 1-1 
of \\hich B220':;:~-IgD~-,th (%) 71 ± 3 36 ± 15 66 ± 5 46 ± 5 37 ± 12 17 ±1O 
Peritoneum CDS+IgM+ B cells (%) 16 ± 8 0,4 ± 0.3 28 ± 16 1-1 ± 7 3 ±:2 ±I 
CDS-lgM+ B cells (%) 24 ± 10 10 ±4 24 ± [5 8±1 -I ±.1 , ±I 
CDS+lgM- T cells ('Xl 31 ±) 46 ±8 29 :!: 5 47 :!: II 65 :!: 4 62 ±8 
Bone marrow BnO+ cdls N-) 37:!: ) 36 ± I 39 ± 10 36 ± 7 37 :!: 5 31 ±2 
CD-B+!gM- pro-B cell,c (%) 6 :!: 0.3 8 ± I 6 :!: 3 8 ± 2 7 :!: 3 6 :!: OA 
CD-B-IgM- pre-S cel1s (%) 15 :!: 2 16 ± I 14 :!: .5 12 :!: 6 13 ± 5 12 :!: 3 
IgM+IgD- B cells (%) 7 :!: 2 8 ± 0.3 9 ± 2 8 :!: 2 S ± 0.3 7 ±I 
IgM+IgD+ B cells (%) 6 ± 2 2 ± 0.5 .5 ± I 2 ± 0.3 I ± 0.3 OA ± 0.2 
'Bt);:+ mice w~re Blk+ty males or Blk+!+ female,; Blk- mice (Hendriks (/ al., 1996) were either Blk-ty males or Blk-l- femaks. bMke wue 6----S 
weeks old. Data arc mean values :!: ~tandard deviations from three mke analyzed, except for spleen I,here values are from 5-20 mke I-""r group. 
The phenotype of lymphocyte popUlations was deteunined by flow cytometry; dead cells and high side scatter cells were e~C!uMd by gating. 
<Classification of pro·S and pre-B cells I\as accoroing 10 Hardy (/ al. (1991). 
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Fig. 2. Depletion of peripheral B cells in E41K-hBlk mice. Row 
C)tometric analysis of (A) mesenteric lymph node and (8) peritoneal 
cal'ity from 7·_lwd;·old mice of non-transgenic Dtk+ or lltk- mice. 
and WT-hB/kor E4IK-hBlk tnmsgenic mice on the Bt);:- background. 
Sing!e..:ell suspensions were stained \Iith biotinylated anti-Ig;\! and 
slrept;l.vidin-TriColor, and either FlTC..:onjugated anti-BnO or PE-
conjugated anti-CD5. Data are displayed as 5% probability contour 
plots of totallymphoc},tes. \\hich were gated by forward and side 
scatt~r ,haracteri~tic>. Percentages of total lymphocytes within the 
indicated gates are gil'en. Data shown are representative of the mice 
e.,amined (Table I). 
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mice manifested an IgMhighigOIOW phenotype, reminiscent 
of the B cell population found in non-transgenic Btk-
mice (shown for spleen in Figure 3A). The peripheral 
blood contained mainly newly-generated B cells that had 
just left the bone marrow (B2201o"1g0"'I" cells), rather 
than recirculating cells migrating between follicles 
(B22orugblgDhigh cells: only 17 ± 10% of B cells in E41 K-
hBlk transgenic mice and 71 ± 3% in normal Btk+ mice). 
As these observations suggested a maturational defect in 
the peripheral B cell compartment, we inwstigated the 
expression levels of B220 and HSA: B cells that are 
B220Io"'HSAhigh have recently left the bone marrow and 
further differentiate into mature B220MghHSAlow cells of 
the long-lived B eell pool (Allman el til" 1993). While 
the spleen of non-transgenic Btk+ or Btk- mice contained 
-60% mature B22orughHSAtow celis, a small reduction in 
this population was observed in WT-hBlk transgenic mice 
and a 3-to 4-fold reduction in E41K-hBlk transgenic mice 
(Figure 3B). These resulis indicated that recent emigrants 
from the bone marrow failed to mature in the spleen into 
long-lived B22orughHSAtow B cells. 
Serum immunoglobulin levels in E41K·hBtk and 
WT·hBtk mice 
Serum Ig levels were determined by ELISA in 2-month-
old non-transgenic Btk+ and Btk- mice, as well as E41 K-
hBlk and WT-hBlk transgenic mice (Figure 4). The Btk-
mice had severely decreased levels of IgM and IgG3, 
variable levels of IgO I and somewhat decreased levels of 
IgG2a as compl1red with conlrol Btk+ Iittcmultes (Drabek 
et af., 1997). When the WT-hBtk transgene was expressed 
on the Btk- background, IgM levels were elevated and all 
other Ig subclasses were restored to normal levels, similar 
to the correction previously observed as a result of MIfCII-
hBlk transgene expression (Drabek el af., 1997). In the 
WT-hBtk transgenic mice on the Btk+ background, senlm 
Ig subclass levels were in the same ranges. In the E41K-
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Fig. 3. E'l:pw;sion of E4IK Bik induces a dominant maturational 
defect in peripheral B .;;:Ils. (A) SUIfacc IgM-lgD profiles of splenic 
B celis. Percentages of 8220+ ~ells that are I~Mkr/;lgD!ii;;b are giwn. 
The,e cells are mature B cells, whereas IgMhighIgDki.,,- cells are more 
immature (Hardy et af., 1982). Data are displa)'ed as dot plols of all 
gated viable 8220+ cells from )Xlo-' total erents. (8) Surface Bna.. 
HSA profiles of splenic B cells. Percentages of TgM+ cells that are 
immature (B220'''''HSAhi£h) or mature (B22o-"',;hHSA"''') are indicated. 
Data are displayed as dot plots of all gated viable IgM+ ceJIs from 10-1 
total events (or 3X 10-1 total events for E4IK-hBlk trarugenic mice on 
the Bue background). Spleen·cell susperuiollS from 7-week-old mice 
of the indicate.:! genot)'pes were incubate.:! with biotinylated anti-IgM 
and slrepta\idin-TriColor, mC-conjugated anti-B220 and either PE-
conjugate.:! anti·IgD or anti-liSA and analyzed by thre.::-color flow 
C)'tometry. Data shollTI are representative of the mice e:l:amined; 
I)mphoc)'tes were gated on the basis of for" .. ani and side scatler. 
hBlk mice serum IgM was restored (0 nonnal or ele\'ated 
levels, IgO I was similar to the levels in Btk- Jittennates, 
while serum Ig03 was corrccted to nonna! \'alues for 12 
out of20 animals analyzcd (Figure 4). The concentrations 
of Ig02a and Jg2b were generally in the nomlal ranges, 
whereas IgA was quite variable but on average reduced 
compared with the other three groups of mice. No influence 
of the Btk+ or Btk- background was detected. 
Except for Ig: ... 1 and Ig02b, the serum Ig concentrations 
of the E4IK-hBlk mice decreased significantly with age. 
In 6-month-old E4IK-hBlk mice, the levels of IgOI, 
Ig02a, Ig03 were only 37 ± 10, 38 ± 20 and 21 ± 
15 Ilg/ml, respectively (If = 3). In age-matched WT·hBlk 
mice these levels were 970 ± 170,470 ± 140 and 280 ± 
100 ~Iglml (II = 4). 
Defective In vivo responses In E41K-hBtk 
transgenic mice 
The absence of a dramatic decrease of serum Ig in E41 K· 
hBtk transgenic mice at the age of 2 months indicated 
that despite the observed maturation defect of peripheral 
E41K Btk transgenic mice 
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~------l 
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o WT·hB,k B(1:+ 
• WT.hBrl: Btk_ 
A E4IK-hB,l Btk+ 
.to E4IK.hB,l Btl:_ 
Fig. 4. Effe.:ts of transgenic WT·hBlk and E41K-hBlk e~pre~sion on 
serum fg levels. Serum concentr;l.[ions of the indicated Ig subc!as~e,; in 
non·transgenic mice (Btk+. n = II; B!k-, II = 16). as well as WT-
hBlk (/I = 7) and E4IK-hBlk (/I = 20) lrJ.nsgenic mice on the Btk-
background. whereby each symbol indicates an indi~·idual animal. 
Mic<1 were 2 month:s old and Ig lewis wer<1 determined by ELiSA. 
B cells, significant numbers of B cells were induccd to 
differentiate into Ig·producing plasma cells. However, the 
possibility remained that these B cells could not mount 
specific antibody responses. Therefore. we tested the 
responses of 2-month-old non-transgenic. WT-hBlk and 
E41K-hBlk transgenic mice on the Btk+ or Btk- back-
grounds to Tl-II and TD antigenic challenges ill l'II'O_ 
TIle responsiveness to the TI-II antigen dinitrophenol 
(DNP)·ficoll was measured seven days after intraperitoneal 
(i.p.) injection by enzyme-linked immunosorbent assay 
(ELISA; Figure SA). Consistent with previous findings in 
Btk-deficient mice (Wicker and Scher, 1986; Kahn et al., 
1995; Drabek et al., 1997), DNP-specific IgM or Ig03 
was completely absent in Btk- mice, as the absorbence 
measured did not differ from the values of unimmunized 
animals. On the Btk+ background. the TI~n response of 
WT-hBtk mice was comparable with the response of 
normal mice, while on the Btk- background, expression 
of the WT-hBlk transgene could only partially restore the 
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Fig. 5. Defectin: in lil'O responses in E4IK-hBrk mice. (Al IgM and 
Ig03 re<;pol1les to !he TI-Ii antigen DNP-ficoli. (8) Primary IgM 
responses to the TO antigen TNP-KLH, determined 1 days after Lp. 
injection. (el Secondary TO responses to TNP-KLH, detemJined 
7 da)'s after i.p. injections performed 5-8 weeks after !he primary 
immunization. Serial serum dilutions were anal)7M for ONPffNP-
spedfic antibodies of the spe.:ific subclasses and optical densities are 
shown as mean \'alues from 4-12 mice in e.'lch group. The optic.'ll 
deILSities in the pre-immune sera did not \'M)' significantly between the 
si'\ groups and are shown in (C). 
TI-II response. The TI-ll antibody response in E41K-hBlk 
mice was very low but detectable, whether on the Btk+ 
or the Btk- background, 
To investigate TO antibody responses, mice were injected 
Lp. with trinitrophenol-keyhole limpet haemocyanin (TNP-
KLH). After 7 days, TNP·specific IgM was measured by 
ELISA (Figure 5B). Btk- mice mounted a moderate 
primary JgM response compared with wild-type Iitter-
mates, as previously found in .rid mice (Wicker and 
Scher, 1986). Whereas Btk overexpression in the WT-
hBtk transgenic mice appeared to have a minor inhibitory 
effect on the levels of TNP-specific IgM and JgO I, the 
TO primary response was completely absent in E41K-
hBlk transgenic mice, both on the Btk+ and on the Blk-
background (shown for IgM in Figure 5B). 
When the mice were 3-4 months old, TNP-KLH booster 
injections were given and secondary TD responses were 
measured at day 7. TNP-specific levels of IgM, IgG 1 and 
IgG2b were not significantly different between the non-
transgenic or WT-hBlk transgenic Btk+ or Btk- groups of 
mice (Figure 5C). TNP-specific IgG2a was decreased in 
WT-hBlk transgenic mice and TNP-specific IgG3 was low 
100 
in WT-hBlk mice on the Blk- background. In strong 
contrast to these limited adverse effects of the WT-hBlk 
transgene, we found that secondary TD responses were 
\'cry low or lacking in E41K-hBfk mice. irrespective of 
their 8tk+ or Btk- background (Figure 5C). Because Blk-
deficient mice show a nomlUi secondary response to TO 
antigens (Wicker and Scher. 1986; Kahn et al .• 1995; 
Drabek et af., 1997; Figure 5C). the finding that TD 
responses are essentially absent in E41K-hBtk transgenic 
micc was striking, 
Aberrant in vitro responses of E41K·hBtk 
transgenic B cells 
To examine the capacity ofB cells 10 respond to mitogenic 
signals ill l'itro, B cell-enriched spleen cell suspensions 
were stimulated with LPS. anti-C040 and IL-4. and 
different concentrations of a goat-antiserum to mouse IgM. 
Proliferative responses to LPS, delemlined by quantitat-
ing [3HJlhymidine incorporation after 60 h of culture, 
were low in Btk- B cells compared with control B 
cells (Figure 6A). Expression of the WT-hlltk transgcne 
completely restored the proliferative capacity. while 
expression of E41K-hBlk had a minor effect. These 
differences in proliferative responses to LPS were 
paralleled by the ;/1 vitro Ig production profiles in LPS-
stimulated cell cultures as measured by ELISA at day 7 
(Figure 6B). The defective IgM. JgOI and IgG3 production 
in Btk- B cells was corrected by transgenic WT-hBlk 
expression, but the effect of E41K-hBtk expression was 
moderate for IgM, and negligible for IgOI and IgG3. 
Consistent with previous reports (Kahn et af .• 1995; 
Anderson et af., 1996; Ridderslad el af., 1996) Blk- B 
cells showed nonnal prolifcration induced via CD.tO in 
the presence of IL-4, Btk overexpression in the WT-hBtk 
transgenic mice was accompanied by a small but significant 
increase in proliferative responses. Transgenic expression 
of the E41K mutant did not have a detectable effect on 
proliferation in response to anti-CD40 and IL-4 (Figure 
6B), nor in response to anti-C040 alone or to anti-CD40 
and INF-y(data not shown). When the production of 19~t 
IgGI and IgG3 in anti-CD40- and IL-4-stimulated cell 
cultures was evaluated, a marginally lower production was 
observed in Blk- and E4IK-hBlk B cells as compared 
with nonnal Btk+ or WT-hlJtk B cells. 
One of the hallmarks of Btk- B cells is that they do 
not enter S phase when triggered through their surface 
IgM receptor (Wicker and Scher, 1986; Kahn et af., 1995; 
Anderson et lIl., 1996). We observed that the absence of 
proliferative response to anti-IgM antibodies was corrected 
by transgenic expression of both wild-type and E41 K 
mutated hBtk (Figure 6C). Moreovcr, whcn the E4IK-
hBlk transgene was expressed, B cells enlargcd Illore 
rapidly in response 10 anti-IgM stimulation (Figure 60), 
After 24 h of culture, the E4IK-hBtk B220+ cells showed 
a significantly higher proportion of large blast cells when 
compared with non-transgenic Btk+ and Btk- or WT-hBtk 
transgenic B220+ cells. Blast fommlion was already 
manifest in the absencc of anti-IgM. but hccame Illore 
pronounced in the presence of anli-IgM up to I Jlg/ml. 
At high anti-lgM concentrations also WT-hBlk transgenic 
B cells showed enhanced blastogenesis when compared 
with B ceUs from non-transgenic mice. Increased blast 
fomlation of E41K-hBrk transgenic B cells was also 
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t'ig. 6. Transgenic E4IK·hBlk B cells show aberrant re5poMes to 
mitogenic ~ignals ilZ l'ilm. (A) Proliferation, detennined by 
eHlthyrnidine incorporation, of cells cultured in medium alone, in the 
prese~e of LPS, or anti·CD40 antibodies and 1L-4. (B) Ig (e\"els of 
supernatants of 7-day cultures in the presence of LPS or anti·CD40 
and IL-4. (C; Proliferation, delennined by eHlthrmidine 
incorporation, in response 10 various concentrations of goat anti·mouse 
IgM. (A--C) Enriched splenic B cell fractions Btk+, BIk-, Wf·hBlk 
tran.sgenic and E4IK·hBlk transgenic mice were ~ultured ilZ dim \\ith 
,"moos mitogens. The groups of transgenic mice ,ontamed animals on 
BIk+ or Btk- background; no differences were detected between mice 
from these two backgrounds. Data are gh'en as mean values ± SE 
Wilh 4-9 animals in each group (A). as symbols thai indicate the 
values in cultures of individual animals (8) or as mean values from 
4-9 mice in e.ach group (CJ. (D) Total splcm>C)1es from Btk+, Btk-, 
WT·hBlk transgenic Btle and E4IK·hBlk transgenic BIk- mice were 
cultured \\ith I Jlgfml goat·anti·mouse IgM for the indicated lime 
points (left). or in the presclKe of the indicated «lgM concentrations 
for 24 h {right}. The ploportion of blast cells was delemined by ftow. 
c)'tometric analysis of forward light scalier of \iable B220+ cells. 
Data are giwn as mean values from 2-4 mice in each group. 
E41K Btk transgenic mice 
observed in response to stimulation with 50 ~g/ml LPS 
(data not shown). 
The impainnent of TO responses in the E4IK-hBtk did 
not appear to be due to defective induction of MHC class 
II or the co-stimulatory molecule B7.2 (CD86) on aclivated 
B cells, as these activation markers were upregulated after 
stimulation with goat anti-mouse IgM. LPS, or anti·CD-10 
and IL·4; culture with anti·CD40 and IL-4 also induced 
upregulation of CD23 on E4IK·hBtk B cells (data not 
shown). 
Disrupted splenic architecture In E41K-hBtk mice 
By immunohistochemical analyses, the spleens of 
2-month·old unimmunized Btk+, Dtk- or WT-hBtk trans-
genic mice demonstrated a characteristic organization. in 
terms of segregation of T and B cells in the white pulp, 
with T cells clustered in the periarteriolar lymphocyte 
sheath (PALS) and surrounded by B cell-rich areas con-
taining follicles. and the presence of marginal zones at 
the outer boundaries of the white pulp. In contrast, E4IK-
hBtk mice derived from all separate founder lines showed 
a specific effect of the E4IK Dtk mutation on the architec-
ture of the spleen. When expressed on the Btk- background, 
a disruption of splenic architecture was observed, charac-
terized by a reduction in the number and size of D cell 
areas (consistent with our flow cytometric analyses), loss 
of the strict compartmentalization of D and T lymphocytes 
and loss of a distinct marginal zone. 
Figure 7 shows double+labeling of serial spleen sections 
with either anti-D220, anti-CD3 or MOMA-I, a mono· 
clonal antibody specific for the metallophilic macrophages, 
which constitute a major component of the marginal zone 
(Kraal, 1992), together with the N418 antibody specific 
for the COile integrin on dendritic cells (Steinm,'ln et al .• 
1997). In the E4IK+hBtk mice, B220+ cells were present 
in B·cell areas neighboring the T cell zones (Figure 7 A, 
B and C), but D cell numbers were reduced. These B cell 
areas contained significantly more T cells than the B cell 
follicles in control Dtk+ or Wt-hBtk transgenic mice 
(compare Figure 7D, E and F), and contained also CDllc+ 
interdigitating dendritic cells. which nonnall), do not 
extend into B cell follicles (Steinman eral., 1997) (compare 
Figure 7G, H and I). No distinct marginal zones were 
present; the outer boundary of the white pulp did not 
contain B220+ cells and metallophilic macrophages were 
only incidently present as a small rim of MOMA-I + cells 
adjacent to the B cell areas (Figure 7H). In this area, an 
expansion was manifest of CDllc+ marginal dendritic 
celis, which nonnally fonn bridging channels into the red 
pulp (Steinman er 01., 1997) (compare Figure 70, Hand 
I). The numbers of ER-TR9+ marginal zone macrophages 
(Kraal. 1992) were severely reduced, and the reticular 
fibroblast network, characteristic for marginal zones, as 
revealed by ER-TR7 staining (VanVliet et al., I986) 
appeared to be absent (data not shown). We observed a 
dose-dependency of the effect of E4IK-hBtk expression 
on the disruption of splenic architecture. because in line 
#14, which showed a higher lransgene expression level 
than line #8 (Figure IB), MOMA-I + cells were essentially 
absent (Figure 7K and L). Nevertheless. in line #10 with 
low-level transgene expression (Figure IB) the MOMA-l + 
cells were reduced in number, COl lc+ cells extended into 
the B cell areas and the strict separation of Band T cell 
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WT-hBlk Btk- E41K-hBlk Btk-
B220 
CD3 
MOMA-l 
E41K-hBIk#8 Btk- E41K-hBlk#14 Btk-
L'-
MOMA-l 
Fig. 7. Disruptoo splenic accbite<:ture in B-IIK·hBrk transgenic mice. Irrununohis/ochemical anal}'sis of 5 11m splenic frozen seclions from B!k+ mice, 
WT·hBlk Btk- mice and E41K-hBlk transgenic mi~ ({C). (F). (1) and (K). line 118, aoo (L). line #14J on the Bue bad:ground. Se-ctions were stained 
with anti·BnO [blue, (A-CJ] for B cells, anti·Cm Iblue, (D-F)] for T cells or MO~fA-1 {blue, (G-L)J for metallophilic marginal zone 
macrophages, together with anti-CDlIclN-418 (bro .... n) to detect dendritic cells. Arrows (s('ctions (I) and (K)] indkate the presence of small rims of 
MO~lA-1 + cells in the marginal zone. a, centra! arterio!~; f, B cell follicle. Original magnifications: x50 (A-I) and Xl6 O-L), 
areas was lost (data not shown). In WT-hBlk mice, 
MOMA-I + cells were not affected and B cell areas did 
not contain COllc+ interdigitating cells (Figure 7H and 
J). The splenic abnormalities of E41K-hBlk transgenic 
mice on the Btk+ background were variable, but became 
more severe with age. When spleens from 4- to 5-month· 
old mice were analyzed, the segregation of Band T cell 
areas was lost and the numbers of MOMA-l+ and ER-
TR9+ cells were severely reduced. 
Germinal center formation was evaluated by immuno-
histochemical analysis of the spleen, both in 4- to 5-month-
old uninullunized mice and in mice 7 days after boosler 
injection with TNP-KLU adsorbed to alum. In contrast to 
the Btk+ mice, Btk- and WT-hBlk transgenic Btk- mice, 
the E4IK-hBlk transgenic Btk- mice did not develop 
genninal centers, as B220+IgO- cells that showed binding 
of peanut agglutinin (PNA) were completely absent (data 
not shown). 
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Analogous to the disruption of splenic architecture, also 
in mesenteric lymph nodes from E41K-hBlk mice on the 
Btk- background B cell distribution defects were observed. 
B220+ cells expressing Igr-.-f and IgO were almost absent 
in the cortical B cell areas, whereas IgM+IgO+ B cells 
were present in low numbers as clusters in the paracortical 
T cell zones (data not shown), 
Discussion 
To date, numerous interactions of the individual domains 
of Btk with various protein or lipid molecules have been 
reported (Fukada etal., 1996; Bence el aI"~ 1997; Li el ai" 
1997; Wahl et al., 1997; reviewed in Maltsson et al., 
1996). To be able to study the impact of these particular 
interactions on B cell differentiation and function ill vil'O, 
we have developed mouse models in which wild-type or 
mutated IIlk can be appropriately expressed as transgenes, 
We previously showed that expression of hBlk driven by 
the class II MHC Ea locus LCR resulted in physiological 
Blk protein levels in the spleen. which completely cor-
rected the features of the xfd phenotype (Drabek et af .• 
1997). 
Limited effects of overexpresslon of Btk 
By the introduction of 16 out of 18 intron segments of 
the Blk gene. together with the endogenous 3' untranslated 
region. high-level Btk expression was obtained. It seems 
likely that these modified transgenes contained endogenous 
regulatory elements of the Blk gene, since BJk intron 
sequences were shown to contain multiple clusters of 
extensive conservation between mouse and man (Oeltjen 
eJ al., 1997). one of which. a 229 bp region in the fifth 
intron with 90% identity. showed co-localization with a 
DNase I hypersensitive site present in B cells but not in 
T cells from human tonsils (G.M.Dingjan, unpublished 
results), Thus, the transgenic Blk expression pattern may 
reflect a combination of the effects of MHC class II Ea 
gene LCR and endogenous Blk regulatory sequences. 
On the ntk~ background. overexpression of hBtk cor-
rected most of the xid defects, as indicated by the 
appearance of normal proportions of mature IgMlo .... lgDh1gh 
circulating B celis, CD5+ B cells in the peritoneum, 
restored serum IgM and IgG3 levels and ill vitro responses 
to anti-IgM or LPS stimulation. However, in contrast with 
our findings in the MHCII-hBJk mice, TI-II responses 
were only partially restored and primaryTD IgM responses 
were somewhat reduced, 
Although WT-hBtk overexpression on the Btk+ back-
ground was found to be associated with partially enhanced 
blastogenesis and proliferation of B cells in response to 
anti-IgM stimulation ill vitro (Figure6C and D), this did not 
appear (0 result in adverse effects on B cell development or 
function: B cell numbers were largely in the nonnal 
ranges, and B cell responses to TI-II or TD antigens 
ill vi\'o or LPS ill vitro were not notably affected. Therefore, 
we conclude Ihat Btk overexpression per se does not lead 
to significant activation of dowllstream signaling pathways, 
E41K·hBtk represents an activated form of Blk 
In contrast, expression of the Blk E4IK gain-of-function 
mutation on the Btk~ background blocked maturation of 
peripheral B cells, leading to a B cell deficiency that was 
more severe than the xit! phenotype. Although E41 K-hBtk 
transgenic mice produced nomml numbers of immature B 
cells in the bone marrow that began to express JgD, they 
failed to become mature recirculating follicular B eeJls in 
the periphery. A severe reduction of B cell numbers was 
observed in all peripheral tissues and those B cells present 
in the periphery were mainly B22010w and HSAbigh. It is 
most probable that these cells represented newly-generated 
virgin B cells, which generally have a lifespan of only 
3 days (Fulcher and Basten, 1997). Total serum Ig levels 
were not seriously affected at the age of 2 months, but 
they decreased significantly with age, The ill ,,11'0 B cell 
response to TI-JI antigen was very low and only marginally 
restored compared with Btk- mice, while B cell responses 
to TD antigen were lacking. The finding that E4IK-hBtk 
transgene expression resulted in a decrease of circulating 
B ceUnumbers and a loss of B cell functions, even in the 
E41K Btk transgenic mice 
presence of inlact endogenous murine Btk, substantiated 
the dominant nature of the E41K mutation. 
When expressed in NIH 3T3 celis ill vitro, the gain-of-
function activity of the E41K Blk mutant was associated 
with increased membrane localization and was shown to 
require kinase activity (U et al., 1995). Our biochemical 
analyses in unstimulated B cells demonstrated that the 
E41K mutant had ill \'itro kina~e activity, but did not 
reveal a dramatic increase in membrane targeting. Never-
theless, we cannot exclude that the E41 K mutation was 
associated with relath'ely small changes in subcellular 
localization of Btk, which are difficult to detect in bio-
chemical assays. In this context, it was shown that subtle 
variations in antigen concentration or expression of CD 19, 
a co-receptor that lowers the threshold for antigen receptor 
stimulation, resulted in dramatic changes of the fate of 
B cells ill \'1\'0 (Cook et al .• 1997; Tedder et af., 1997). 
Nevertheless, two of our findings indicated that the E41 K 
mutation represented an activated foml of Blk. (i) Expres-
sion of E41 K enhanced ill vitro blast fonnation of splenic 
B cells in culture, either with or without mitogens (Figure 
6D). (ii) Splenic E41K-hBtk B cells showed proliferation 
upon stimulation with anti-IgM antibodies (Figure 6C), 
despite the unusually high proportion of immature 
B22Q1°"HSAhigh cells in this population. Nonnally. such 
B220Jo"HSAhigh virgin B cells are refractory to anti-IgM 
stimulation (Allman et al., 1992), 
Expression of E41K-hBtk impedes follicular entry 
and disrupts marginal zone microarchltecture 
Our findings in the E41K·hBtk transgcnic mice indicate 
that constitutive activation of Btk blocks the developmcnt 
of follicular B cells. The numbers of recirculating B cells 
were severely reduced, specifically in peripheral blood 
and lymph nodes. In the spleen, B cell areas typically 
contained CDllc+ interdigitating dendritic cells, which 
normally do not extend into B cell follicles, as well as 
unusually high numbers of T cells. Signals thai induce 
B cells to become recirculating follicular B cells are 
mediated by the B-ccll antigen receptor, as most peripheral 
B cells are ligand-selected (Gu eJ af., 1991) and mutations 
of the CD79uJ1ga or Syk signaling components of the 
B cell antigen receptor block the entry of D cells into 
follicles (Torres et al., 1996; Turner et al., 1997). These 
findings demonstrated that low-level stimulation of the 
B cell antigen receptor provides a signal that is required 
for follicular entry, Our results show that in the presence 
of EIK-hBlk expression such signals were not transduced. 
Together with the reported abnormal maturation into 
Igl>.110'-'lgDhlgh follicular B cells in Btk-deficient mice 
(Wicker and Scher. 1986; Kahn el al .• 1995; Hcndriks 
et al .• 1996), this argues for a crucial role of Btk in the 
recruitment of B cells in the long-lived recirculating 
B-cell pool. 
Although the possibility that constitutive activation of 
Blk leads to a general defect that impedes the survival or 
affects the migration of B cells in the periphery cannot 
be excluded. it is attractive to hypothesize that expression 
of the E41 K Btk mulant mimics B cell antigen receptor 
engagement. In the E41K-hBtk mice those cells that 
were present in the spleen were IgMbighHSAhighB22010 ..... 
immature B cells that have just left the bone marrow. 
Normally, immature B cells in the bone marrow are 
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susceptible to negative selection (Goodnow et af., 1995) 
and immature HSAhlgh splenic B cells are refractory to 
stimulation with anti-IgM or phorbol ester and calcium 
ionophore (Allman et af., 1992). Therefore, the immature 
status of the E41K-hBtk activated B cells may hamper 
their subsequent expansion or differentiation and induce 
their elimination instead. In this context, E41K-hBtk B cells 
may resemble auto-reactive B cells which have received 
a stimulatory signal through their antigen receptor, 
resulting in arrest in the outer PALS where their lifespan 
is reduced to 3-4 days in the absence of T cell help 
(Fulcher and Basten, 1994; Goodnow et al., 1995). Addi-
tional paraUels with auto-reactive B cells include the rapid 
increase in size of auto· reactive B cells upon self-antigen 
recognition immediately before their disappearance 
(Fulcher et af., 1996; Rathmell et al., 1996) and their 
absence in the splenic marginal zones (Mason el al., 1992). 
The lack of splenic marginal lone B cells in E41K-
hBlk mice could be a direct result of the impeded follicular 
entry of B cells, as marginal zone D cells are deri\'ed 
from follicular B cells (Kumararatne and MacLennan. 
1981). The B cell abnonnalities in E41K-hBlk mice may 
also hamper the nonnal development of marginal zone 
macrophage populations. Further studies will be required 
to clarify whether the B cell or the macrophage population 
of the marginal zone is intrinsically affected in E41K-
hBlk mice, or whether the defects in both populations are 
secondary to accessory cell dysfunction. Since we have 
observed a similar disruption of splenic marginal zone 
architecture in mice that express the E41K-hBtk mutant 
under the control of the B cell specific CD 19 promoter 
(A.Maas, unpublished results), it seems less probable that 
macrophage development is intrinsically affected by the 
expression of the E4IK Btk mutant. Clues about the 
relationship between these cell populations may come 
from experiments in mutant mice that present with closely 
related phenotypes, such as mice deficient in members 
of the nuclear factor-KB family of transcription factors 
(Franzoso el af .• 1997, 1998; Caamai'io et al., 1998) or 
tumor necrosis factor ligand and receptor family members 
(Matsumoto el af.. 1997), which present with defects in 
humoral responses, gemlinal center fommtion and mar-
ginal zone macrophage subpopulations. 
The role of Btk fn B cell development 
Studies in transgenic mice carrying rearranged Jg genes 
have established that strong antigen receptor signals (e.g. 
transmitted by autoantigens) can result in antigen receptor 
editing or elimination of immature B cells in the bone 
marrow (reviewed in Goodnow el a1., 1995; Melamed 
et al., 1998). The absence of any defects in developing 
D cells in the bone marrow of E4IK·hBtk mice (except 
in the recirculating mature cells) does not imply that 
constitutive activation of Btk would not have any effect 
in the bone marrow. Our intracellular ftow-cytomelric 
analyses indicnte that the expression level of the E4IK-
hBlk transgene may not have reached a critical threshold 
value in the bone marrow to affect B cell development. 
In facl, the first defects in the B cell lineage only became 
apparent in the spleen. where we identified a significant 
increase in expression of the hBtk transgenes during 
maturation from IgMhi,g.h to IgMIOW B cells. 
In summary, we conclude that Blk is essential for the 
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transduction of signals that govern the development of 
recirculating follicular B cells. The absence ofBtk leads to 
abnonnal maturation into IgMlo"lgDhigh follicular B cells 
(\Vicker and Scher, 1986; Kahn el af., 1995; Hendriks 
el af .• 1996). We have shown that transgenic expression 
of the E41K Blk mutant blocks the development of 
recirculating follicular D cells. indicating that constitutive 
activation of Btk induces the elimination of virgin peri-
pheral B cells. Further experiments are required to investi-
gate whether this elimination is caused by the absence of 
a basal antigen receptor signal that is thought to direct 
developmental progression of B cells, or by the presence 
of a signal that mimics B cell receptor occupancy by 
self-antigens. 
Materials and methods 
In vitro mutagenesIs 
The E4IK mutation was (:feat~d by a G to A replacement at position 
257 in the bElk eDNA done phElk2.55 in pBlueSeript {Drolbek (llll., 
t997). Double-stranded site-directed mutagenesis (Stratagene. La Jolla. 
CAl was perfonned with the E4IK mutagenic primer 5'-OCACA 
AACTC TeCTA CTATA AGTAT GACIT TGAAC GTOGG·3' and a 
39 bp KpllI-tBgfil scleZlion primer, and the Obtained mutant plasmids 
were sequenced, using standard melhods. From the original .... ild·type 
hElk and the E4IK mutated cDNA done, 303 bp Pvuf-NMV fragments, 
encompassing the fifit two e.lons and part of e.~on 3, were used in the 
consli\lction of the transgenes. 
Construction of WT·hBtk and E4fK-hBtk transgenes 
Th" two transgene consli\lcts WT-hElk and E4IK·hBlk are shown in 
Figure IA. From th" MHC class II Ea gene cosmid 32.1 (Can;on and 
\Vlles. 1993) a 4.0kb Kpnl fragment, containing DNase I hypersensitivity 
sites (HSS) I and II and a unique Pml site at position +14 in th~ Ea 
gene, was cloned into pBlueScripl, using a NOII--Smal-Kpnl--Slrtll-
X/wI-NoII polylinker. The resulting plasmid was partially dig~sted \\ith 
Asp71S in the presence of ethidium bromide to introduce a 9.4 kb 
A.5p71S fragment from cosmid 32.1, encompassing HSS III to V. 
Subsequently, a 13.4 kb 1'.'011 fragment from this plasmid was cloned 
into a NOII-dig~sted oosmid \"ector pTLS (lund (/ 0/ .. 1982). in .... hich 
the same po\)'linker as described abow was introduced at a unique Bgm 
site. In a ne.\t step IWO fragments w~re cloned into this plasmid. using 
the unique p..·uI site in the Ea gene and the unique SlrtlI site within the 
polylinker. (I) a 303 bp P."u!-NltlIV WT or BHK·mutated hBlk cDNA 
fragment (as described abo"e) and a 97 bp N/tlIV-Slrat frolgment 
obtained by PCR amplifkation using primers al positions 46846 and 
47019 of the hBlk gene (Oeltjen el 01" 1997) and 5ubsequent digestion 
with NlaIV and SII·al. In the two resulting plasmids with the WT or 
E-IIK·mutated first three Blk ewns, a 109 bp Soft-Xhol fragment 
containing 10xP sequences (obtained by insertion of a /cuP oligonucleo-
tide, 5'·ATAAC TICGT ATAGC ATACA TIATA CGAAG lTAT-3' 
into the Asp718 site of the pPolyJII \'ector) was cloned into the Xhol site 
within the NOII-Smtll-Kpnl-SlI'al-XIIOI-Nml polylinker. Subsequently, a 
23.1 kb SlI'tll-Stlft fragment, encompassing Blk e!>';ons 5-19, was intra-
du.:ed using unique Sl\"ol and X/wI sites within th~ polylinker. This 
23.1 kb SwaI-Saft fragment was from a 32.9 kb cosmid .... hich was 
isolated from a mini· library com;truCled from a 340 kb YAC clone 
containing the hElk gene (DeWeers a 01., 1997). Finally. a -4 kb Swtll 
frJgment from th~ same cosmid clone, which Contained Blk c.>::on 4, WJS 
introduced into the unique S\\"ol site. 
Generation 01 transgenic mice 
The WT-hElk and E41K·hBlk construct> were digested with Noll 10 
release the -38.2 kb DNA fragment> sho .... n in Figure I. Gel.purified 
DNA was injected into pronuclei of FVBxFVB fertilized oocyte, at a 
conc~n!I:llion of -2 nglfll and implanted into pseudopregnant female 
mice. Tail DNA was analyzed by Southern blotting using a partial hBlk 
cDNA probe (bp 133--1153) to determine the g~nolype of th" founder 
mice and mice generated in sub,equent crosses \\ith Rlk-llacZ mice of 
mi.\ed t29fS\'XC57BU6 background (Hendriks (I af., 1996). 
Flow cytometr!c analyses 
PrepJ.f"oltion of single-cell su~pensions and three- or four·color now 
cylOmetry have been described (Hendriks (I al .• 1996). Intmcellular now 
cytometri~ dete.:tion of cytoplasmic Elk protein was performed on cell, 
that were first staint"d for cell surface marters and subse\juently fixed 
in 2% pamformaldehyde and permeabilized using 0.5% saponin. Ewnts 
(3-5X laI) wt"re scored using a FACScan or FACSCalibur flow cytometer 
and analyzed by CellQuest software (Becton Dickinson, Sunnyvale, 
CAl. The follov.ing monoclonal antibodies were obtained from 
Pharmingen (San Diego, CAl: FITC~onjugated anti~B2201RA3·6B2, 
anti-HSNMlf6, anti·COl, anti~DX5,and anti-BP~lf6C3, PE~onjugated 
anti-CDB/S7, anti·CDllbn.lacl, anti-CD5/Ly-l, ilI1ti-CN, Cy-Chrome 
conjugated anti-B220IRA3-6B2 and anti-CDS, and biotin),lated anti-
HSAf?>flf6 and anti~lgM. PE~onjugated anti·lgD was purchased from 
Southern Biotechnology (Birmingham, AL). Anti·CD23 (B3B4) and 
anti-CD28/B7.2 (GLi) were purified monoclonal antibodies conjugated 
to biotin and mc, respe.:tiwly, a.:.:ording to stilI1dard procedures. 
Affinity.purified poJydonal rabbit anti·BIk was from Pharrningen. 
Secondary antibodies u!.<--d were TriColor- or PE~onjugated strepta\'idin 
(Caltag Laboratories, Burliogame, CAl, strepta\idin·APC (Ph:mningen) 
Of FITC~onjugated goat anti·rabbit Ig (Nordi<;-, Capistrano beach. CAl. 
19 detection and In vitro immunizations 
levels of Ig subclasses in scrum or culture supernatants were measured 
by sandwich ELISA, using unlabeled and pero.\idase-Iabeled anti-mouse 
Ig i,otype-specific antibodies (Southern Biotechnology). Serially diluted 
sera were incubated at room temperature for 3 h, anduino-bis-ethylben1.-
thiazoline sulfonic acid was used as a subllrate. Antibody concentr.uions 
were calculated by using purified isot)'pe Ig proteins as standards. TD 
and 11-ll immunizations and lNP·sjX'dfic ELISA were essentially 
performed as described pre\'loudy (Maas £/ a/., 1997). Booster doses 
were gh'en after >-S we.>ks. SeOim dilutions were incubated at room 
temperature for 3 h and the biotinylated TNP-KLH S\t"p was overnight 
at4'C. 
In VitlO B cell cuftules 
Whole spken cell suspensions from 7- to IO-week-old mice were 
depleted of erythrOC)1es by standard NlI~CII)sis and enriched for B cells 
hy incubation with anti-ThyL2 (30-1Il2), anti·Crn (GK1.5) and anti~ 
CD8 (YTSI91) at room temperature for 30 min, and subsequent treatment 
.... ith rabbit complement (Cedarl.ane Laboratories, Hornby, Ontario, 
Canada) at 37"C for 30 min. The fr-.lctions of B210+ cells remaining 
after treatment were determined by FACS analyses. The enriched B 
cells were cultured in round-bottomed microculture plates at a final 
CtJncentration of lOS B cellsfwdl in RPMI 16.\0 culture medium 
supplemented with 5% FCS and 5X!O-5 M 2.mercaptoethanol, in the 
presence of 50 IlgfmI EJc/lericliia coli LPS (serotype 026:B6, Difco 
Laboratories, iXtroit, Mil, sever.!1 concentrations of poiyclonal goat-
anti·mouse IgM (Southern Biotechnology), 10 J.lglml rut anti·molL<.e 
CD-tO (FGK-45.5, kindly provided by D_Grny), 100 ngfmi rlL-4 (R&D 
Systems. Inc., Minneapolis, MN) or 200 U/ml rlNF-y (R&D Systems. 
Inc.). To measure DNA synthesis, after 2 days of culture cells were 
pulsed with eHjthymidine for 16--18 h, harwsted and CGunted using 
standard. methods. Culture sUjX'rnatants were assayt"d for Ig productiou 
by ELISA on day 7. E'l:pression of CD281B7.2, CD23 and ;\UlC class 
II was evaluated by flow c)10metry at various time points. 
Biochemical analyses 
For Western blotting eXjX'riments, Iysates of2 X lOS total spleen cells were 
analyzed as de"ribed (Hendriks rt a/., 1996). Subcellular fractionation, 
immunoprecipitations and in l'itro kina~e a~sa)'s were jX'rformed e,~$en­
tially as described pre\iously (DeWeers et al., 1994b). A polyclona! 
rabbit anti·hBtklGST antiserum (kindly provided by C.Kinnon) was med 
for We>tem blotting and for Btk immunopredpitation. Rabbit anti-hBIk 
(raised agaimt a jX'ptide containing amino adds 69--88 and used as 
biotinylated purified Ig; DeWeers (/ a/., 1994b) and anti·pTyr (4GIO, 
Upstate Biotechnology Inc .. LaJ.:e Pladd, NY) were used in immuno-
blotting. 
ImmunohIstochemistry 
Spleens were cmb..--dded in ocr compound; froun 5 )1m cl)'ostat 
se.-:tions wue li~cd in acetone or plfafll;aniline and sing!'~- and dllub!e-
labeling was performt"d as pre\'iously described (Dejong rt al., 1991; 
Lcenen rt a/., 1998). Monoclonal antibodies anti-B2201RA3-6B2, anti-
CD3IKTJ, anti·CDllcJN418 (Steinman etaf., 1997), ER-TR7 (VilI1Vliet 
(I al., 1936), ER-TR9 and MOMA~I (Kraal, 1992) were applied 
as hybridoml cullUre supernatants; biotinylated anti-lgM was from 
Pharmingeo, anti-JgD was from Southern Biotechnology and biotinylated 
PNA from Sigma (St Louis. MO). Second'step reagents were pcro_~idase­
labeled goat anti-rat Ig (DAKO, Glostrup, Denmark) or anti·hamster Ig 
E41K Btk transgenic mice 
(Jaci..~on ImmunoResearch Labor.ltories. We,t Grove. PAl and goat anti-
rat Ig alkaline phosphatase (South~rn Biotechnology). 
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Abstract 
\Ve generated transgenic mice that express a constitutively activated form of the 
cytoplasmic tyrosine kinase Btk, the E41K gain~of-function mutation, under the control of thc 
CD19 promoter. In these mice, B cell de"elopmellt was arrested at thc transition of IgM10w to 
Igl\'1highIgD- immature B cells in the bone marrow, representiug the first immune tolerance 
checkpoint where auto-reactive B cells become susceptible to apoptosis. A correlation was 
observed between Btk activity and Ig Ki).. L chain usage: the proportion of Ig }.. L chain 
expressiug B cells was increased in E41K-Btk transgenic mice and decreased in mice with a 
targeted deletion of the Btk gene. \Ve also observed that Btk - cells accumulated within a 
subpopulation of small resting pre-B cells. These findings in the mouse define a role for Btk in 
Ig L chain assembly at the transition of prc-B to immature B cells, coinciding with the 
developmental arrest in X-linked agamma-globulinemia in man. 
Introduction 
B lymphocyte development in the bone marrow is characterized by assembly of immunoglobulin 
(Ig) heav), (H) chain and light (L) chain variable region genes from component V, (D) and J gene 
segments (reviewed in Tonegawa, 1983; Rajewski, 1996). V(D)J recombination is a highly ordered 
process, initiated by DNA rearrangements at the H chain loci in pro-B cells. The expression of a 
functional ~l H chain is monitored through the fonnation of a pre-B cell receptor (pre-BCR) 
complex, together with A5 and VpreB proteins (Melchers el at., 1995). Signaling through the pre-
DCR results in feedback inhibition of H chain V(D)J recombination to ensure allelic exclusion and 
IL-7 dependent proliferative expansion. The rapidly proliferating pre-B cells then exit cell cycle and 
perfonn Ig L chain gene rearrangements (reviewed in Lin & Desiderio, 1995). Productive L chain 
expression leads to the fonnation of complete Ig molecules and the transition of pre-B cells into 
surface IgM+IgD- immature D cells. \Vith the acquisition of antigen specificity, maturing B cells 
pass through a tolerance-susceptible stage (Goodnow, 1996). Auto-antigen binding in newly 
generated IgMloWIgD- B cells results in continued Ig L chain rearrangement, i.e. receptor editing. In 
constrast, B cells that have advanced to the IgMhigh stage lose this ability and concomitantly acquire 
sensitivity to antigen-mediated apoptosis (Tiegs et a/., 1993; Melamed et a/., 1998). IgMhigh B cells 
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that do not bind to auto~antigen acquire various differentiation markers on their cell surface, such as 
IgD, CD21 and CD23. and migrate out of the bone marrow to colonize peripheral lymphoid organs. 
One of the molecules that is involved in BCR signaling and directs B cell development is the 
Tee family non~rcceptor tyrosine kinase Btk (Bruton's tyrosine kinase), which when mutated results 
in X~1inked agammaglobulinemia in humans and X-linked immunodeficiency (xid) in mice 
(reviewed in Sideras and Smith, 1995; Desiderio, 1997). Patients with XLA have very low B cell 
numbers in the peripheral blood. and those few B cells present exhibit an immature IgMhigh surface 
phenotype (Conley, 1985). As the numbers of pre-B cells in the bone marrow are not significantly 
reduced. XLA reflects impaired developmental progression or increased cell death at the pre~B to B 
cell transition. XLA patients manifest protracted recurrent bacterial infections due to a profound 
reduction of sennl1 Ig of all classes. 
The xid phenotype. present both in CBAIN mice carrying an Arg28 mutation and in mice with 
targeted disntptions of Blk in their genn line, is distinct from XLA (Scher, 1982; Kahn et al., 1995; 
Hendriks et al., 1996). Compared to normal mice, Blk-deficient mice have ~50% fewer B cells in 
the periphery, with an over-representation of immature IgMhighIgDlow cells. The CD5+ B~ 1 B cell 
population is absent, and the levels of IgM and IgG3 in the sennn are reduced. Although Btk-
deficient mice do not make antibodies to a subset of T cell independent (TI) type II antigens, they 
are able to respond to most T cell dependent (TD) antigens. Btk~deficient B cells do not enter S 
phase when triggered through the B cell receptor (Scher, 1982; Kahn, 1995). Whereas xid is 
characterized by a defect in peripheral B cell maturation and function, there is no substantial block 
in early B cell development, as in XLA. Nevertheless, by analysis of competition ill vivo between 
wild-type and Btk~deficient cells, it was shown that the first selective disadvantage of Blk-deficient 
cells in the mouse is also at the transition from pre-B to immature B cell (Hendriks el al., 1996). 
Btk is a 659 amino acid protein that contains a single C~tenninal catalytic domain, the Src 
homology domains SH2 and SH3 and a unique pleckstrin homology (PH) domain at the amino 
tenninns, with an adjacent proline~ and cysteine~rich Tee homology (TH) domain (see for review: 
Sideras and Smith, 1995; Desiderio, 1997). Btk is expressed throughout B cell development, but not 
in plasma cells (de Weers et al., 1993; Sideras and Smith, 1995; Hendriks et al., 1996). It has been 
shown that Btk tyrosine phosphorylation and ill vitro kinase activity increase upon BCR stimulation 
(Saouaf et al., 1994; de Weers et al., 1994; Aoki et al., 1994). BCR engagement leads to activation 
of phosphatidylinositol 3~kinase (pI3~K), which generates the second messenger 
phosphatidylinositol-[3,4,5jtriphosphate (Ptdlns-3,4,5,-P3). In concert with Src family kinases 
(Rawlings et al., 1996; Wahl el al., 1997), Ptdlns-3,4,5,-P3 initiates Btk activation by targeting the 
kinase to the plasma membrane through interactions with the Btk PH domain (Salim el a/., 1996; 
Scharenberg el al., 1998; Bolland et al., 1998). These interactions are critical to the activity of Btk 
and result in PLC-y tyrosine phosphorylation, inositol triphosphate (IP3) production and calcium 
mobilization. This pathway is inhibited by engagement of the Fc receptor yIIB through the activity 
of SH2-containing inositol polyphosphate (SHIP) which regulates the association of Btk with the 
membrane by reducing the level ofPIP3 (Bolland et al., 1998; Scharenberg et al., 1998). 
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Btk-deficient B cells exhibit a reduced IP3 peak level and Ca2+ flux following BCR cross-
linking (Fluckiger et al., 1998). Conversely, a consitutively active fonu ofBtk, E41K, a Glu-to-Lys 
mutant at position 41 in the PH domain close to the predicted inositol phosphate binding site 
(Hyvonen and Saraste, 1997) is associated with increased membrane localization and tyrosine 
phosphorylation ofBtk (Li et al., 1995). Expression of the E41K Btk mutant was shown to stimulate 
growth of NIH 3T3 fibroblasts in soft agar (Li et al., 1995), to enhance the sustained increase in 
[Ca2+] following BCR cross-linking in Ramos B cells (Fluckiger ef at., 1998), and to enhance blast 
fonnation of splenic B cells in response to BCR cross-linking (Dil1gjan et al., 1998). Transgenic 
expression of the E41K Btk gain-of-function mutant driven by the MHC class II Ea gene locus 
control region resulted in an immunodeficient phenotype that is more severe than xit!: recirculating 
B cells were lacking, ill vivo B cell responses to TD or TI-IJ antigens were essentially absent and 
splenic architecture was dismpted (Dingjan et al., 1998). The arrest in development in the spleen 
coincided with a marked increase in expression of the transgene during maturation from IgMhigh to 
IgMlow B cells. 
To be able to study the effect of constitutive activation of Btk in early B cell development, we 
generated transgenic mice in which expression of wild-type or E41K human Btk (hBtk WT or 
hBtkE41K) is driven by the human CD19 promoter, which contains a critical high-affinity binding 
site for the B-cell-specific transcription factor BSAP/pax-5 (Kozmik et al., 1992). Expression of a 
human CD19 transgene was reported to be completely restricted to the B cell lineage and to appear 
early in development (Zhou et al., 1994). Here, we show that transgenic expression of the E41K Btk 
mutant driven by the CD 19 promoter resulted in an arrest at the transition of IgM10w to IgMhigh 
immature B cells in the bone marrow, and in an increase of the proportion of Ig A L chain 
expressing cells. Conversely, mice with a targeted deletion of the Btk gene (Hendriks et al., 1996) 
had decreased proportions of A expressing B cells. A role for Btk in Ig L chain assembly was further 
supported by the observed accumulation of Btk-deficient cells within a subpopulation of small 
resting pre-B cells. 
Results 
Transgenic expression of hBlkWT and hBtkE41K under the control of the CD19 promoter 
A 6.3 kb genomic fragment with the CD19 promoter, containing the critical BSAP/pax-5 site 
(Kozmik ef al., 1992), and 5' flanking DNA was used to express the hBfklVT aud hBftt'41K 
transgenes (Figure lA). To constmct the transgenes, a 27.4 kb hBlk eDNA-genomic DNA fusion 
segment containing either the wild-type or the E41K mutant human Btk was ligated at an MspI site 
in exon 1 of the human CD19 gene, located 18 bp 5' of the ATG translation start. After micro-
injection into fertilized oocytes, two CD19-hBtk"rr and four CD19_hBtkE4IK founder mice were 
obtained. These founders were mated onto a Btk-deficient background, in which the Btk gene is 
inactivated by a targeted in-frame insertion of a lacZ reporter (Hendriks et al., 1996). The offspring 
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of these founders did not exhibit developmental defects or any increased susceptibility to 
malignancies for over 9 months of age. 
In the transgenic lines, expression of Btk was detected by \Vestem blotting analyses (data not 
shown) and intracellular flow cytometry using a polyclonal rabbit antiserum specific for Btk (Fig. 
IB). Expression of transgenic Btk was restricted to B220+ cells and increased while bone marrow B 
cell progenitors matured to surface Ig + peripheral B cells. As compared to the endogenous levels, 
both CD19-hBtk\VT and CD19_hBtkE41K transgenic B cells manifested a significant overexpression 
ofBtk protein, in particular in the peripheral lymphoid tissues. T celis, granulocytes, monocytes and 
macrophages did not express detectable amounts oftransgenic Btk (data not shown). 
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Figure 1. Structure alld expression of the CD19_hBtkWT alld CD19-hBtIf4JK trallsgelles.(A) Map 
of the trallsgelle constructs, showing the 6.3 kb humall CD19 promoter region alld the 27.4 kb hBtk 
cDNA-gellomic DNAfusioll segment with exollS 1 to 19, as well as a 10xP sequence. l1,e position of 
the E41K mutatioll ill e.mu 3 is illdicated. E=EcoRJ, Eg= Eagl,' P=Pl'ul; S=SwaI. (B) Intracellular 
Btk expression ill B cells from 2-mouth-old lIoll-tra1lsgenic Btk + 01' Btk- mice, ami CD19_hBtkWT 
alld CD19_hBtJt-4JK transgenic mice all the Btk- background. Cell suspensions were stailled for 
sill/ace B220 alld IgM and subsequently for intracellular Btk. The indicated populations of pro-
/pre-B cells (B22dOll'lgA1") alld immature B cells (B22r/Oll'lgM+) ji'om bone marrow, as well as 
mature B220+lgM+ B cells ji'om spleen were gated alld analyzed for Blk expression. The results 
are displayed as histograms of the indicated mice (solid lines), tO$ether with the background 
staining as determined ill Btk- mice (dashed lines). Data are from J(Y total events (B cell Ilumbers 
were significantly lower ill the CD19_hBtJt-4JK transgellic mice, see Table f). 
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Table 1. 
Frequencies of lymphocyte populations in CD 19_hBtk\VT and CD 19-hBt~41 K transgenic mice 
Compartment Cell populalion Non-transgenic CDI9-hBtkWT CD 19_hBt~41K 
Blk + aJ Blk Blk 'f Blk - Blk 'f Blk-
Spleen b) Nucleated cells, x I 0-6 114±29 58±13 103±17 88±21 47±14 40±ll 
B220+ cells, % 42±5 22±3 38±7 42±5 0.2±0.1 0.5±0.4 
CD3+CD4+ T cells, % 27±3 29±2 23±1 26±4 41±5 42±2 
CD3+CD8+ T cells, % 14±3 19±1 14±1 14±1 30±5 30±7 
Lymph Node B220+ cells, % 18±2 6±0.4 20±0.3 19±1 <0.1 <0.1 
CD3+CD4+ T cells, % 50±4 56±1 47±2 47±2 65±4 63±4 
CD3+CD8+ T cells, % 25±3 32±2 26±4 26±1 34±3 36±4 
Blood B220+ cells, % 52±2 27±0.2 ND c) ND <0.1 <0.1 
Peritoneum CD5+ IgM+ B cells, % 24±8 0.5±0.2 22±14 19±5 0.9±0.2 1±0.4 
CD5- IgM+ B cells, % 34±7 19±4 24±1 28±6 0.6±0.5 0.7±0.7 
CD5+ Ig~ T cells, % 30±6 48±1 28±1 30±5 64±15 62±9 
Bone B220 + cells, % 48±5 35±8 46±8 47±3 27±4 25±5 
Marrow Ig- pro/pre B cells, % 29±4 23±5 32±6 30±2 22±4 21±4 
IgM+lgD- B cells, % 10±2 9±2 9±2 1O±5 4±1 3±1 
IgM+lgD+B cells, % 8+3 3+1 5+2 7±2 <0.1 0.2+0.2 
The phellotype of lymphocyte populatiolls were determilled by flow c.J.tomefly; dead cells and high 
side scatter cells were excluded by gating. a) Btk + mice were Btk /Y males or Btk +/- females, 
Blk - mice were Btk -/Y males (Hendriks et al., 1996). b) mice were 6-9 weeks old. Data are mean 
values standard deviatiolls from 5-10 mice analyzed pel' group, except/or blood, where values are 
/rom 2-4 mice per group. c) ND = 1lot determined. 
Transgcnic CD19_hBtkE41K expression blocks B cell developmcnt at the immature B cell stage 
To examine the effect of CDI9_hBtkWT and CDI9_hBtkE4IK expression on B cell 
development. total cell suspensions from various lymphoid tissues from transgenic and Ilon-
transgenic mice, either on a Btk + or a Btk- background were analyzed by flow cytometry (Table I; 
Figure 2). As previously described (Hendriks et al .• 1996). the Btk- mice had fewer mature;: B cells 
(~30-50% of normal) in spleen. lymph node, peripheral blood. and bone Illarrow (B220hlghIgM+ 
fraction; Figure 2A). In addition, these mice exhibited a specific deficiency of mature 
IgMloWIgDlugh B cells in the spleen (Figure 2B). and CD5+ B-1 B cells in the peritoneal cavity 
(Figure 2C). In mice that expressed the CDI9-hBtk'VT trallsgene 011 the Btk- background, a 
cOlllflete correction of the B cell numbers w~s observed in all lymphoid tissues analyzed. On the 
Btk background, expression ofCDI9-hBtk"T did not appear to have any effect 011 the sizes ofB 
cell sUbpopulations (Table I; Figure 2). 
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- non-Tg CD19-hBtkWT CD19_hBtkE41K 
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Figure 2. The effects of transgenic CD19-hBtkWT and CDJ9_hBt!!i41K expression 011 B cell 
developmellt. FloH' cylometric alia lyses of (AJ bone marrow, (B) spleell, and (C) peritolleal cavity of 
the indicated mice on the Btk + or Btk- background. Single cell suspensiolls were stailled with 
biotillylaled allti-IgAI alld slreplavidill-TriColor, and either FITC-colljllgated anli-B220, PE-
conjugated IgD or PE-conjugated anti-CD5. Dala are displayed as dOl plots of lotal lymphocytes, 
which were gated on the basis oflheirf01ward and side scatter characterislics. Percelllages of lola I 
lymphocytes within Ihe indicated gates are given. Data shown are representative of the mice 
examined (Table J). 
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In contrast, transgenic CD 19-hBtkE4 IK expression resulted in a block of B cell development at 
the immature B cell (B2201oWIgM+IgD-) stage in the hone marrow, irrespective offhe Btk + or Btk-
background. Compared with wild-type or Btk- mice, the size of the immature B cell population was 
reduced by a factor of two to three, and lacked IgMhigh cells (Table I; Figure 2). The ahnost 
complete absence of the B220highIgM+ population of mature recirculating B cells in bone marrow 
and peripheral lymphoid compartments indicated a reduction ofthe mature B cell pool to <1% of the 
nOllllai size (Table 1; Figure 2). In addition to the defect in conventional B cells, the CD 19-
hBtkE41K transgenic mice also lacked both CD5+ and CD5- B-1 B ceJls in the peritoneal cavity. The 
six groups of mice analyzed did not manifest significant differences in pro-B or pre-B cell fractions 
in the bone marrow, as assayed by expression of the surface markers B220, CD43, heat stable 
antigen and BP-l 
(Hardy et al., 1991); they also did not manifest differences in the thymocyte subpopulations (data 
not shown). In the CDI9_hBtkE41K transgenic mice a relative increase of the proportions ofT cells 
was observed in spleen, lymph node and peritoneal cavity (Table 1). 
IgI\1 is present, but antigen responses are defective in CD19_hBtkE41K transgenic mice 
To evaluate the capacities of the residual B cells present in the CDI9_hBtkE4lK transgenic mice, 
we analyzed semm Ig levels and ;1/ vivo immune responses. 
Senn1J Ig levels were determined in 2-month-old CDI9_hBtkWT and CDI9_hBt~41K transgenic 
mice, with non-transgenic Btk + and Btk- mice as controls (Figure 3A). The levels of IgM and IgG3 
in the sera of Btk- mice were decreased as compared with those in control Btk + littermates (Scher, 
1982; Kahn et al. 1995; Drabek et al., 1997). This defect was corrected by transgenic CD I 9_hBtkWT 
expression: IgM levels were somewhat elevated and Ig03 levels were in the nonnal range. By 
contrast, in CD19-hBtx£4 1K transgenic mice the serum levels ofIgM were low, with values between 
those for Btk-deficient and control mice. Notably, the sennn levels of all other subclasses were 
strongly reduced, whether on the Btk + or Btk- background (Figure 3A). In the CDI9_hBtkE41K 
transgenic mice the semm IgM levels increased with age: when the mice were 6-7 months old. the 
IgM concentration in the serum was elevated, as compared to nonnal or CD19-hBtkWT transgenic 
mice (Figure 3B). At this age, IgGi and IgG2a remained undetectable, IgG2b and IgG3 were in the 
range ofBtk- mice and IgA was variable. 
The finding of substantial IgM levels in CD19-ltBttE41K transgenic mice implied that - in spite 
of the reduction of the mature B cell pool to <I % of the noruml size - significant numbers of IgM 
secreting plasma cells were present. To investigate whether functional antibodies could be produced, 
we analyzed the immune responses to a TI type II antigen, dinitrophenol(DNP)-Ficoll, and a TD 
antigen, trinitrophenol-keyhole limpet haemocyanin (1NP-KLH). 
Consistent with the reported findings (Scher, 1982, Kahn et al., 1995, Drabek et al., 1997), the 
Btk- mice were unresponsive to DNP-Ficoll: the detected NP-specific IgM or IgG3 levels at day 7 
after i.p. injection did not differ from the values of un immunized animals. \Vhercas expression of the 
CD19-hBtkWT transgene restored the TI type II response, expression of the CD19_hBt.z.E41K 
transgene abolished this response. already on the Btk + background (Figure 3C). 
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The primary IgM response at day 7 or the secondary IgGl, IgG2a or IgG2b responses, at day 7 
after booster injection with TNP-KLH, were not significantly different between Btk +, Btk - or CD 19-
hBtkWT transgenic mice. However, the CD19_hBtkE4IK transgenic mice were unable to mount 
detectable primary or secondary humoral immune responses against the TD antigen TNP-KLH 
(Figure 3D). 
In summary, we conclude that those few B cells that populated the peripheral immune system 
and were able to develop into plasma cells did not respond productively to TD or TI type II antigens. 
Follicular and marginal zone B cells are absent but plasma cells are present in CD19_hBtkE41K 
mice 
Seven days after booster injection with the TD antigen TNP-KLH, the spleens from 3-month-old 
non-transgenic, CD19-hBtk'VT and CD19-hBtJt!4IK transgenic mice, each on the Btk+ or Btk-
background, were examined by immunohistology. Double labelings of serial spleen sections with 
monoclonal antibodies specific for B cells (anti-IgM, anti-IgD and anti-B220), T cells (anti-CD3), 
metallophilic macrophages (MOMA-I) or interdigitating dendritic cells (anti-CDllcIN418), as well 
as peanut agglutinin (PNA) are shown in Figure 4. The spleens of non-transgenic or CD 19-hBtk WT 
mice, either on the Btk + or Btk - background, demonstrated a characteristic histological organization, 
in {enns of separate T and B cell areas in the white pulp, with T cells surrounding central arterioles 
(Figure 4, a-d) and B cells in foHicles (a·c,e-g,i-k) with PNA + genninal centers (e-g), In these mice, 
the marginal zones at the outer boundaries of the white pulp contained IgDlow B cells, as well as 
MOMA-l+ macrophages interrupted with nests of strongly N41S-expressing dendritic cells that 
foml bridging chatmels into the red pulp (Stehmlan et al., 1997). 
By contrast. in the CDI9_hBI.l!41K transgenic mice only few B cells were detected. They were 
present partly as isolated cells in the T cell areas, and partly in small clusters, close to the N4lShigh 
dendritic cells at the periphery of the white pulp nodule (Figure 4, d,hJ). There was no evidence for 
the presence of a distinct marginal zone, as the outer boundary of the white pulp did not contain 
B220+ cells and MOMA-l+ metaltophitic macrophages were largely absent, except for the 
incidental presence of some M01v1A-l + cells close to the small B cell clusters (Figure 4p). In the red 
pulp. IgM+ plasma cells were present in apparently nomlal numbers (Figure 4d), Consistent with the 
absence ofTD immune responses ill vivo, PNA + genninal center B cells were not detectable (Figure 
4h). 
In summary, these findings show that in CD19_hBt~4IK transgenic mice, those few B cells that 
emerged frOI11 the bone marrow did not develop into follicular or marginal zone B cells, but were 
present in T cell areas and were subsequently driven into plasma celt differentiation. 
The splenic B cells in CD19_hBtkE41K transgenic mice have an aberrant surface phenotype 
The residual splenic B cells of CD19_ltBt~41K transgenic mice were further characterized by 
three- and four-color flow cytometry, As shown in Figure SA, those B220+ B cells present 
manifested close to nomlal IgM expression on the membrane, but the level of cell surface IgD was 
decreased, as compared to CD19-hBlkwT transgenic B cells. The B cells manifested a nonnal 
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fonvard scatter profile and did not appear to belong to the B-1 lineage, as CDS or Mac-l were not 
present on the cell surface (data not shown). The B cells had a B22o!°wHSAhigh phenotype. 
reminiscent of recent emigrants ITom the bone marrow that have not yet differentiated into mature 
B220highHSA'ow cells of the long-lived B cell pool (Allman ef al., 1993). The lack of 
B220highHSAlow cells (Fig. SA) indicated that in CD19_hBtkE41K transgenic mice those few 
immature B cells that have left the bone marrow failed to mature in the spleen into long-lived 
recirculating cells. 
Figure 3. Serum Ig le\'els alld humoral immune responses ill CD19-hBtkWT and CD19_hBt~41K 
transgeJlic mice. (A, B) Serum concentrations 0/ the illdicated Ig subclasses in lion-transgenic Btk + 
or Btk- mice, CD19-hBtkWT transgenic mice 011 the Btk + or Btk- background, as well as CD19-
hBtkE41K transgenic mice 011 the Blk + or Btk- background. Mice were 2 l1Iollths (A) or 6-7 mOllths 
(B) of age. (C) IgA1 and IgG3 respollses against the TI type II antigen DNP-Ficoll at day 7 after i.p. 
illjection. (D) Primmy Igkf respollses agaillst the TD antigen TNP-KLH (determined 7 days after 
i.p. injectioll) and secolldmy TD responses of the indicated subclasses (determhled 7 days after (III 
i.p. booster injection approximately 4 weeks after the primmy immunization). Pre-immune levels 
were <10 Ullllifor JgM, <2 Ullllifor JgG3, <5 gllllifor JgG2a alld <10 gllllifor JgGI alld JgG2b. 
Mice were 2 months old, total or NP-specijic Ig levels were determined by ELISA and each symbol 
indicates all individual animal. (Next page). 
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Figure 4. Histology of the spleen from CDJ9·hBtkWT and CDJ9·hBtkE4JK tra1lsgenic mice. 
Immunohistochemical analysis of 5 m splenic frozen sectiolls ji'om Btk + mice, Blk- mice, as well as 
CDI9·hBtkWT alld CDJ9_hBfJ!4JK transgenic mice 011 the Btk· background. Sections were stained 
with allli-CD3 (bille, a-d) Jar T cells, allli-IgM (brown, a-d), anli-IgD (bIlle, e-h) or allli-E220 (bIlle, 
i-I) Jar B cells, PNA (brown, e-h) Jar germinal eelller B cells, anli-CDllc/N4IS (brown, i-p) Jar 
dendritic cells alld AlOMA-J (blue, m-p) for melallophilic marginal zone macro phages. Open 
arrows illdicate the presence of plasma cells ;11 a·d or PNA+ germinal centers ill e-g. Closed arrows 
indicale Ihe localion oj small elllslers oj B cells (d)I,/) or MOMA-I+ cells (P) ill CiJ19_hBltf41K 
transgenic mice. Origillal magnificatiolls are 16x. 
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MHCII-hBtkE41K 
J--.--,~-+----.J 
o 5 10 0 5 
Proportion of Ig ,,-+ cells (%) 
Figure 5. Aberrant sm/ace phellof)pe of CD19·hBtJ!4JK transgenic mice. (A) SUllace profiles q{ 
splenic B cells. B220+ cells were gated alld analyzed for IgM ami /gD expression (top). CD19 
cells were gated and analyzed for B220 alld HSA expression (middle) or B220 alld Ig )... L chain 
(boltom)_ Data are displayed as (lot plots, alld the percellIages of gated cells withill the illdicated 
quadranls are shown. (B) The proportions of Ig }.. L chain expressing cells of the total 
B220+ CDJ9+ /raction ill 'he spleen (left) alld of the Ig + B22dolVCD19'+ immature B cell fi'actioll ill 
the bone marrow (right) of the illdicated mice as determined by flow cytomell),. Data are shown as 
mean ± standard error from 5-10 mice per group, except for the MHCII_hBIk?4JK mice where 3 
mice were analyzed. 
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Bfk and Ig}.. L chain expression 
In nomlal mice -95% of B cells express Ig K L chains, while only -5% express}.. L chain. In 
CD19_hBtkE4IK transgenic mice the proportion of Ig }.. L chain expressing cells in the spleen was 
found to be increased to ~9.0%, compared to CD19-hBtkWT transgenic mice (-6.5%) or wild-type 
mice (-4.9%) (Figure SAB). Conversely, in Btk- mice we noticed a significant reduction of the 
proportion of Ig A + cells to ~2.3%. \Vhen we analyzed the transgenic mice in which the expression 
of the E41K Btk mutant is driven by the MHC class II LCR (Dingjan el al., 1998), also a significant 
increase in the proportion of Ig A L chain expressing cells in the spleen was observed (Figure 5B). 
To further investigate whether the expression of A L chain is more dependent on Btk function 
than K L chain, we investigated the competition ill vivo between Btk + and Btk - A + B cells in female 
Btk +/- heterozygous mice. In these mice, expression of the disrupted Btk allele could be monitored 
by lacZ expression (Hendriks et al., 1996). Because of the process of random X-chromosome 
inactivation, ~SO% of the B-lineage cells will have the disrupted Btk allele on the active X 
chromosome. When these cells reach a differentiation stage at which Btk is required, their further 
development is arrested and the proportions of lacZ+ cells decrease below this value of 50% 
(Hendriks el al., 1996). In 4-month-old female Btk +1- heterozygous mice, we found that the fraction 
of lacZ+ cells in the most immature population of IgD1oWB220+ B cells in the spleen was 22% ± 5 
(n=S). However, within the subpopulation of surface Ig A L chain positive IgD1oWB220+ B cells, the 
fraction of lacZ+ cells was only 11 % ± 4 (n~5). Consistent with our findings in wild-type and Btk-
mice (Figure 5B), we found that within the immature IgD1oWB220+ splenic B cell population of 
heterozygous Btk +/- females, the proportion of Ig A L chain expressing cells was 4.4% ± 0.7 for 
lacZ - Btk + cells, and 1.9% ± 0.5 forlacZ+ Btk- cells. 
The reduction of Ig A L chain expression in Btk - mice was confinlled in an Ig A-specific ELISA: 
the percentage of A L chain containing IgM in the semm was found to be <0.4% in Btk - mice, 
4.4%±OA in wild-type littennates and 6.9%±0.8 in CD19_hBlkwT transgenic mice. In the CDI9-
hBt~41K transgenics this fraction was rather variable, ranging between 1.1 % and 8.7%. 
The observed differences in kI)" ratios could partly result from differences in peripheral B cell 
selection mechanisms between the mouse groups. Therefore, A L chain expression was also analyzed 
in the fraction of B2201oWIg+ immature B cells in the bone marrow, and was found to be -2.0% in 
Btk - mice, -3.2% in heterozygous Btk +/- females, --4.9% in wild-type mice and -6.6% in CD 19~ 
hBtkWT transgenic mice (Figure SB). The low levels ofIg expression on the surface of immature B 
cells in CDI9_hBlkE41K transgenic mice (Figure 2A) precluded a reliable estimation ofK/l. L chain 
distribution. These data demonstrated that the correlation between Btk activity and Ig KiA L chain 
usage was already present at the level of the immature B cell in the bone marrow. 
Accumulation of Btk- cells within the pre-B cell population 
\Ve previously reported a selective disadvantage of Btk- cells to contribute to the population of 
immature B cells in the bone marrow, as in heterozygous Btk +/- female mice the percentage of laeZ 
expressing cells decreased from -50% in pro-B and pre-B cells to -30% in "immature IgM+ B cells. 
(Hendriks et al., 1996). This finding could reflect a selective disability of Btk- cells in Ig L chain 
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assembly at the small pre-B cell stage, or aUemativeJy a decreased survival ofBtk- cells within the 
immature B cell population. To discriminate between these two possibilities, we tried to identify 
subpopulations of cells within the pre-B cell or immature B cell stage that would manifest an 
accumulation of cells that are blocked or delayed in development. In such subpopulations, the 
propOliion oflacZ+ cells was expected to be >50%. 
A four-color flow cytometric analysis of bone marrow suspensions of 5 week-old Etk + and Btk-
males, as well as heterozygous Blk +/- females was performed, using the markers B220, CD43/S7, 
IgM and lacZ. The earliest slages of B cell development, pro-B cells and large cycling pre-B cells 
express CD43 on their cell surface but the expression is down-regulated at the transition to small 
resting pre-B cells which are IgM-CD43duIV- (Hardy el at., 1991). Within this IgM"CD43dutV-
population of small resting B cells, we identified a subpopulation of IgM-CD43- cells, in which 
Btk- cells appeared to accumulate: the size of this subpopulation was 1.5% ± 0.4 of all B220+ in 
wild-type mice (n~3), 7.1% ± 2.2 in Btk- mice (n~4) and 4.4% ± 1.8 in Elk +/- heterozygous females 
(n=5) (Figure 6). Most importantly, when Btk- cells were in competition with wild-type cells ill vivo 
in the Btk+/- heterozygous female mice (n=5), a substantial accumulation of lacZ+ Btk- cells was 
observed within this IgM-CD43- subpopulation, which contained 72% ± 9lacZ+ cells (Figure 6). 
\Vithin the fraction of immature B cells (IgM+IgD-), we could not detect any accumulation of 
Blk - cells: the fraction of lacZ+ cells was ~30%, irrespective of the surface IgM expression level 
(data not shown). In summary, these findings in male Btk- and female Btk+l- mice indicate an 
accumulation of Btk - cells within the pre-B cell poputation, as a result of impaired progression into 
the stage of immature sIgM expressing B cells. 
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Figure 6. Btk- cells are arrested at the pre-B cell stage. (A) SIII!"ce CD43-IgM profile of B220+ 
cellsfi'om bone marrOW of the indicated mice. For each sample the percelllage of total B220+ cells 
which is within the indicated gate of CD4TlgAl pre-B cells is indicated. (B) The gated 
sllbpopulatioll of CD4TlgAI pre-B cells were analyzed for lacZ expression and the results are 
displayed as histograms. The percentages of lacZ+ cells withill /ractioll A are indicated. The data 
shown are represelltative of 3-5 mice examined withill each group. 
Discussion 
\Ve have generated transgenic mice in which expression of wild-type human Btk or the E41K 
Btk mutant is under the control of the promoter and 5' flanking region of the CD19 gene. High-level 
Btk expression was obtained, specifically in B cells, but since the trans gene constmcts used 
contained -27 kb of genomic DNA from the Btk gene itself, it is very well possible that Btk 
endogenous regulatory elements contributed to the expression pattems of the transgene. When the 
CD19-hBtkWT transgenic mice were mated onto a Btk- background, correction of all .tid features 
was observed, comparable to our earlier findings in transgenic mice in which Btk expression was 
driven by either the MHC class II Ea gene locus control region or endogenous regulatory regions in 
a 340kb yeast artificial chromosome (Drabek et aI., 1997; Maas et aI., 1997; Dingjan et aI., 1998). 
Constitutive activation of Btk leads to a developmental block at the immature B cell stage 
The present data demonstrate that expression ofa constitutively activated fomI ofBtk, the E41K 
mutant, causes an almost complete arrest of B cell development within the IgM+IgD- immature B 
cell population at the progression from IgMlow to IgMhigh IgO- B cells. Since the IgMhighIgD-
inunature B cell stage reflects the first immune tolerance checkpoint where auto-reactive B cells 
become susceptible to apoptosis, we conclude that constitutive activation of Btk mimicked B cell 
occupancy by self-antigens. An alternative explanation, that expression of the CD19_hB/~4IK 
transgene would impede basal BCR signaling, which is thought to direct developmental progression 
ofB cells, seems less likely, because in mice which lack essential signaling components of the BCR 
complex, such as the CD79a (Iga) cytoplasmic tail or the syk tyrosine kinase, B cell development is 
arrested at a slightly later stage, i.e. the stage of recmitment of IgMhighIgD- immature B cells into 
the circulating B cell pool (Torres et aI., 1996; Tumer et aI., 1997). 
The phenotype differed markedly from our previously reported MHCII_hBtkE41K transgenic 
mice, which did not show detectable defects in developing B cells in the bone marrow, but 
manifested a deficiency of recirculating B cells (Dillgjan et al., 1998). The differences between the 
two BtkE41K expressing mouse strains most likely resulted from differences in the expression level 
of the transgene in the bone marrow, which was found to be higher in the CD 19_1tBtkE4 IK transgenic 
mice. 
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Constitutive activation ofBtk drives peripheral B cells into plasma cell differentiation 
In the CD19~hBtkE41K transgenic mice the block at the IgMhigh immature B cell stage was 
leaky, allowing very small numbers ofB cells to populate the peripheral immune system. Such cells 
were almost exclusively found in the spleen as B220'owHSA high cells, which nonnally represent 
immature B cells that have just left the bone marrow. In parallel to our findings in the of MHCII~ 
hBtkE41K transgenic mice (Dingjan et al., 1998), the expression of BtkE41K further impeded 
follicular entry of these cells, as B220highHSAlow cells were absent in the spleen and recirculating B 
cells in the bone marrow or lymph nodes were completely lacking. 
In spite of the reduction of the mature B cell pool to <1 % of the nannal size, significant numbers 
of IgM secreting plasma cells were present in the splenic red pulp. Serum IgM levels were 
substantial, and increased with age to levels that were elevated, as compared to those in nonnal 
mice. However, specific TD or TI antibody responses were lacking, indicating that B cells failed to 
interact productively with T cells or antigen presenting cells. Therefore, we conclude that 
constitutive activation ofBtk drives the residual B cells that have been able to emerge from the bone 
marrow into plasma cell differentiation, apparently without functional selection. 
Btk and Ig L chain assembly 
Our findings in the Btk~deficient mice and the CD19~hBtkE41K transgenic mice indicate a role 
for Btk during the L chain rearrangement process at the transition of pre·B cells into immature B 
cells. 
Btk-deficient cells accumulated within a subpopulation of small resting B cells, suggesting a 
delay in the onset of L chain rearrangement. In this respect, Btk- deficient mice show resemblance 
with mice carrying a targeted deletion in the Ig K locus, which manifest an increase in the percentage 
of small resting CD43- pre-B cells (Zon ef al., 1993; Chen ef al. 1993). It is possible that Btk is an 
essential transducer of signals that initiate rearrangement of the Ig L chain locus, e.g. by regulating 
the re-expression of the RAG gene products, which are absent in the large cycling pre~B cells and re-
activated in the small resting pre~B cells (Grawunder et al., 1995). TIllS would be supported by the 
finding that expression of the RAG genes is dependent on BCR signaling in immature IgMlow B 
cells (Melamed et al., 1998). Btk could also transduce signals that result in changes in chromatin that 
allow the recombinase access to the Ig L chain gene segments. This would be analogous to findings 
in the T cell system, in which anti~CD3e treatment of CD4-CDS- cells of RAG~deficient mice 
induces the opening of the TCR a locus, as monitored by genu-line Ja transcription and methylation 
status (VilIey et a1., 1997). Concomitantly, large numbers ofCD4+CD8+ thymocytes are generated, 
a process that was also seen when an Ick transgene encoding a constitutively active kinase was 
introduced into RAG~deficient mice (Mombaerts et al., 1994). 
The proportion of ) ... L chain expressing cells was decreased in Btk- mice (~2%), and 
significantly increased in CDI9~hBt~4IK transgenic mice (~9%), as compared to Hannal mice 
(~5%). Low-level expression of the E41K mutant in bone~marrow of MHCII~hBtkE4IK transgenic 
mice already increased the proportion of').. + B cells to -10.6% (Figure 5B). Also overexpression of 
wild~type Btk appeared to increase').. L chain usage, as we found 6~7% ).+ cells in CD19-hBtk\\rr 
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transgenic mice. Collectively, these findings indicate a critical role for Btk activity at the pre-B to 
inunature B cell transition. Also in human the absence ofBtk results in a deviation from the nonnal 
K + to A + ratio of 50:50, as was shown by the finding of only ~25% , .. + ceHs in the peripheral blood 
B cell population or in B lymphoblastoid cells lines from XLA patients (Conley, 1985; Timmers et 
01., 1993). 
The observed ratio of K + to A + B cells of 95:5 in nonnal mice is thought to reflect the earlier 
initiation of rearrangements at the K locus and the ...... 3-fold higher probability of productive K + versus 
A + rearrangements per chromosome, within the limited life span of tile small pre-B cell (Hieter et al. 
1981; Ramsden and Wu, 1991; Arakawa el al., 1995). It was estimated that only those small pre-B 
cells that failed to produce K L chain after up to three sequential K rearrangement attempts per allele, 
would proceed with A rearrangements (Arakawa et al., 1995). As L chain rearrangement occurs 
without cell division or substantial cell loss (Osmond, 1991), the K to A ratio ofthe immature B cell 
population directly reflects the probability of productive K + and A + rearrangements (Arakawa et al., 
1995). Therefore, our finding of reduced A L chain expression in Btk - mice, indicates that the 
absence of Btk resulls in a delay in the initiation of L chain rearrangements, a reduced survival of 
pre-B cells that are in the process of L chain rearrangement, andlor impaired receptor editing of 
immature IgMlow B cells. 
In this context, the CDI9_hBtkE4IK transgenic mice parallel transgenic mice with enforced 
expression of the Bcl-2 apoptotic inhibitor in B cells, which also showed a significant increase in the 
percentage of A + B cells, either in vivo in the presence or absence of auto-reactive Ig transgenes 
(Tiegs et aI., 1993; Lang et at. 1997) or in bone marrow cultures ill vitro (Rolink et ai., 1993). These 
results were explained by assuming that B cells nonnally have too little time to take fuJi advantage 
of the potential A L chain repertoire that could rescue non-functional or auto-reactive B cells (Lang 
et al., 1997). It is attractive to hypothesize that, like Bc/-2 transgene expression, also CDI9-
hBtkE41K expression results in an extended life-span of pre-B cells (or immature IgMlow B cells) 
providing an extended time window per cell for L chain rearrangement or editing. Conversely, the 
absence of Btk would limit the survival of pre-B cells that are in the process of L chain 
rearrangement and therefore result in low )JK ratios. A role for Btk in (pre-)B cell survival would be 
supported by the findings that Bcl-2 expression is reduced and sIg-mediated bel-xL induction is 
absent in xid B cells (Anderson et al.. 1996; Choi et al., 1996; Woodland et at., 1996). In addition, 
the large variation found in the numbers of pre-B cells present in the bone marrow of XLA patients 
(Sideras and Smith, 1995) could be explained by a crucial role for Btk in pre-B cell survival. 
FurthemlOre, this would be consistent with experiments that indicate that a certain level of basal 
BCR signaling is required for developmental progression or survival of {pre-)B cells (Gu et al., 
1991, Lam el 01.,1997). 
Btk tl'ansduces signals at multiple checkpoints in B cell development 
The phenotypes of the xid and the MHCII_hBtkE4IK transgenic mice already indicated that Btk 
is essential in signaling pathways that govern the maturation of peripheral B cells (Scher, 1982; 
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Khan et al., 1995, Dingjan et al., 1998). Now, we report that constitutive activation of Btk can drive 
peripheral B cells into tenninal plasma cell differentiation. 
Our findings in the mouse show that Btk also transduces signals at several check-points in B cell 
development in the bone marrow. The lack of pro gressi OIl ofBtkE4lK B cells into the IgMhighIgO-
cell stage, would place Btk in the BeR signal pathway that eliminates auto-reactive B cells in the 
bone marrow. Moreover, the present data provide the first evidence for a role for Btk in Ig L chain 
assembly at the transition of pre-B cells to inunature B cells, whereby defective Btk function results 
in an almost complete developmental arrest in XLA and only a minor selective disadvantage ofBtk-
cells in xid. In the absence of Btk, signaling through the pre-BCR complex still mediates its nonnal 
checkpoint function (Rajewski, 1996) by effecting Ig H chain allelic exclusion, 11-7 driven 
proliferative expansion and progression to the resting small pre-B cell stage. However, the 
subsequent assembly ofIg L chain, resulting in progression into the IgM+ immature B cell stage, is 
impaired when Btk is defective, e.g. because of defective re-expression of the RAG genes or 
insufficient accessibility of Ig L chain loci, or because of reduced survival of pre-B cells that are in 
the process of L chain rearrangement. Further experiments are needed to directly demonstrate the 
involvement ofBtk signaling in any ofthese events. 
Experimental procedures 
Generation of CD19-hBlk"'T and CD19_hBlkE41K transgenic mice 
The transgene constmcts CD19-hBtkWT and CD19- hBt~41K, in wlliclt the E41K mutation was 
introduced by site-directed mutagenesis (Dingjan et al., 1998), are shown in Figure lA. The cosmid 
clone containing the human CD19 promoter region (kindly provided by M. Busslinger, Research 
Institute of Molecular Pathology, University of Vienna, Austria) was isolated from a human 
genomic cosmid library by screening with a homologous murine CD19 cDNA probe (Kozmik el al., 
1992). A -16 kb Xbal fragment containing 5' flanking DNA, and a 317 bp Xbal-Mspl(blunted) 
fragment (positions 1072-1389 of the human CD19 gene; Kozmik el al., 1992) were cloned into 
cosmid vector pTLS (Lund el al., 1982), using a Bg/II-MIIII-Xbal-Smal-PI'III-NoII-Bg/II polylinker. 
A unique Eagl site in the 16 kb Xbal fragment was used to isolate a 6.3 kb Eagl(blunted)-PI'1I1 
fragment and to ligate it to the 27. I kb PI'III-NoII fragment, containing 400 bp (Blk exon 1-3) of the 
wild-type or E41K mutated hBlk eDNA, a -27 kb genomic DNA fragment (Blk exon 3-19), and a 
109 bp LoxP fragmcnt (Dingjan el al., 1998). 
The ~34 kb A1IuI-NotI inserts of the CD19-hBtkWT and CDI9_hBtkE41K constmcts were excised 
from the vector and gel-purified. DNA (~2 ngl~tl) was injected into the pronulcei of FVBxFVB 
fertilized oocytes, which were subsequently implanted into pseudopregnant foster mice. Tail DNA 
was analyzed by Southern blotting of BamHI digests and hybridization to a partial hBtk cDNA probe 
(hBtk pos. 133-1153), to detennine the genotype of the founder mice and next generations generated 
by crosses with Btk-ILacZ mice of mixed 1291Sv x C57BLl6 background (Hendriks el al., 1996). 
Southern and \Vestem blotting techniques have previously been detailed (Hendriks et al., 1996). 
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Flow cytometric analyses 
Preparation of single·cell suspensions. and three· or four·color flow cytomctry have previously 
been described (Hendriks et al .• 1996; Dingjan et al .• 1998). The following monoclonal antibodies 
wcre obtained from Phanningen (San Diego, CA): FITC·conjugated anti·B2201RA3·6B2. anti·IgK 
IRS-240, anti-HSNM1I6, anti-CD3 and anti-BP-1I6C3, PE-conjllgated anti-CD43/S7, anti-CDS/Ly-
I, anti-CD4, allti-CDI9, anti-CDllblMac-l, CyChrome-conjllgated anti-B2201RA3-6B2 and anti-
CDS, and biotinylated anti·HSAJMI/6, anti·lgAIR26-46 and anti·lgM. PE·conjugated anti·lgD was 
purchased from SBA (Binllingham. AL). Affillity·purified polyclonal rabbit·anti~Btk (Phanningcn) 
was used for intracellular flow cytometric detection of cytoplasmic Btk protein. as previously 
described (Dingjan et al., 1998). Secondary antibodies used were TriColor~ or PE conjugated 
streptavidin (Caltag Laboratories, Burlingame. CA). streptavidin-APC (Phanningcn) or FITC 
conjugated goat~anti~rabbit Ig (Nordic. Capistrano Beach. CA). 
Sel'Urn Ig detection, ill vi/ro immunizations and immunohistochemistry 
Total or NP~specific levels of senlrn Ig were measured by subclass-specific sandwich ELISA as 
described previously (Dingjan et al .• 1998). In these assays TNP-specific standards were used for 
IgGt, IgG2a and IgG2b, whereas for IgM and IgG3 values were calculated as arbitrary units, using a 
reference serum sample. Immunizations with TD and TI type II antigens were essentially perfomled 
as described (Maas et al., 1997). Booster doses were given after 4 weeks. 
For inmlUllohistochemical analyses, tissue samples were embedded in OCT compound and 
frozen 5 ~m cryostat sections were acetone-fixed and single and double labelings were perfonned 
using standard procedures (Leenen et al., 1995). Monoclonal antibodies anti-B2201RA3~6B2, anti~ 
CD3IKT3, anti-CDllelN4lS (Steinman el al., 1997) and MOMA-I (Kraal, 1992) were applied as 
hybridoma culture supematants; biotinylated anti-lgM was from Phamlillgen, biotinylated PNA 
from Sigma (St. Louis, MI) and anti~lgD from SBA. The second~reagents used have been previously 
described (Dingjan el al., 1998). 
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xid as a model for XLA 
B lymphopoiesis is regulated by multiple signals derived from stromal cell contact, cytokines, 
antigens and helper T cells. In vitro biochemical and gene targeting ill \'ivo experiments have 
implicated tyrosine kinases as key regulators of many of these signaling pathways (Satterthwaite and 
Witte, 1996). 
Btk is one of several kinases involved in regulating the differentiation of the Been lineage. 
Defects in the Btk protein lead to XLA in humans. Since the discovery ofthe Btk gene {Vetrie et al., 
1993, Tsukada et al. 1993) over four hundred mutations, distributed over the entire Btk coding 
region have been characterized in XLA patients (Vihinen et al., 1998). There is phenotipical 
heterogeneity among patients, even among patients from single XLA pedigrees (Vihinen et al., 
1998, Holsinki-Feder et al., 1998, Bykowsky et al., 1996). Sofar, it has not been possible to 
correlate severity of the phenotypic presentation with the genotype. Also the precise arrest ofB celt 
development in XLA patients has not been revealed (Campana et al., 1990). Recently developed 
new techniques, such as single cell PCR, and the characterization of cell surface markers could help 
to study the Elk expression pattem and its role in B cell development in human. However, the large 
genetic variety, differences in habitat or therapeutic interventions between patients might complicate 
these shldies. Mouse models therefore could serve as an altemative to study the effect of Elk 
mutations and its role in B celt development, since they exhibit an unifonllly genetic background 
and can be kept under comparable conditions. However, mice do not develop a phenotype as severe 
as the human XLA (Khan et at.., 1996, Kemer, et al., 1995, see introduction, Table 2). The 
molecular bases of these differences between the two species are not wetl understood. In addition, 
severity of the xid phenotype is dependent on the genetic background of mice (Bona el al., 1980, 
Khan et al., 1996). Differences in phenotype severity between human and mouse can be caused by 
the relative contribution of altemative pathways of B cell differentiation in a Btk-independent 
manner. This hypothesis is supported by the observation that Btk·deficient mice that also lack CD40 
have decreased numbers of peripheral B cells and lower semm immunoglobulin levels, comparable 
to XLA patients (Oka et al., 1996, Kahn el al., 1997). This would imply that the mechanism by 
which mice call compensate to some degree for Btk·deficiency is T cell dependent. An alternative 
explanation, are differences in availability or functionality ofBlk-relatives that may compensate Btk 
fhnction. The BCR-induced hydrolysis of phospholipids in Btk·deficient chicken DT40 and XLA 
cell lines is severely reduced, leading to a strong reduction in Ca2+ flux, whereas xid B cells 
demonstrate only a twofold reduction in phosphatidyl·inositide hydrolysis (Takata el al., 1996, 
Fluckinger et al., 1998), Expression of wiJd·type Btk as well as other members of the Tee family 
including human Uk and murine Tee, restored Ca2+ flux in these cells (Fluckinger et al., 1997). 
While Itk expression is restricted to the T and NK cells, Tee is expresscd in multiple haematopoietic 
lineages, including myeloid cells and B cells, as well as in liver, kidney ovary and heart (Siticiano e( 
al., 1992, Heyeck et al., 1993, Mano et al., 1993, Sato et al., 1994). Since murine Tee expression 
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was able to correct impaired Calf flux in cell lines derived from XLA patients, the expression ofTec 
endogenously in xid B cells may compensate, at least ill part, for the absence of Btk. Therefore the 
differences in phenotype between XLA and .l·id may be caused by differences in expression level or 
expression pattems of Btk-relatives (Tee). An altemative, but not mutually exclusive, explanation 
could be a higher degree of homology bctw~en murine Btk and Tee. It would therefore interesting to 
see the phenotype of mice lacking both Btk and Tee. 
In spite of the obvious differences in severity of the phenotype, Btk appears to he a conserved key 
factor involved in both murine and human B cell development. Btk has been shown to be involved 
in the BCR signal transduction pathways in both human (Hinshelwood el al., 1995, De \Veers et al., 
1994) and murine (Aoki el al., 1994, Saouf et al., 1994) B cells. III vivo competition experiments in 
female Blk +f_ mice between B cells either expressing the wild-type Blk gene or the LaeZ gene from 
the disrupted Btk allele, demonstrated that the fIrst defects of Btk' cells became apparent at the 
transition from the pre-B cell stage to the immature B cell stage (chapter 2). Moreover, the 
accumulation of Btk- celts within & sUbpopulation of pre-B cells indicated that Btk- cells arc 
defective in the pre-B to B cell transition (chapter 6). This arrest ofB cell transition is the hallmark 
of XLA. Moreover, the genomic organization of the murine Blk gene is very homologous to the 
human Blk gene and the Btk proteins share 99.3% homology. As is described in chapters 3-6, 
transgenic human Blk could fully compensate for the absence of murine Btk, indicating that the 
essential sites for Btk interaction with other signal transduption components are conserved between 
human and mouse. In addition, large scale comparative sequence analysis of the human and murine 
Blk loci revealed clusters of sequence conservation in non-coding regions throughout the loci 
(Oeltjen et al., 1997), which may play an essential role in the complex gene regulation, Moreover, 
when human Btk was expressed under the control of the endogenous cis-acting clements, the 
expression pattern of transgenic Btk paralleled that of the endogenous Btk. \Ve concluded that also 
cis-acting elements that regulate Btk expression have been conserved. Studies on Btk using mouse 
models, therefore, lead to a better understanding of the regulation of expression and the role of Btk 
and its domains in human B cell development. 
Mouse models for other X-linked immunodeficiency diseases 
A comparison between the XLA- and xid-phenotypes is given in the general introduction (chapter 
I, Table 2.). From this comparison it is clear that xid represents a less severe phenotype. A similar B 
cell differentiation disorder results from defects in the AS pseudo-light chain component. The 
difference in severity of B cell defIciency resulting from the Blk gene mutation in mouse and man is 
reminiscent of that which arises due to mutations in the AS gene, resulting in a less severe phenotype 
in mice, and a more severe phenotype CVID in man (Conley el al., 1994, Scher, 1982). The effects 
of the human B-lineage developmental defect appear to be more severe than those seen in A5-
defective mice. \Vhile nornlal numbers ofCD19+ TdTt pro- and pre-B cells were detectable in CVID 
patients, as in the AS-defective mice, there were even fewer pre-B-II cells in mouse, and the 
peripheral B cells were IgM!o\\" and CD3Sfo \\". Since the patient's father was heterozygous for the 
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),5(14.1) mutation and had Honnal numbers of B cells, an additional dominant negative mutation 
contributing to the severity of the B cell defect appears unlikely. In other X-linked 
immunodeficiencies, also differences between the phenotypes of human immunodeficiency patients 
and phenotypes of mouse models for these diseases are observed. A comparison of these differences 
in phenotypes for the XSCID, X-linked-hyper-IgM-syndrome and Wisckott-Aldrich syndrome 
(\V AS) inununodefciencies are sunul1arized in Table 1. Mouse models tend to have a less severe 
phenotype as the human patients, although the bases for these differences are not clear yet. 
Table I. Comparison of phenotypes of human immunodeficiencies and mouse models 
human 
XSCID (IL-2 R); 
Severe impaimlent ofB and T cell function 
T cells absent or low 
Peripheral B cell numbers HornIal or increased 
Ig class switch defects 
NK cell numbers nonnal or reduced 
Thymus lacks cortex/medullar demarcation, 
Hassal1's corpuscles not detectable 
\Vith age, T cell numbers remain low 
X-iiI/ked hyper-IgM (CD40L) 
Low levels of senlln IgA and IgE 
IgM serum levels generally elevated 
Immune responses are impaired 
No genllinal centers 
Nonnal Band T cell numbers 
WAS; 
Severely decreased platelet numbers, reduced 
platelet size 
Defective T cell activation 
Eczema 
Variable B cell defects 
Poor responses to carbohydrate and protein 
antigens 
Lymphoreticular malignancies 
No chronic colitis 
mouse 
Severe impainllent ofB and T cell fUllction 
T cells absent or low 
Peripheral B cell numbers decreased 
Ig class switch defects 
NK cells absent 
Size of thymus diminished, differentiation of 
cortical and medullary zones, Hassall's 
corpuscles present 
Development of a peripheral pool of 
(activated) CD4' T cells with age 
Low serum levels ofigGI, IgG2b and IgA, lack 
ofIgE, IgG3 levels slightly reduced, IgM 
semm levels nomlal 
Immune responses are impaired 
No germinal centers 
Nomlal Band T cell numbers 
Modest reduction in platelet number, nonnal 
platelet size 
Defective T cell activation 
No eczema 
Nomlai antigen-induced B cell stimulation 
Nonna! Ab responses to TD and TI-JI antigens 
No haematopoietic malignancies 
Devciopment of chronic colitis 
References: XSCID: Fischer el al., 1997, Sugamura et al., 1996, Cao e/ al., 1995, DiSanto et al., 
1995; X-Linked-hyper-IgM: Foy ef 01., 1996, Renshaw ef 01., 1994; WAS: Snapper ef 01., 1998. 
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XLA, m01lse models alld gene therapy 
For the development of fuhlre strategies towards gene therapy as a means of correcting the XLA 
defect, experiments in which mouse models are used, will be essential. Using mouse models, the 
efficiency of gene transfer strategies, the final Blk expression levels in B cells and the obtained 
correction of the xid phenotype can be investigated. 
Despite the fact that most XLA patients respond quite well to current treatments, it is obvious that 
repetitive administration of antibodies (gamma globulin) or antibiotics, is inferior to a natural 
immune response. Many XLA patients manifest chronic pulmonary infections of a disabling 
character. Gene therapy is the obvious future choice for correction of this hereditary disease, as it 
would restore an active immune response to infection. Several features of the Btk gene make XLA 
an attractive model to develop methods for somatic gene therapy. Firstly, XLA, which is one of the 
most frequent inherited immunodeficiencies in man, affects only one single cell lineage, without any 
defects outside the B cell system. Secondly, the findings that (I) the first selective disadvantage of 
Btk- B cells occurs at the transition from pre-B to B cells (chapter 2), and (2) Blk expression from 
the pre-B cell stage onwards is sufficient to correct thexid phenotype (Drabek et al., 1997), indicates 
that the Btk gene does not need to be introduced in the very small population ofhaematopoietic stem 
cells to restore B cell development in XLA patients. Instead, Elk gene transfer to any of the 
precursor B cell stages up to the small pre-B cell stage would correct the XLA defect, thereby 
increasing the target population to ...... 10 % of total cells in the bone marrow. In addition, Btk 
expression only needs to be transient, since Btk is not required in plasma cells (Sideras and Smith, 
1995, De Weers et. al., 1993). Furthennore, bone marrow cells are easily accessible for e.\" vivo gene 
transfer, and there is a natural selective advantage for developing B cells that have been corrected 
(Drabek el al., 1997, chapter 3). Finally, in contrast to the fact that certain protein tyrosine kinases 
have been implicated in tumor fomlation when mutated or overexpressed, we have shown that 
overexpression of Btk or the E41K mutated fonn of Btk did not lead to the development of 
lymphomas or leukemias in mice (chapter 4 and 5). As the constmct that eventually will be used to 
express an intact Blk gene in pre-B cells of XLA patients should preferably contain regulatory 
sequences from the Blk gene itself, it is of importance to identify all elements involved in the 
regulation of Btk gene expression. 
A1ulliple roles of Blk ill B cell development 
The main subjects of the research described in tIils thesis was the analysis of the regulation of Blk 
gene expression and the function ofBtk in the individual subsequent stages ofB cell development ill 
vivo. Therefore we have generated one Btk-knock-out mouse model and several transgenic mouse 
models that express either wild-type or E41K mutated Btk under the control of different promoters 
or regulatory elements (chapters 2- 6). As the data described in each chapter have already been 
discussed at length at the end of each chapter and represent our current view, this section will 
overview the involvement of Btk during B cell development (Fig. 1). 
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Each successive step in B cell differentiation, as well as the mature B cell response to antigen, 
depend on signals mediated by the (pre-)BCR complex (Kitamura et ai" 1991, Lam et ai" 1997, Gu 
et ai" 1991), The majority ofB-lineage cells that are generated in the bone marrow do not migrate to 
peripheral tissues to participate in an immune response but, instead, undergo apoptosis and are 
disposed of by resident macrophages (Osmond et ai" 1994). Two reasons for the death of B cell 
precursors are the non-productive assembly of the heavy or light chain segments and the generation 
of a BCR that is self-reactive. A third, related reason for pre-mature cell-death may be that cells have 
exhausted their potential for additional V L chain gene rearrangements by receptor editing. 
Studies on the in vivo expression pattem of murine Btk, using the LaeZ-Iabeled dismpted Blk allele 
(Chapter 2 ) or intracellular flow cytometric Btk detection (Chapter 4) demonstrated that Btk is 
expressed ill vivo throughout B cell development, from the pro-B cell stage to the most mature 
IgMl°"IgDhigh peripheral B cell and activated B lymphobJasts stage. These expression pattems were 
consistent with other Btk expression pattern studies in cell lines and leukemias (Dc \Veers el al., 
1993, Genevier e/ at., 1994, Smith e/ at., 1994, Tsukada e/ at., 1993). The fiuding that Btk is 
expressed throughout B cell development and the involvement of Btk in BeR-signaling pathways 
(De Weers e/ at., 1994, Aoki e/ at., 1994, Saouf e/ at., 1995, Hinsheiwood e/ at., 1994), support the 
idea that signaling cascades activated by Btk have a crucial role during the B cell differentiation 
process, as well as in the activation of mature B cells in the periphery (Fig. 1). 
(0) Blk is 1/01 required ill pro alld large pre-B cells 
A critical role for Btk in the assembly of the !1 H chain and the subsequent transition from the 
pro-B to the small pre-B cell stage is very unlikely. Firstly, this transition is not affected in human 
XLA, since pre-B cells are generally present at nonnal numbers in XLA patients (Sideras and Smith, 
1995). Secondly, in addition, in mice, the absence ofBtk did not result in a selective disadvantage 
up to the small pre-B cell stage, as was shown by the ill vivo competition assays in female Blk fl· 
mice (chapter 2). Thirdly, the xid phenotype can be corrected by transgenic expression of Btk from 
the pre-B cell stage onwards (Drabek el al., 1997). Finally, proliferation of pre-B cells that have 
successfully rearranged their IgH chain locus and have perfonned allelic exclusion (both indicated 
by pre~BCR signaling) are not affected in Btk-deficient mice. \Ve conclude that Btk is not required 
in pro- and large pre-B cell stages (Fig. 1). 
(1) A role for Blk ill Ig L ehaill assembly 
The first role for Btk becomes apparent at the transition of the small resting pre-B cell stage to the 
IgM1°"'IgD' immature B cell stage (Fig. 1). This transition is affected both in XLA patients (Conley, 
1985) and in mice, in which B cells that lack Btk show a selective disadvantage compared to B cells 
that express Btk (Chapter 2). The observed accumulation of Btk-deficient cells within a 
subpopulation of small resting pre-B cells (Chapter 6) further indicates that Btk is involved in 
signaling pathways, leading to the initiation of IgL chain rearrangement and/or expression of a 
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complete IgM-molecule on the membrane, needed for fmiher B cell maturation (Rajewski, 1996). It 
might be possible that Btk is an essential transducer of signals, involved in regulating the re-
expression of the RAG gene products, which are absent in the large cycling pre-B cells and 
reactivated in small resting pre-B cells (Grawunder et al., 1995) needed for Ig L chain 
realTangements. This hypothesis is consistent with the finding that expression of the RAG genes is 
dependent on BCR signaling in iuunature IgM'QW B cells that are in the process of receptor editing 
(Melamed et al. 1998). Altematively, Btk could also transduce signals that result in chromatin 
stmcture changes that allow the recombinase access to the IgL chain gene segments. 
A role for Btk in Ig L chain rearrangement events is also suggested by the finding that the 
proportion of A. L chain expressing B cells is decreased in Btk-deficient mice whereas proportion of 
A. L chain expression B cells is increased in CDI9-hBt!f41K transgenic mice, compared to wildtype 
mice (Chapter 6). The observed 95:5 ratio of K:A. expressing L chain B cells in nonllal mice is 
thought to reflect the earlier rearrangement initiation at the K locus and the higher probability of 
productive K+ rearrangements within the limited life span of the small pre-B cell (Hieter et al., 1981, 
Ramsden and \Vu, 1991, Arakawa et al., 1995). As L chain rearrangement occurs without cell 
division or substantial cell loss (Osmond, 1991), the KIA ratio of the immature B cell population 
directly reflects the probability of productive K and A. Ig L chain rearrangements. The reduced A. L 
chain expression found in Btk-deficient mice, therefore, indicates that the absence of Btk results in a 
delay in the initiation ofIg L chain rearrangements (e.g. by defective RAG activity upregulation, or 
L chain locus accessibility), a reduced survival of pre-B cells that are in the process of L chain 
rearrangement, andlor impaired receptor editing of immature IgM1QW B cells. 
The increased proportion of A L chain expressing cells in the E41K transgenic mice may be due 
to early initiation of the IgL chain rearrangement, caused by the constitutively activated fonn ofBtk, 
or, altematively be a result of an extended life-span ofpre-B cells (or immature IgM1QW B cells), each 
of which would increase the limited time window for Ig L chain rearrangements. In the latter case, 
the CD 19_hBtiC'41K transgenic mice parallel transgenic mice with enforced expression of the anti-
apoptotic protein bcl-2 in B cells, which also showed a significant increase in the percentage of A. L 
chain expressing B cells, either in vivo in the presence or absence of auto-reactive Ig transgenes 
(Tiegs et al., 1993, Lang et al., 1997) or in bone marrow cuihlres in vitro (Rolink et al., 1993). The 
high A\K ratio in Bcl-2 transgenic B cells were explained by assuming that B cells nonnatly have too 
little time to take full advantage of the potential A. L chain repertoire that could rescue non-functional 
or autoreactive B cells (Lang et al., 1997). Conversely, the absence ofBtk would limit the survival 
ofpre-B cells that are in the process ofL chain rearrangement and therefore result in low ]JK ratios. 
A role for Btk in (pre-)B cell survival would be supported by the findings that hcl-2 expression is 
reduced and sIg mediated bcl-xL induction is absent in xidB cells (Anderson et al., 1996, Choi et al., 
1996, Woodland e/ al., 1996). 
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(2) A role Jor Btk il1 celltral immulle tolerance 
With the expression of the IgM and the resulting antigen specificity on the cell surface of 
inunature B cells. they become susceptible to immune tolerance (Goodnow. 1996). Recently, two 
subpopulations within the immature B cell stage with differences in apoptosis sensitivity were 
described (Melamed and Nemazee, 1997). Upon BCR stimulation in an ill vitro IL-7 driven BM 
cultwe system, IgM11ig"IgD- immature B celis, representing an intennediate bet~veen early IgM!o"IgD-
immature and recirculating B cells, were extremely sensitive to apoptosis, whereas stimulation of the 
BCR ofIgM1oWlgD- immature B cells promoted nested L chain rearrangements, i.e. receptor editing. 
In mice, the absence of Btk did not affect the transition from the IgM10WlgD- to IgMhighlgD-
immature cell stage (chapter 6), indicating that the absence of Btk expression is not critical for 
transition to the IgMhighIgD- cell stage. Conversely, expression of the constitutively activated E4lK 
Btk Illutant driven by the CD 19 promoter resulted in an almost complete absence of IgMhighIgn 
immature B cells (Chapter 6). The IgMhigblgD- immature B cell stage reflects the first immune 
tolerance checkpoint where autoreactive B cells become susceptible to apoptosis. Therefore, the 
absence ofIgMhighlgD+ immature B cells in CD19·hBtR'4IK transgenic mice, suggests that constitutive 
activation of Btk mimics autoreactive BCR crosslinking. The absence of the IgMhighlgD- B cells 
would imply that Btk is involved in the BCR signaling pathway that eliminates auto·reactive B cells 
at the IgMhighlgO' B cell stage. An alternative explanation for the absence of IgMhighlgD- B cells 
could be that the E41K Btk mutant blocks the transition ITom the IgM10"lgD' to IgMhighlgD-
immature cell stage. because of sustained receptor editing (Melamed and Nemazee, 1997). Finally, 
cells might die due to exhausted potential for nested L chain rearrangements. 
(3) A role for Elk illfolliclliar elliry 
In contrast to the phenotype of the CD19·1lB/~IK transgenic mice, mice in which E41K Btk 
expression is driven by the MHC class II LCR (MHCII·llBtR'41K mice) display normal B cell 
development in the bone marrow, but manifest a deficiency of recirculating follicular B cells 
(Chapter 5). Cells that were present in the spleen were IgMhigh HSAhigh B22010w immature B cells that 
have recently left the bone marrow. The differences between the two BtkE41K expressing mouse 
strains can be explained by the escape of negative selection in the bone marrow of the MCHII-
IlBtJ!41K expressing cells because the expression level had not reached a critical threshold value. Due 
to the nature of the MHCII·LCR, transgenic BtkE41K expression is llpregulated after cells have 
arrived in the spleen (chapter 5). As a result only late in B cell development an active state of the B 
cell is mimicked. In this context, MHC·II-E41K Btk transgenic B cells may resemble transgenic B 
cells, autoreactive for antigens present in the periphery (Eibel et al., 1994, Goodnow et al., 1995, 
Russel et al .• 1991). In these mice, immature B cell numbers in the bone marrow were present in 
nonllal numbers but were eliminated shortly after leaving the bone marrow, bearing an immature 
phenotype. In comparison, cell transfer studies with antigen·specific transgenic B cells have shown 
that naive cells could migrate into follicles, but were retained in the outer T cell zones in the 
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presence of antigen, even without competition of follicular B cells (Cyster and Goodnow, 1995). 
This is consistent with the observation that antigen-specific B cells accumulate in the outer T cell 
zone within the first days of an immune response where they are in close contact with T helper cells, 
specifically recognizing the presented antigen. As the outer T cell zone is a major trafficking region 
for T cells, it is likely that selective retention of antigen-reactive B cells in this zone functions to 
promote encounter between antigen-specific T and B cells. Activated B cells that are excluded from 
follicles can be rescued from cell death and stimulated to proliferate and differentiate, in response to 
stimuli, provided by the activated T helper cells. Likewise, the activated state of the MHCII-hBt~~IK 
B cells may result in follicular exclusion. Concomitantly, the immature IgMhig"HSAhig"B22010W 
phenotype may inhibit rescue by T helper celis, thereby resembling the apoptosis-sensitive 
Igi\1highIgD· immature B cells in the bone marrow, in which apoptosis is induced upon strong BCR 
signaling. 
(4) Follicular maturation alld sUJ1Iival 
B cells are positively selected to become long-lived IgM10"'TgDhigh recirculating follicular B cells 
by BCR mediated signaling (Gu e/ al., 1991, Lam e/ al., (997). Mutations in BCR signaling 
components such as Ig-a or Syk, block the entry ofB cells into follicles (Torres et al., 1996, Tumer 
et al., 1995). Btk-deficient B cells are not excluded from B cell follicles, but fail to develop from the 
immature IgM~ighIgD(OW stage into the long-lived recirculating follicular IgM10"\Igb~lgh B cell stage 
(Wicker and Scher, 1986, Khan et al., 1995, chapter 2). As xid B cells express only low levels of 
bcl-2 and undergo spontaneous apoptosis more rapidly than wild-type B cells in vitro (Woodland et 
al., 1996), Btk must playa critical role in survival and maturation, mediated by low-level BCR 
signaling (Gu e/ al., 1991, Lam e/ al., (997), to become long-lived recirculating B cells (Fig. I). 
(5) Plasma cell differentiation 
Another role for Btk was observed in the CD19-hBtIf'IK transgenic mice. As the block at the 
IgMhig"IgD- immature B celt stage was leaky, B cells were found in the peripheral organs in very low 
numbers, almost exclusively bearing a IgMhighHSAhigh B22010w immature phenotype. In parallel to the 
MHCII-hBt~~IK transgenic mice, the expression of BtkE~IK impeded follicular entry of these 
immature B cells and their subsequent maturation. Despite the severe reduction of the mature B cell 
pool, significant numbers of IgM secreting plasma cells were present in the splenic red pulp. Senllll 
IgM concentrations were substantial and increased with age as compared to those in nonnal mice. 
Therefore, we conclude that Btk activation quite efficiently induced the tenninal differentiation of 
the residual B cells into IgM-producing plasma cells. In the CD 19_hBt~~IK transgenic mice, serum 
levels of the IgG and IgA subclasses were severely decreased, conftnning that constitutive BCR 
signaling in the absence of co-stimulation by CD40-CD40L interactions does not induce B cells to 
perfonn IgH chain class switch or genninal center fonnation (Foy et al., 1996). 
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Figure 1. Scheme of the B cell di/JereIlNatioll. The multiple stages at which Btk is involved are 
shmvlI, together with the mouse models that provided evidence Jor a role of Btk (ill parenthesis). 
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Downstream targets of Blk activation during B cell development 
Although our analysis of transgenic and knock~out mice ill \'ivo have defined at least five stages 
of B cell development in which Btk activity is involved, it is unknown by which downstream 
signaling pathways these effects on B cell development are accomplished. Only two possible targets 
ofBtk have been identified so far (see also introduction). Btk-deficient cell lines display a reduced 
phosphorylation of PLC-y upon BCR cross-linking (Takata et al., 1996, Fluckinger et al., 1998). 
PLC~y is involved in the hydrolysis of phosphatidyl-inositol 4,S-biphosphate (PI4,5~P2) into 
diacylglycerol (DAG) and IF). (Bijsterbosch et al., 1985). DAG activates most protein kinase C 
(PKC) isofomls and IF3 generates an increase in Ca2+ flux. The involvement of Btk in the PLC-y 
signaling pathway is suggested by the phenotype of PKCp-deficient mice, which is similar to xid. 
Moreover, deletion of PLC-y2 in DT40 cells, abolished IF3 production and Ca2+ mobilization 
(Takata et al., 1995). As a result, the induction of apoptosis, which nonnally follows BCR 
stimulation in these cultured cells, was blocked. Increases in the intracellular [Ca2+1 are required for 
the induction of the mitogen-activated protein kinase (MAPK), c-JmlN temlinal kinase (c-JNK) and 
p38 cascades, as well as the calcium~dependent transcription factors NF~AT and NF-KB (Dolmesch 
et al., 1997, Healy eJ ai" 1997). These are important signals that lead to cell proliferation and 
differentiation (Fluckinger et aI" 1998). In contrast, intemlittent or subthreshold oscillation in 
calcium concentrations result in activation of only a subset of these downstream signals and lead to 
decreased survival and apoptotic death (Fluckinger et aI" 1998). In mast cells, c~JNK plays a role in 
apoptosis in a Btk dependent way (Kawakami et aI" 1997). It would be interesting to investigate 
whether apoptosis, stimulated by BCR~lllediated signaling, in immature IgMhighIgD' B cells is also 
regulated via c-JNK in a Btk dependent mamler. 
Another important downstream signaling pathway, activated by Btk may involve proteins leading 
to the activation of cell survival proteins, such as bcl~2 and bcl~xL (see discussion section of chapter 
6). 
Recently, the widely expressed transcription factor BAP-13SrrFII~I was shown to be tyrosine 
phosphorylated by Btk in response to BCR crosslinking ill vivo (Yang et al,. 1997). It is presently 
unclear, whether Btk is also present in the nucleus, BAP~ 135/TFII-I, interacts with E~boxes and 
initiator (Inr) sequences (Gmeneberg et al., 1997, Roy et al., 1997). Moreover, the protein is 
suggested to be involved in the fonnation of a multiprotein complex at the promoter of the early B 
cell response gene c-fos (Grueneberg el aI" 1997). C~fos is involved in the regulation of the Ig K L 
chain transcription (Schanke et al., 1994) and it is intriguing to hypothesize that c~fos may cause an 
increase in the accessibility of the IgL chain loci for recombination, The almost complete block of B 
cell development at the pre-B cell stage in XLA could then be explained by defective initiation ofIg 
L chain rearrangement. 
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Concluding remarks 
Our findings in the mouse show that Btk is expressed throughout B cell development. except in 
plasma cells. and that signaling cascades activated by Btk are critical at several checkpoints 
throughout B cell differentiation. The transition into IgM+ immahlre cell stage is impaired when Btk 
is defective. indicating a role for Btk in re-expression ofthe RAG genes. insufficient accessibility of 
Ig L chain loci, or a reduced survival of pre-B cells that are in the process of L chain rearrangement. 
Expression of the CD19-hBtlr4IK transgene resulted in a lack of progression of B cells into the 
IgMhighlgD- immature cell stage. placing Btk in the BCR signaling pathway that eliminates auto-
reactive B cells in the bone marrow. A similar role for Btk was observed in the periphery: in 
transgenic mice expressing MHCII_hBlI!4IK, the development of recirculating follicular B cells is 
blocked, showing that constitutive activation of Btk induces the elimination of virgin B cells. Btk-
deficient B cells manifest an impaired survival and mahlration in the periphery, indicating a role for 
Btk in basal nCR signaling needed to direct developmental progression of B cells. Finally, the 
phenotype ofCD19-hBlkE41K transgenic mice. provide evidence that Btk activation (in the absence of 
co-stimulatory signals) drives B cells into IgM+ plasma cell differentiation. 
Our studies show remarkable similarities between XLA and Xid. XLA patients show a block in B 
cell development at the transition of the small pre-B cell stage to the immature B cells. In 
comparison, in Btk-deficient mice. the first selective disadvantage for Btk-deficient B cells occurred 
at the same transition. Moreover. the proportion of 'A. L chain expressing cells is decreased in Btk-
deficient mice comparable to humans, in which the absence of Btk results in a deviation from the 
nomlal K + to A + ratio of 50:50, to only ...... 25% A + ceJls. We therefore conclude that xid is a good 
animal model for XLA. 
The molecular mechanisms by which Btk mediates B cell development, cell activation and cell 
death need further elucidation and further identification of downstream signaling targets and 
pathways. Knowledge of the regulatory elements involved in Blk gene expression ill vivo would help 
the design of a Blk mini-locus. Such a mini-locus would not only he essential for the progress of 
gene therapy strategies as a means to correct the B cell defect in XLA patients, but would also he 
helpful for the achievement of physiological levels of Blk expression in studies of the ill vivo 
function of the separate Btk-domains in transgenic mouse models. Different domains can easily be 
mutated and the effect on interacting proteins and signaling pathways activated by Btk can be 
studied. The biochemical characterization of proteins that associate with the individual domains of 
Btk at the subsequent stages of B cell development could be facilitated by the generation of 
transgenic mice that express a tagged fonn of Btk. Similar approaches could be used for other 
signaling molecules implicated in BCR signaling which will eventually lead to a better insight in B 
celt development and function. 
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SUlluuary 
X-linked agammaglobulinemia (XLA) is olle of the most frequent inherited 
immunodeficiency diseases in man and is characterized by severe, reCllrrent bacterial infections. 
Affected males manifest a dramatic decrease in mature B cell numbers and inununoglobulin (Ig) 
levels of all isotypes. Current treatment of XLA patients includes gammaglobulin substitution and 
antibiotics. XLA reflects an arrest in B cell differentiation at the pre-B cell stage. The gene defective 
in XLA has been identified to code for a cytoplasmic signaling protein, named Bruton's Iyrosine 
kinase (Btk). In the mouse, inactivation of Btk results in a relative mild B cell disorder, xid, 
characterized by a reduction of mature IgM10"'IgDhigh B cells in spleen and lymph nodes, lack of 
CDS f B-1 B cells and low senUll levels of IgM and IgG3. In contrast to XLA patients, Btk-deficient 
mice generally make fUllctional antibodies to proteins, however, they manifest impaired responses 
to T cell independent type II antigens. Blk is expressed throughout B cell development, except for 
plasma cells and is implicated in several receptor coupled signal transduction pathways, including 
the B cell antigen receptor (BeR). 
To study the role of Btk in B cell differentiation ill vivo, we have developed mouse models, 
in which wild-type or mutated human Blk are expressed as transgenes. The aim of the thesis was to 
investigate the role of Btk at the individual steps of B cell development, to answer the central 
question why B cell development is arrested at the level of the pre-B cell in XLA patients. 
Chapter 1 is the general introduction and presents an overview of murine B cell 
development. Furthennore, identification and cloning of the Blk gene as well as clinical and 
molecular aspects of XLA and xid are described. 
Chapter 2 describes the generation of a Btk-deficient mouse model by inactivating the Elk 
gene through an in-frame insertion of a LaeZ reporter by homologolls recombination in embryonic 
stem cells. The phenomenon of X-chromosome inactivation in Btk+!- heterozygous female mice 
enabled us to evaluate the competition between B cell progenitors expressing wild-type Blk and 
those expressing the Blk/LaeZ allele in each successive step of development. Although Blk was 
already expressed in pro-B cells, the first selective disadvantage of Btk-deficient cells only became 
apparent at the transition from small pre-B cells to inunature B cells in the bone marrow. A second 
differentiation arrest was found during the maturation front IgMMghIgDlo'o\" to IgMIO"IgObigh stages in 
the periphery. 
Chapter 3 describes the generation of two yeast artificial chromosome (Y AC)-transgenic 
mouse strains in which high-level expression of human Blk was provided by endogenous regulatory 
cis-acting elements that are present on a 340-kb transgene, Y c340-hBtk, which contained the Blk 
gene and ",100 kb 5' flanking DNA and -200 kb 3' flanking DNA. The expression pattem of the 
transgenic human Blk was found to parallel that of the endogenous murine gene. \Vhen the Y c340-
hBlk-transgenic mice were mated onto a Elk-deficient background, all features oLrid were corrected. 
\Ve conclude that expression of human Btk can fully compensate for the absence of ell doge no us Btk 
in the mouse, and that in the Y AC-transgenic mice Blk was appropriately expressed in the context of 
native regulatory sequences. 
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Chapter 4 describes the generation of yeast artificial chromosome (YAC) transgenic mouse 
strains in which the human Blk is expressed from a 240 kb Y AC transgene Y c240·IIBlk, containing 
the entire Elk gene and -6 kb of 5' flanking DNA and -200 kb of 3' flanking DNA. When the 
Y c240·hBtk transgenic mice were mated onto a Btk~deficient background, B cell development was 
fully restored. Using intracellular flow cytometry, the expression pattenls and expression levels of 
the transgenic human Blk were found to parallel the endogenous murine Blk gene, indicating the 
conservation ofBtk regulatory sequences between mice and men. 
As a first step to identify cis-acting clements, involved in the regulation of expression of Blk, 
DNAseI hypersensitive site mapping (HSS) were perfonned within the Blk genomic region. Nine 
HSS were identified, one of which was found to be B cell specific and strongly conserved between 
mouse and man. Furthennore, we show that Spl, Sp3 and PU.l are able to transactivate 
synergistically the Blk promoter in ill vitro transfection assays, while targeted deletion of Sp I or Sp3 
does not result in decreased Btk expression ill vivo. 
Chapter 5 describes the generation of transgenic mice, in which Btk expression was driven 
by the MHC class II Ea gene locus control region. Btk overexpression did not have significant 
adverse effects on B cell function, and essentially corrected the xid phenotype in Btk' mice. By 
contrast, expression of a constitutively activated foml of Btk carrying the E4lK gain·of~function 
mutation, resulted in a B cell defect that was more severe than xid. \Ve demonstrate that expression 
of constitutively activated Btk blocked the development of follicular recirculating B cells. The levels 
in the senlln of most Ig subclasses decreased with age and ill vivo B cell responses were essentially 
absent. Expression of the E41K Btk mutant enhanced blast fonnation of splenic B cells in response 
to anti·IgM stimulation ill vitro. 
Chapter 6 describes the generation of transgenic mice that express the E41K Btk mutant 
under the control of the human CD19 promoter. In these mice B cell development was arrested at the 
transition of IgM!OIV to IgMhighIgD' immature B cells in the bone marrow. and the proportion of t.. L 
chain expressing cells was increased. Conversely, Btk·deficient mice manifested a decrease in the 
proportion of t.. expressing B cells. Together with the observed accumulation of Btk~deficient cells 
within the small pre·B cell stage, these results indicate a role for Btk in the developmental control 
ofIg L chain assembly at the transition from pre-B to immature B cells. coinciding with the arrest of 
B cell development in XLA patients. 
Chapter 7 discusses the data presented in tIus thesis and gives an overview ofthe role ofBtk 
in B cell development. Our findings in the mouse show that Btk is expressed throughout B cell 
development and that signaling cascades activated by Btk are critical at multiple checkpoints 
throughout B cell differentiation. When Btk is defective, the transition from pre·B cell into IgM+ 
immature cell stage is impaired and the proportion of /..,+ cells is reduced. These findings indicate a 
role for Btk in re·expression of the recombination activating genes, that accomplish V(D)J 
recombination, the regulation of accessibility of Ig light (L) chain loci for recombination, or the 
survival of small pre·B cells that are in process of Ig L chain rearrangement. Expression of the 
CD 19~hBtIf4!K transgene resulted in a lack of progression of immature B cells into the IgMhighIgD' 
cell stage in the bone marrow, placing Btk in the BCR signaling pathway that eliminates auto· 
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reactive B cells. A similar role for Btk, but at a late stage in the periphery, was observed in mice 
expressing transgenic :MHCII~hBt~4IK, which resulted in a block in the development of recirculating 
follicular B cells. In the periphery, Btk is essential for B cell survival and maturation, indicating a 
role for Btk in basal BCR signaling needed to direct developmental progression of B cells. Finally, 
the phenotype ofCD19~hBt1f41K transgenic mice, provided evidence that Btk activation in peripheral 
B cells drives them into temlinal IgM+ plasma cell differentiation. 
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X-gebonden aganunaglobulinemia (XLA) is een van de meest voorkomcnde erfelijke 
immuundefecientie ziekten bij de mens en wordt gekenmerkt door emstige, vaak temgkomende 
bacteriele infeeties. In XLA patienten is het aantal rijpe B cellen in perifeer bloed sterk verlaagd. 
Antistoffen van aile sllb-klassen zijn nauwelijks detecteerbaar in het senllll. De huidige behandeling 
van XLA patienten bestaat vooralliit het toedienen van gammaglobuline en antibiotica. XLA wordt 
gekenmerkt door een blokkade in de B eel differentiatie op het pre-B eel niveau. Het gen dat defect 
is in XLA eodeert v~~r een cytoplasmatisch signalering eiwit, BrutoJl's tyrosille kinase (Btk). In de 
muis, mutaties in het Btk gen resulteren in een relatier mild B eel defect, xid. gekelllllerkt door een 
afhame van rijpe immuunglobuline (lg)_Mt ... gIgDhoog B cellen in milt en lymfekHeren, de afwezigheid 
van CDS+ B-1 B eellen en cen verlaging van de antistof sub-klassen IgM en IgG3 in het serum. Btk-
deficiente muizen maken, in tegenstelling tot XLA patienten, nomlaliter wei funetionele antistoffen 
tegen eiwitten, maar een rcspons tegen T eel onafhankelijke type 2 antigenen is afwezig. Het Btk gen 
komt gedurende de hele B eel ontwikkcling tot expressie, maar niet in plasma eellen. Het Btk eiwit 
maakt deel uit van signaaltransductie routes van verschillende receptoren, o.a. de B eel antigeen 
receptor (BCR). 
am de in vivo rol van Btk gedurende de B eel differentiatie te bestuderen hebben we 
transgene muizen modellen ontwikkeld, waarin wildtype of gemuteerd humaan Elk tot expressie 
wordt gebracht. Het doel van het onderzoek, beschreven in dit proefschrift, was het bestuderen van 
de rol van Btk gedurende de individuele stappen van de B eel differentiatie, om de centrale vraag, 
waarom in XLA patienten de B eel ontwikkeling is geblokkeerd op het niveau van de pre-B eel, te 
beantwoorden. 
Hoofdstuk 1 vonnt de algcmene inleiding en geeft een overzicht van de B eel ontwikkeling 
in muizen. Verder is in dit hoofdstuk de identificatie en klonerlng van Btk besehreven, alsmede de 
klinische and moleculaire aspecten van XLA en xid. 
Hoofdstllk 2 besehrijft een Btk-deficient mllizenmodel, dat werd verkrcgen door inactivatie 
van het Btk gen door middel van een in-frame insertie van een LaeZ reporter gen door homologe 
reeombinatie in embryonale stameellen. Door het fenomeen van X-ehromosooUl inactivatie in Btk+!-
heterozygote vrouwtjes muizen, waren we in staat de competitie tussen vroege B eellen die het 
wildtype Btk allel en B eellen die het Btk'/LacZ allel tot expressie braehten te onderzoekeu, 
gedurende elke opeenvolgende stap van de B eel ontwikkeling. Ondanks het feit dat Blk al in pro-B 
eellen tot expressie kwam, trad het eerste selectieve nadeel voor Btk~deficiente B eellen op bij de 
overgang van het kleine pre~B eel stadium naar het immature B eel stadium in het beenmerg. Een 
tweede bJokkade in de differentiatie werd gevonden tijdens de maturatie van het IgMhooglgD'aall naar 
IgM'alllIgDhoog B eel stadium in de perifcrie. 
Hoofdstuk 3 beschrijft de ontwikkeling van twee transgene l11uizen stammen, waarin de 
expressie van het humane Blk gen wordt verzorgd door regulerende elementen die aanwezig zijn op 
cen 340-kb transgen. Dit transgen (Yc340~hBtk) bestond uit een 'yeast artificial chromosome' 
(YAC), met het Elk gen en-lOa kb DNA aan de 5' zijde en-200 kb DNA aan de 3' zijde. Het 
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expressic patroon van het transgene humane Blk kwam overeen met dat van het endogene muize Blk. 
Na het inkmisen van de Yc340-hBlk transgene muizen op een Blk-deficiente achtergrond, werd het 
xid B eel defect volledig gecorrigeerd. \Ve coneluderen dat expressie van humaan Blk, de 
afwczigheid van Btk in de muis kan eompenseren en dat in de Y AC-transgene muizen de 
regulerende elementen die aanwezig zijn op de 340-kb YAC zorgen voor eenjuiste expressie van het 
humane Blk. 
Hoofdstuk 4 besehrijft de ontwikkeling van YAC-transgene muizen stammen waarin 
humaan Blk werd geexpresseerd door een 240 kb YAC transgen, Yc240-hBlk, dat het hele Blk gen 
bevat en -6 kb 5' DNA en -200 kb 3' DNA. Het inkmi,en van de Yc240-hBtk tran'gen op een Btk-
deficiente aehtergrond herstelde de B eel ontwikkeling voHedig. Met behulp van intracellular flow 
cytometrie werd gevonden dat de expressie patroncn en expressie niveaus van het transgene humane 
Blk overeen kwamen met die van het endogene muizen Btk gen. 
Ais eerste stap in de identificatie van regulerende elementen, betrokken bij de regulatie van 
Blk expressie, werden 'DNAseI hypersensitive sites' (HSS) in kaart gebracht. Er werden negen HSS 
gevonden, waarvan er een B cel specifiek bleek te zijn en geconserveerd bitmen rnuis en mens. 
Verder laten we zien in ill vitro experimenten, dat de transcriptiefactoren Spl, Sp3 en PU.I samen in 
staat waren de Blk promoter additief te activeren, maar dat de afwezigheid van Spl of Sp3, door 
specifieke inactivatie van het desbetreffcnde gen, niet resulteerde in vennindering van Blk expressie 
niveaus ill vivo. 
Hoofdstuk 5 beschrijft de ontwikkeling van transgene muizen, waarin Blk expressie wordt 
gereguleerd door de 'Major Histocompatibility Cluster' (MHC) class II Ea genlocus control region. 
Overexpressie van Btk had geen significante effecten op de functie van B cellen en corrigeerde in 
essentie het xid fenotype. Expressie van een E41K gemuteerde vonn van Btk, resulterend in 
constitutieve activatie, leidde tot eell B cel defect dat ernstiger was dan xid. In deze transgene 
muizen was het B eel compartiment in de milt, lymfknoop, perifeer bloed en in de buikhoHe, sterk 
gereduceerd. De semm concentraties van de meeste antistof sub-klassen gingen omlaag naarnlate de 
muize ouder werden en ill vivo B cel waren in essentie afwezig. Onze resultaten laten zien dat de 
ontwikkeling van folliculaire reeirculerende B cellen werd geblokkeerd door de expressie van 
constitutief actief Btk. Expressie van de E41K gemuteerde Btk verhoogde de vonning van B eel 
blasten cellen van B eellen uit de milt na anti-IgM stimulatie ill vitro. 
Hoofdstuk 6 beschrijft de ontwikkeling van transgene muizen waarin expressie van het 
E4lK gemuteerde Btk wordt gereguleerd door de humane CD19 promoter. In deze muizen trad een 
blokkade op in de differentiatie van het IgM1Ug naar het IgMboogIgD- immature B eel stadium in het 
beenmerg. De fraetie van Ig '}." lichte keten expresserende eellen was verhoogd, in tegenstelling tot 
Btk-deficiente muizen, waarin deze fractie juist was verlaagd. Samen met de waargenomen 
opeenhoping van Btk- eellen binnen het kleine pre-B cel stadium suggereren deze bevindingen dat 
Btk is hetrokkell bij de regulatie van Ig lichtc keten assemblage tijdens de differentiatie van het pre-
B naar het immature B eel stadium, samenvallend met de blokkade in de B eel ontwikkeling in XLA 
patienten. 
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Hoofdstuk 7 bediscussieert de gepresenteerde reslIllaten van dit proefsehrift en geeft een 
overzicht van de rol van Btk in de B eel ontwikkeling. Onze resultaten in de mnis gevell aan dat Btk 
tot expressie komt gedllrende de hele B cel ontwikkeling en dat signalering eascades, geaetiveerd 
door Btk, kritiek zijn op verscheidende eontrole punten in de B eel differentiatie. \Vanneer Btk 
defect is, is de ovcrgang van het kleille pre~B eel stadium naar de IgM+ immature B eel stadium 
gestoord en het percentage Ig A, liehte keten expresserende eeJlen significant verlaagd. Oit belekent 
dat Blk betrokken zon kUlmen zijn bij her~expressie van de recombinatie activerende genen, die 
verantwoordelijk zijn voor de recombinatie vall Ig gen segmellten, de regulatie in toegangkelijkheid 
van de Ig Iichte keten gen segmenten voor het recombinase eomplex, of de overleving van kleine 
pre~B eelIen, die bezig zijn met Ig L keten reeombinatie. Expressie van het CD19~hBtlfA1K transgen 
resulteerde in een blokkade in de progressie naar het IgMboo8IgO- immature B eel stadium. Oit geeft 
aan dat Btk een fUlletie heeft in de BCR signalering route die verantwoordelijk is voor de eliminatie 
van auto~reactieve B eellen. Een vergeJijkbare rol voor Btk, maar in een later stadium van de B eel 
ontwikkeling, werd gevonden in muizen die het MHCII~hBt~4IK transgen tot expressie braehlen, 
hetgeen resulteerde in een blokkade in de ontwikkeling van recirculerende follieulaire B eellen. In de 
periferie blijkt Btk essentieel voor B eel overleving en maturatie, hetge~n betekent dat Btk betrokken 
is bij de basale BCR signaiering, die essentieel is voor het sturen van de B eel ontwikkeIing. 
Tenslotte geeft het fenotype van de CO 19~1illt~41K trans gene muizen aan dat aetivatie van Btk in 
perifere B cellen de differentiatie naar IgM+ plasma cetlen stimuleert. 
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Abbreviations MHC Major histocompatibility 
complex 
Ab Antibody NK Natural killer 
Bp Basepair PD Properdin deficiency 
BCR B cell receptor PH Pleckstrin homology 
BM Bone marrow PI3-K Phospho~inositol-3 kinase 
Btk Bmton's tyrosine kinase PI Phosphalidylinositol 
C Constant PLC Phospholipase C 
CD Cluster of designation PKC Protein kinase C 
CDR Complementary detemlining PTK Protein tyrosine kinase 
region RAG Recombination activating gene 
eM Centimorgan RFLP Restiction fraugment lcnght 
CRAC Calcium release activated polymorphism 
calcium RSS Recombination signal sequence 
CREB cAMP response element SH Src~homology 
binding protein SHIP SH2 containing inositol 5 t ~ 
D Diversity phosphatase 
DAG Diacylglycerol Sos Son of Sevenless 
DNP 2,4-dinitrophenyl SRE Semm response element 
ER Endoplasmic reticulum TCR T cell receptor 
FDC Follicular dentritc cell TD Thymus dependent 
FISH Fluorenscense in situ TH Tec homology 
hybridization TH T helper cell 
FITC Fluorescein isothiocyanate TI-I Thymus independent class I 
FR Framework region TI-II Thymus independent class II 
GC Genninal center TNP 2,4, 6~ trinitrohenzenesll I fon i c 
H Heavy acid 
hBtk Human Blk UTR Untranslated region 
Ig Immunoglobulin V Variable 
IL Interleukin WAS Wiskott-Aldrich syndrome 
IP, Inositol 1 A,5~triphosphate WASP Wiskott-Aldrich syndrome 
ITAM Immunoreceptor tyrosine~based protein 
activation motif X-CGD X~linked chronic 
ITIM Immunoreceptor tyrosine~based granulomatous disease 
inhibitory motif Xld X~linked ioununodeficiency 
J Joining XLA X~linked agammaglobulinemia 
Kb Kilobase XLP X~linked lymphoproliferative 
KDa Kilodalton syndrome 
Kde K deleting element XSCID X~linked severe combined 
KLH Keyhole limpet hemocyanin immunodeficiency 
L Light 
LCR Locus control region 
MAP Mitogen activated protein 
MAPK Mitogen activated protein 
kinase 
Mb Megabase 
mBtk murineBtk 
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